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ABSTRACT 
The worldwide increasing demand for medicine from natural sources motivated our 
research group to search for plants with potential cardiovascular effects. Medicinal 
plants have been and continue to be used by over 80 % of people in the developing 
countries. Most of the African medicinal plants contain triterpenoids. Recent reports 
have shown that triterpenoids may have antihypertensive effects in rats. This result was 
surprising since unlike diterpenes, triterpenoids are not generally considered as 
hypotensive, and their cardiovascular effects have not been researched. This prompted 
our investigation on the cardiotonic and antiarrhythmic effects of these triterpenoids. We 
screened 16 African medicinal plants for their triterpenoids content and cardiovascular 
effects. The working hypothesis of this study was that if triterpenoids of plant origin 
have cardiotonic and antiarrhythmic effects in addition to their hypotensive effect, they 
might provide cheap and accessible treatment for hypertension complicated with cardiac 
failure and stenocardia in developing countries. 
Upon identification and authentication of the plants by a botanist, leaves were collected 
and air-dried. The dried leaves were grounded before subjecting the plant material to an 
extraction process. We subjected the crude ethyl acetate extracts of each of the 16 plants 
to a further isolation and purification process that yielded four different triterpenoids 
namely, oleanolic acid (OA), ursolic acid (UA), uvaol (UV) and methyl maslinate (MM). 
The spectral properties of these triterpenoids were identical with literature values. Acute 
toxicity was evaluated using brine shrimp bioassay, and optimal, non-toxic dose for in 
vivo application was defined. 
v 
Blood pressure measurements were done using both the direct method and tail-cuff 
method. Urinary parameters were evaluated in urine collected from treated animals 5 and 
24 hours after the administration of the test compounds. Antiarrhythmic effects were 
investigated in both chemically induced arrhythmia and mechanically induced 
arrhythmia. For chemically induced arrhythmia, we used the CaCh-, BaCh-, and 
adrenaline models of arrhythmia. For the ischaemia-reperfusion induced arrhythmia, we 
used the coronary artery ligationireperfusion model. The cardiotonic effects of the 
triterpenoids and the phytochemicals were evaluated in electrically driven left atria 
isolated from reserpinised guinea pig and in anaesthetised rats. 
All the triterpenoids and some of the phytochemicals showed a significant dose-
dependent vasodepressor effect and sinus bradycardia that lasted for more than 1 hour 
from drug application. The test compounds had a diuretic and natriuretic effect that was 
comparable to that of hydrochlorothiazide. The isolated triterpenoids had a protective 
effect against adrenaline- and BaCh- induced arrhythmias but not on CaCh-induced 
arrhythmia. The protective effects were comparable to that of a class II agent for the 
former and class III for the latter. In terms of the ischaemia-reperfusion model, the 
triterpenoids conferred a protective effect that was comparable to that of Classes II and 
IV antiarrhythmic agents. The triterpenoids showed a positive inotropic effect that 
involved p-adrenergic receptors. 
Therefore, evidence provided in this study indicated that triterpenoids have hypotensive, 
cardiotonic and antiarrhythmic activities. Since the triterpenoids have been demonstrated 
to be present in many of the medicinal plants of Southern Africa, the triterpenoids would 
provide a cheap and accessible traditional medicine source for the treatment of 
hypertension, complicated with stenocardia and cardiac failure. 
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1.0 INTRODUCTION 
In developed countries and in developing countries alike, hypertension affects 25-35% of 
the adult population, and up to 60-70% of those beyond the seventh decade of life 
(Staessen et ai., 2003). The World Health Organisation ranks hypertension as the third 
leading killer in the world since high blood pressure causes one in every eight deaths 
worldwide (WHO, 2002). Recent reports have shown that contrary to earlier reports, cases 
of hypertension are back on the increase in the United States of America (Hajjar and 
Kotchen, 2003). There are also reports that show that hypertension and its associated 
cardiovascular diseases are increasing in epidemic proportions in developing countries to 
the extent that it was envisaged that by 2010, cardiovascular diseases would be the number 
one cause of death in both developing and developed countries (Gandhi, 1997). 
Hypertension is rampant among blacks in Africa just as is the case amongst blacks in 
America (Seedat et ai. , 1978; Sefiel et ai., 1980; Seedat et ai. , 1984; Greffer et ai. , 1994; 
Gillum, 1996; Hajja and Kotchen, 2003). In South Africa, hypertension is one of the five 
major diseases that need emphasis since there is an increase in the risk factors for 
cardiovascular diseases. F or instance, urban black Africans are consuming a lot of fat, 
there is an increase in smoking rates and alcohol consumption amongst them (Sefiel, 1985; 
Yach and Townshed, 1988; Bourne et ai. , 1993). 
There have been great strides made in the diagnosis and treatment of hypertension and 
cardiovascular diseases. However, most of these treatments are too expensive and 
inaccessible to the majority of the population in the developing countries. This problem is 
exacerbated by the fact that most developing countries are undergoing economic problems 
that are resulting in reduction of budgetary spending on health services. For instance, sub-
Saharan Africa has 38 of the world' s 63 low-income countries where 40% of its 500 
2 
million people have less than US $1 a day to live on (World Bank report, 2002). 
Governments' spending on health is also undermined by debt repayment burden and cost of 
conflicts that are going on within the continent. Overall, most African countries have a 
shortage of money and face increasing restrictions and pressure in their efforts in health 
promotion and practices. 
The economic problems facing the African population and the poor health infrastructure 
call for easily accessible and cheap treatment for most diseases like hypertension. This 
need has seen an increased interest in new therapy for hypertension from natural sources. 
These natural remedies would be used either as substitutes for the costly western-type 
drugs or as adjuvant to the western-type medicine. The obvious natural sources of 
treatment are the medicinal plants that are readily available in Mrica. Medicinal plants 
with potential therapeutic values for hypertension would be both cheap and accessible to 
the people in developing countries. The other advantage of using medicinal plants as 
treatment for hypertension is that people would easily comply in taking the full dosage 
since the use of medicinal plants is part of their culture. It is estimated that more than 80% 
of the world's population relies on medicinal plants for the primary health care needs 
because modem drugs are either unobtainable or prohibitively expensive (Chiwuzie et ai. , 
1987; Groombridge, 1992; WHO/IUCN/WWF, 1993). Thus, despite the considerable 
progress made in conventional medicines and the establishment of several health 
institutions, traditional medicine continues to flourish and the scientific interest in it is 
increasing globally. It is with this in mind that the World Health Organisation (WHO) has 
set aside 31 st August as the African traditional medicine day with 2000-2010 as the decade 
for African traditional medicine (WHO, 2003). 
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The increase in hypertension among Africans and the need for cheap and accessible 
treatment for hypertension lead our research group to look for plants with cardiovascular 
properties. Preliminary work was done with the leaves from African wild olive plant (Olea 
europaea, subspecies africana). Olive leaves have been used for treating cardiovascular 
diseases for centuries and its hypotensive, hypoglycaemic, antiarrhythmic, coronary vessel 
dilating effects have been documented (Petkov and Manolov, 1972; Ribeiro et al. , 1986; 
Zarzuelo et al. , 1991; Fehri et al. , 1994; Cherif et al. , 1996). These reports of the 
therapeutic values of the European olive leaf prompted us to check whether the African 
subspecies would have similar effects. Olea europaea subsp. africana is widespread 
throughout Southern Africa and northwards through East Tropical Africa (Neuwinger, 
1994). According to Hutchings et al. , (1996), the plant is used in traditional medicine as a 
diuretic, hypotensive, emollient, tonic for urinary and bladder infections, and for 
headaches. The preliminary work with wild olive leaves revealed that indeed the plant had 
antihypertensive, antiatherosclerotic and antioxidant activities. Comparative work on Olea 
europaea L. and Olea europaea subspecies africana showed that there were chemical 
differences in the active principles of the two species (Somova et al., 2003a). This 
suggested that the active principles of the African wild olive had different chemical 
structure and activity from that of the European olive plant. 
Studies on the Olea europaea L. (European olive) have attributed the hypotensive, 
coronary vessel dilating and antiarrhythmic action to a glycoside called oleuropein. There 
are also reports that secoiridoid oleacin isolated from Olea europaea L. by fractionation, 
has a distinct angiotensin converting enzyme inhibitory effect (Hansen et al. , 1995) and an 
anti-oxidant activity (Bruneton, 1995). Thus, the cardiovascular effects of the extracts 
from the European olive leaves have been attributed to the two secoiridoids, oleuropein and 
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oleacein. On the other hand, the studies with the Olea europaea subsp. africana showed 
that the antihypertensive, antiatherosclerotic and antioxidant effects were due to the 
triterpenoids contained in the leaves (Somova et ai, 2003b). The particular triterpenoids 
were shown to be oleanolic acid and ursolic acid. These activities of these two 
triterpenoids were a surprising observation since to the best of our knowledge, there is no 
report of the hypotensive effect that was attributed to these triterpenoids. However, 
Lindner et at., (1978) have reported that diterpenes have cardiovascular effects. 
Triterpenoids are found ubiquitously in plants (Price et al., 1987; Liu, 1995). Many of the 
African medicinal plants used in folk medicine contain triterpenoids (Hutchings, 1989). 
Triterpene refers to a particular type of molecular structure that has a four or five ring 
molecular structure containing 30 carbon atoms (Hostettmann and Marston, 1995). It is 
synthesized from very simple compounds (acetate units) that are found in all plants, but 
mainly synthesized in higher plants (flowering plants) by linking the acetate units "head to 
tail". The triterpenes are subdivided into about 20 groups depending on their particular 
structures. The base structure found in the largest variety of medicinal plants is the 
oleanane triterpene. This type of compound is represented by four of the most frequently 
occurring forms; oleanolic acid, ursolic acid, alpha-amyrin and beta-amyrin (the latter three 
are sometimes put in the subdivision of ursane triterpenes). There are two adverse effects 
of triterpenoids when the dosage is too high, and these are haemolytic effect and nauseating 
effect (Dharmananda, 2000). 
The main biopharmacological effects attributed to triterpenoids such as oleanolic acid and 
ursolic acid as listed by Duke (1992) and Liu (1995) are: anti-inflammatory (Tsuruga et al., 
1991; Simon et al., 1992; Han et al., 1997; Ringbom, et al., 1998; Honda et al., 2000); 
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hepatoprotective (Ma et at., 1982; Saraswat et ai., 2000; Kuzuhara et at., 2000); anti-
diabetogenic (Liu et ai., 1994; Matsuda et ai., 1998; Yoshikawa and Matsuda, 2000; 
Taniguchi et ai., 2002); anti-oxidant (Balanehru and Nagarajan, 1991; Kitani et at., 1999; 
Zhang et at., 2001; Somova et at., 2003); anti-hyperlipidemic (Ma, 1986; Liu et at., 1987); 
anti-ulcer (Gupta et at., 1981; Wrzeciono et at.,1985; Farina et at., 1998); and more 
importantly cardiotonic and diuretic (cited by Duke, 1992). There have also been reports 
that oleanolic acid and ursolic acid may have anti-HIV activity (Kashiwada et at., 1998 and 
2000). Recently it has also been reported that oleanolic acid may have the potential of 
being used as a male contraceptive agent as it has been shown to induce 100 % reversible 
contraception in male rats and mice (Rajasekeran et at., 1988; Mdhluli and Van der Horst, 
2000). Triterpenoids have also been used as antispasmodic agent (Mata et aI., 1996). 
Physiologically, a combination of the hypotensive effect of the triterpenoids as shown by 
our preliminary work, and the cardiotonic effect, as cited by Duke (1992), is contradictory 
but of high therapeutic value, ideal for treating complicated hypertension. Presently, no 
pharmacological drug that has both the hypotensive and cardiotonic effects exists. Thus, 
different drugs are used for lowering blood pressure and stimulating the heart. This makes 
the treatment of hypertension to be very costly. Moreover, the total number of 
hypertensive subjects in the developing countries is very high, and a cost analysis of 
possible antihypertensive drug treatment indicates that these countries can not afford the 
same treatment as is used in developed countries (Nissinen et ai., 1988). 
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AIM 
The aim of this study was to investigate the cardiovascular effects of triterpenoids of plant 
origin obtained from South African medicinal plants. 
Working Hypothesis 
We hypothesized that if triterpenoids of plant origin like oleanolic acid and ursolic acid 
have, in addition to their hypotensive effect, antiarrhythmic and cardiotonic effects as well, 
they might provide cheap and accessible traditional medicine source for treatment of 
complicated hypertension in developing countries. 
OBJECTIVES 
1. To screen African medicinal plants with suggested triterpenoids content. 
2. To find out whether there is interdependent link between the chemical structures of the 
triterpenoids isolated from the African medicinal plants and specific cardiovascular 
biological activity like hypotensive, diuretic, cardiotonic and antiarrhythmic. 
3. To clarify the mechanisms of action of the above cardiovascular effects. 
4. To establish whether the expected cardiovascular effects have potential therapeutic 
value on various experimental models of hypertension. 
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2.0 LITERATURE REVIEW 
2.1 HYPERTENSION 
Hypertension is a frequent, chronic, age-related disorder that often entails debilitating 
cardiovascular and renal complications (Staesssen et ai., 2003). Long term hypertensives 
often have other cardiovascular risk factors including elevated cholesterol levels, reduced 
high-density lipoproteins, diabetes, left ventricular hypertrophy and obesity. Hypertension 
imparts an increased risk of stroke, myocardial infarction, heart failure and renal failure. 
Many clinical trials have shown that incidences of these cardiovascular risks can be 
reduced by a reduction in blood pressure (August, 2003; Chobanian et ai., 2003). 
Hypertension is a complex trait that is affected by multifactor genetic and environmental 
factors in varying combinations rendering it difficult to treat. Cohn (1998) defines 
hypertension as a state of abnormal arterial function and structure associated with 
endothelial dysfunction, vascular smooth muscle constriction or remodelling, increased 
impedance to left ventricular ejection and propensity for atherosclerosis, often but not 
always manifested by an elevated blood pressure. Human hypertension is usually a slowly 
developing disorder of middle to old age that predisposes to cardiovascular disorders that 
cause most of the morbidity and mortality in the elderly. The incidence and sequela of 
hypertension vary markedly depending on the subgroup of the patient for instance gender 
and race (Cooper and Kaufman, 1998; O'Donnell and Kannel, 1998). In the USA, it has 
also been shown that during the past decade there was a high proportion of hypertensive 
people in non-Hispanic blacks than in any other race, and that women had less incidences 
of hypertension than males (Hajjar and Kotchen, 2003). 
8 
Human hypertension is probably triggered by environmental influences acting on a genetic 
predisposition. Examples of these environmental influences are; physical inactivity, excess 
sodium intake, excess alcohol consumption, obesity particularly visceral, acquired or 
congenital reduction of nephrons number (Barker et al., 1992; Hall et al., 1992; Barenbrock 
et al., 1995; Kaplan, 1995; Woelk, 1995; Rosmond and Bjomtorp, 1998; Keller et al., 
2003). Specific genes responsible for hypertension have not been identified though there 
has been a lot of break through in the past decade that have led to the discovery of 17 
human genes that cause mendelian forms of either hypertension or hypotension (Nabel, 
2003; Staessen et al., 2003). 
In general there are two kinds of hypertension, namely essential also known as primary 
hypertension and secondary hypertension. Essential hypertension is loosely defined as an 
elevated blood pressure above a predetermined cut off point that result from an unknown 
underlying cause. On the other hand, secondary hypertension results from an underlying, 
identifiable and often correctable cause (Onusko, 2003). According to the World Health 
Organisation as well as the American National Heart, Lung and Blood institute, a person is 
considered to be hypertensive if their average systolic blood pressure is more than 140 mm 
Hg and/or their average diastolic blood pressure is more 90 mm Hg (WHO Guidelines, 
1999; Chobanian et al., 2003; Haggar et al., 2003). For patients with diabetes or chronic 
kidney disease, the cut off point for systolic blood pressure is 130 mm Hg whilst the for 
diastolic blood pressure is 80 mm Hg (Chobanian et al., 2003; Haggar et al., 2003) 
2.1.1 Secondary Hypertension 
Only about 5 to 10 % of hypertension cases are thought to result from secondary causes. 
Secondary hypertension is curable because once its cause is identified it can be treated. 
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Some of the causes of it are; Cushing' s syndrome, coarctation of the aorta, diseases of the 
kidneys and urinary tract like nephritis, diabetes, amyloid contracted kidney, chronic 
pyelonephritis, disease of the renal arteries, obstructive sleep apnoea, aldosteronism, 
endocrine disorders, excess catecholamines, excess erythropeietin and drugs (Pickering, 
1995; Onusko, 2003). In most cases, the above causes can lead to pulmonary hypertension 
or renal hypertension. 
2.1.2 Essential Hypertension 
Essential hypertension affects around 90 % of the hypertensive population. Although it is 
said to have no known cause, its pathophysiology depends on a number of factors like the 
inability of the kidney to excrete electrolytes like sodium at a normal blood pressure, 
malfunction of the central nervous system, endocrine factors and diseased blood vessels (Ie 
Noble et al. , 1998; Staessen et al. , 2003). Blood pressure deregulation is also caused by 
genetic factors, both monogenic and polygenic factors. These genetic factors are said to 
contribute approximately 30 -50 % of the variation in blood pressure between individuals 
(Dominiczak et al. , 1998). It is also thought that in essential hypertension, the number of 
nephrons is reduced though it is not known what determines this reduction though the intra-
uterine events are thought to playa major role (Ingelfmger, 2003; Keller et al. , 2003). 
From here on hypertension will refer to essential hypertension. 
2.2 DIAGNOSIS OF HYPERTENSION 
Hypertension is diagnosed mainly through the measurement of blood pressure in 
combination with other parameters like electrocardiogram, urinalysis, complete blood 
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count and blood chemistry profile (e.g. potassium, sodium, creatine, fasting glucose, fasting 
lipid levels). These parameters determine the cardiovascular risk factors that are associated 
with hypertension. Although new methods of assessing hypertension are being introduced, 
conventional blood pressure measurement remains the standard method of determining 
hypertension. 
As said before, a blood pressure reading of more than 140/90 mm Hg is defined as 
hypertensive. This reading is supposed to be an average of at least two reading taken on 
different times. Hypertension is further classified into stages (refer Table. 1). 
2.3 REGULATION OF BLOOD PRESSURE 
Arterial blood pressure is the product of cardiac output times total peripheral resistance. It 
is monitored continuously by baroreceptors in the cardiopulmonary region and in the 
carotid sinus. The baroreceptors transmit their information to the vasomotor center in the 
central nervous system. The vasomotor center in turn changes afferent sympathetic tone, 
regulating cardiac output and peripheral vascular resistance (Osswald and MUhlbauer, 
1995). 
The physiological regulatory systems for blood pressure include neurotransmitters and 
humoral factors acting on the cardiac and vascular smooth muscle and endothelium. 
Excessive vasoconstriction, commonly involving the endogenous peptides, angiotensin II, 
endothelin, or deficient vasodilatation, often involving nitric oxide (NO), are common 
mechanisms in hypertension. Functional changes that have been implicated to playa role 
in hypertension include structural vascular changes, sodium retention by the kidneys, 
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increase in sympathetic activity, abnormalities in the rennin-angiotensin system and the 
integrity of the endothelium. 
Table 1 Classification of blood pressure 
Category Systolic blood pressure Diastolic blood pressure 
(mmHg) (mmHg) 
Normotension 
Optimal < 120 < 80 
Normal < 130 < 85 
High normal 130 -139 85 -89 
(prehypertesive) 
Hypertension 
Stage 1 (mild) 140 - 159 90-99 
Stage 2 (moderate) 160 - 179 100 - 109 
Stage 3 (severe) 180 -209 110 -119 
Stage 4 (malignant) ~210 ~ 120 
Isolated systolic ~ 140 <90 
hypertension 
Adapted from Staessen et al. , (2003) with slight modifications. 
2.4 MODELS OF HYPERTENSION 
Since most cases of hypertension are of unknown causes, it is difficult to study the 
underlying causes in humans. Thus, in additional to clinical studies of hypertension, most 
of the studies are done in animals in what is called experimental hypertension using animal 
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models. As hypertension is a complex trait due to a combination of genetic and 
environmental factors, it is impossible to study all the possible causes in just one model and 
as such different models have . and are being developed to study a particular aspect of 
hypertension. Animal models have allowed the study of hypertension and cardiovascular 
diseases in the early stages as well as the investigation of the mechanisms of the 
pathogenesis and the effects of drug intervention. These models have their advantage over 
humans because they include complete genetic homogeneity, large number of progeny can 
be obtained, and it is possible to produce large genetic crosses. In addition, an investigator 
can tightly control the environmental influences unlike in humans. The animals that are 
mostly used are dogs, rabbits, cats and rats. The rat is mostly preferred over the other 
animals because its use is rational from the economical viewpoint and for the fact that 
many techniques have been developed to measure relevant functional parameters. Rat 
models of hypertension developed by selective breeding over many generations have been 
in use for a long time (Smirk and Hall, 1958; Dahl, Heine and Tassinari, 1962; Rapp, 
1982). On the other hand, rat models of hypertension posses a number of problems. For 
instance, cardiovascular diseases like hypertension and heart failure in humans usually 
slowly develop with wide ranging neurohumoral adaptations in contrast to the acute onset 
of symptoms in many surgical or drug induced rat models of these diseases. Secondly, 
hypertension is uncommon in young humans but markedly increases with age yet most 
models of hypertension use young adult rats (Doggrell and Brown, 1998). 
2.4.1 Spontaneously hypertensive rats (SHR) 
This is the most used model of cardiovascular disease with the wistar Kyoto rat (WKY) as 
the normotersive control. SHR are descendants of an outbred wistar male with 
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spontaneous hypertension from a colony in Kyoto, Japan, mating with a female with 
elevated blood pressure (Doggrell and Brown, 1998). The brother vs. sister mating is 
continued with selection for spontaneous hypertension, defined as a systolic blood pressure 
of over 150 mm Hg persisting for more than one month. As in humans, hypertension 
becomes more severe in males than females. Thus, male SHRs are commonly used as a 
model of established human hypertension. 
SHR has the disadvantage of only modelling one of the many possible causes of human 
hypertension due to its lack of inter-individual variation. However, it has a number of 
advantages for studying human hypertension. Firstly, it is useful for mapping and 
identifying genes responsible for developing hypertension since it is an inbred genetic 
model. Secondly, it follows the same progression of hypertension as human hypertension 
with pre-hypertensive, developing and sustained hypertensive phases with each phase 
lasting at least several weeks. Lastly, the SHR is a useful model since compounds that 
lower blood pressure in SHR also lower blood pressure in hypertensive humans and as 
such, it is used to test new antihypertensive medication (Doggrell and Brown, 1998). 
2.4.2 Stroke-prone Spontaneously hypertensive rats (SHR-SP) 
The SHR-SP was developed to study stroke since hypertension is the major risk factor for 
stroke. These rats are hypertensive at five weeks and systolic blood pressure rises to at 
least 250 mm Hg in males. Salt loading has been shown to accelerate the development of 
hypertension and the occurrence of stroke (Okamoto, Yamori and Nagaoka, 1974). The 
disadvantage of this model according to Doggrell and Brown (1998) is that the rats die at a 
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very young age and as such, the model misses out the common age at which strokes are 
common in humans, which is above the fourth decade of life. 
2.4.3 Dahl/Rapp salt-sensitive rats 
Understanding salt-sensitive hypertension has been helped by the introduction of the inbred 
rat models, especially the DahllRapp salt-sensitive and salt-resistant rats. The development 
of hypertension and heart failure in these rats can be controlled by titration of the amount of 
salt in their diet. As is the case in most rat models of hypertension, the development of 
hypertension is more rapid and greater in males than female rats. When both the salt-
sensitive and the salt-resistant strains are fed a higher salt diet (8 % NaCl) , the salt-
sensitive strain express a significantly increased sodium and water retention, and an 
increased activity of the sympathetic nervous system (Dahl et al., 1962; Rapp, 1982; 
Somova, Channa and Khan, 1999). It has also been shown that the adrenal gland of the 
Dahl salt-resistant strain produce less 18-hydroxydeoxycorticosterone (18-0H-DOC) than 
that of the salt - sensitive strain and that the circulating levels of 18-0H-DOC were lower 
in the former (Kurtz, 1995). These genetically induced alterations in the levels of 18-0H-
DOC are thought to contribute to the relative salt resistance of the Dahl salt-resistant strain. 
This model therefore provides an interesting model for the interaction of an environmental 
factor (salt in this case) with genotype. This is a more relevant model to study 
hypertension in sub-Saharan Africans where studies have shown that most of the 
hypertension amongst the population is salt-sensitive (Mufunda and Somova, 1993). It has 
also been shown that blacks retain a lot of sodium and that there is a greater prevalence of 
salt sensitivity among blacks compared with white adults and children (Luft et al., 1991; 
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Wilson et ai., 1992; Edwards, 1995). It has also been shown that in black adolescents, 
boys are most likely to be identified as salt sensitive based on sodium load than girls 
(Wilson et ai., 1996). The other advantage with this model is that it is easy, non-invasive, 
relatively quick and consistent thereby making it easy to be used by any laboratory without 
any need of expertise. 
2.4.4 Diabetic hypertensive rats 
Diabetes is an important risk factor in patients with hypertension and heart disease. The 
common model for diabetes in rats is obtained by administering streptozotocin to adult rats. 
Rapid injection of streptozotocin to adult rats produces many of the characteristic 
cardiovascular and renal features of humans with uncontrolled insulin-dependent diabetes 
(type 1 diabetes mellitus). Other studies have injected streptozotocin to spontaneously 
hypertensive rats (SHR) to produce a model of hypertensive insulin-dependent diabetic 
humans (Doggrell and Brown, 1998). Streptozotocin selectively destroys Beta W) cells of 
the pancreas (Grussner et ai., 1993) thereby impairing insulin production leading to 
hyperglycaemia. Any changes occurring thereafter are considered related to the induced 
hyperglycaemia. Complications of diabetes mellitus such as impairment of kidney function 
can therefore be studied using this model. However, this model is criticized for not being 
appropriate for most humans since most diabetic patients suffer from non-insulin dependent 
diabetes (type 2 diabetes mellitus). Thus, the more relevant model to type 2 diabetics is the 
genetically determined obese Zucker rat or the Otsuka Long-Evans Tokushima fatty rats 
(Doggrell and Brown, 1998). These two models develop mild hypertension with typical 
cardiac and renal complications. 
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2.4.5 Transgenic Rats 
Transgenic techniques are now increasingly being used since they offer the possibility of 
analysing responses to selected genes. In transgenic animals, overexpression or 
suppression of individual candidate genes involved in hypertension permits a systematic 
testing of gene function, regulation, and its relationship to a particular phenotype 
(Hoffmann et al., 1995). Transgenic rats develop hypertension, hypertrophy and heart 
failure. The commonly used species for transgenic experiments is the mice. An example 
of a transgenic model is the murine Ren-2 gene that has been used to generate transgenic 
rats to study the rennin-angiotensin system and its contribution to the cardiovascular 
system. Male rats have a sustained angiotensin II-dependent increase in blood pressure 
with low circulating rennin levels (Hoffmann et al., 1995; Doggrell and Brown, 1998). 
According to Staessen et al., (2003), some experts favour the whole genome approach and 
exploit synteny between species in the search for major genes that could lead to 
hypertension. Inbred rats and genetically engineered mice, in which gene activities have 
been specifically manipulated, produce new insights in the long-term regulation of blood 
pressure. However, these rodent models do not stand comparison with the complexity and 
heterogeneous nature of the human disease. 
2.4.6 Models for studying renovascular hypertension 
The kidney has long been known to be vital in cardiovascular homeostasis though renal 
damage is a relatively minor cause of human hypertension. The importance of the kidney 
in hypertension has recently been emphasized in studies of the number of nephrons in 
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relation to hypertension. In this study, it was observed that white hypertensives have very 
few nephrons than normotensive subjects (Keller et ai., 2003). Renovascular hypertension 
develops in response to renal ischaemia and models for it involve restricting blood flow by 
clips on the renal arteries as first described in the classical Goldblatt experiments 
(Goldblatt, 1995). 
The three common models are; Firstly, the one-kidney one clip model (lKIC) that involves 
the removal of one kidney and the placement of a clip on the renal artery of the remaining 
kidney. Secondly, there is the two-kidney two clip model (2K2C) that involves clipping 
the renal arteries of both kidneys. This model mimics the bilateral renal artery stenosis in 
humans. Thirdly, there is the two-kidney one clip model whereby one clip is placed on the 
renal artery of one of the kidneys. The contra lateral kidney remains untouched. The 
major problem with the above models is that they induce a sudden increase in blood 
pressure unlike the slow onset of human hypertension. 
2.4.7 Models for Pulmonary hypertension 
In human pulmonary hypertension, pulmonary artery systolic and mean pressures exceed 
30 mm Hg and 20 mm Hg respectively at rest whilst during exercise the pulmonary artery 
mean pressure exceeds 30 mm Hg. Some of the causes of pulmonary hypertension are 
chronic hypoxia, congenital heart defects, autoimmune disease, thromboembolism, left 
sided heart failure, ingestion of anorexigens and over expression of angiopoietin-l in the 
adult lung (Du et ai., 2003). 
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There are two commonly used rat models for pulmonary hypertension and these are the 
monocrotaline model and the hypoxia model. In the former model, a subcutaneous 
administered single dose of a crotalaria alkaloid, monocrotaline, is made to rats. It is used 
as a non-invasive, slowly developing, and haemodynamically relevant model for 
pulmonary hypertension. In the hypoxia model, hypoventilation in rats by prolonged 
exposure to normobaric hypoxia is used to induce pulmonary hypertension. Hypoxia in rats 
produces pulmonary vascular remodelling and an increase in endothelin, a vasoconstrictor, 
resulting in hypertension. This model mimics the human disease better since alveolar 
hypoxia is often a stimulant of the pulmonary vasoconstriction that underlies the 
hypertension seen in humans ((Doggrell and Brown, 1998). 
The above rat models of hypertension are not exhaustive as there are other models that 
have not been mentioned here. Examples of those not mentioned are; Deoxycorticosterone 
acetate (DOCA) rats, Milan hypertensive strain (MHS), Lyon hypertensive rats (LH) and 
New Zealand genetically hypertensive rats (GH). 
2.5 MEASUREMENT OF BLOOD PRESSURE IN EXPERIMENTAL 
HYPERTENSION 
The recording of blood pressure in rats is one of the most widely used techniques in 
experimental hypertension. Experimental hypertension, defined as a sustained and long-
lasting blood pressure elevation, can only be shown to exist by measuring blood pressure 
repeatedly in the same animals. Preferably, the measurement should be done while the 
animals are conscious to avoid artefacts due to anaesthesia (Bufiag, 1991). Rats are the 
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preferred animals of choice due to amongst other reasons, their uniformity in body size and 
genetic background, relatively low costs, and the availability of several models of 
experimental hypertension as has already been described above. In principle, there are two 
techniques for measuring blood pressure in rats, that is the indirect measurement using the 
tail-cuff method, and the direct recording via arterial catheters. 
2.5.1 Indirect blood pressure recording 
All indirect methods require the use of a cuff for occluding the blood flow in a peripheral 
artery and thus this method is related to that used in humans. The blood pressure can be 
taken either from the rat tailor from a hind leg. The tail is the preferred area since rats use 
their tails for regulating body heat. This makes the tail vessels to aptly respond to stimuli 
that increase sympathetic vasomotor tone to induce localised vasoconstriction (Bufiag, 
1991). 
In principle, an annular occluding cuff applied to the base of the rat tail is inflated to 
occlude the arterial blood supply. Upon slowly deflating the cuff, the reappearance of 
pulsation (signifying resumption of blood flow) is taken as systolic blood pressure. 
Systolic blood pressure can also be determined when the pulsation disappears at inflating 
cuff pressure. Different sensors have been employed to identify pulsatile blood flow in the 
tail artery. These sensors operate based on plethsmographic instruments, microphones, 
ultrasonic sensors, piezo crystals, photoelectric devices, infrared-light sensors, or 
impedance techniques. In general, the sensor has to be sufficiently sensitive to detect the 
first arterial pulsation that appears as the occluding cuff is gradually deflated (Bufiag, 1991 ; 
Sponer et ai. , 1993). 
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With most tail-cuff methods, unanaesthetised rats have to be restrained and preheated 
during measurements. This may affect the reliability of the readings since restraint and 
heat may elicit substantial pressor effe.cts. Thus, in order to get reliable pressure values, the 
rats need to be accustomed to the conditions of pressure recording by means of a training 
program. The training consists of all parts of the procedure such as handling, restraining, 
warming up, and cuff-pressure increase and decrease. Most laboratories train their rats for 
five consecutive days prior to the starting of the actual experimental pressure readings. In 
this way, the rats become familiar with whole procedure thereby minimising stress 
reactions, and thus obtaining reliable pressure values. 
The advantages of using the tail-cuff method are firstly, that no surgical procedure is 
required before starting blood pressure reading. This makes it possible for the method to 
be used by anyone. Secondly, the method is appropriate for chronic experiments since it 
does not confer any serious risk to the health of the animal. On the other hand, the major 
limitation with this method is that it does not provide continuous recording of blood 
pressure. This makes it difficult for the method to be used in some pharmacological 
investigations where one might miss the peak effect of a drug in particular those with a 
short duration of action. 
When monitoring drug-induced responses it is advisable not to solely rely on the tail-cuff 
measurements due the possible errors that occur with this method. Therefore to verify the 
blood pressure values, it is advisable to validate the readings by comparing the values 
obtained simultaneously by the tail cuff method with those obtained by the direct method in 
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the same rats (Bufiag, 1991; Sponer et al. , 1993). Each laboratory is supposed to do its 
own validation whenever possible. 
2.5.2. Direct blood pressure recording 
Intra-arterial pressures can be recorded continuously by inserting catheters made of small-
bore tubing into suitable arteries like the carotid, iliac, femoral, caudal or renal arteries 
(Sponer et al. , 1993). The catheter is then connected to a mercury manometer or pressure 
transducer. 
The major advantage of this method is that the whole procedure can be done under almost 
physiological conditions with no requirement for warming, restraining or stress. The 
method also allows continuous recording of blood pressure. This make it appropriate for 
registering any rapid changes of blood pressure caused by the test drugs thereby allowing 
the determination of their peak effect. On the other hand, the method is not appropriate for 
chronic studies because of the risk to the healthy of the animal introduced by the surgical 
procedure. It is also unattractive because it requires trained technicians to prepare and 
implant the catheters. 
In order to reproduce authentic blood pressure values, a number of principles need to be 
followed. Firstly, the size and shape of the catheters must be adapted to the body weight of 
the animal as well as the artery where they are going to be implanted. Normally, rigid-
walled tubings (polyethylene or Teflon) are used to make catheters. Secondly, clot 
formation can be reduced by filling the catheters with dilute heparin solution and also all 
tubes, plugs and needles must fit exactly. Thirdly, during the blood pressure measurement, 
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the whole tubing system is supposed to be free of air bubbles to avoid dampening of pulse 
pressure (Buiiag, 1991; Sponer et at., 1993). 
2.6- CURRENT THERAPY FOR HYPERTENSION 
Before starting treatment, there is a need to assess blood pressure level and the absolute 
risk of cardiovascular disease. Depending on the assessment, intervention can either be 
through lifestyle modifications or/in conjunction with drug treatment. Treatment can be 
with lifestyle modifications alone for up to one year if there are no other risk factors. Drug 
treatment is then administered if there is no improvement with the lifestyle modifications. 
On the other hand, patients with stage 2 hypertension or more, or those with high 
cardiovascular risks, and patients with diabetes, drug therapy is indicated. 
2.6.1 Intervention through lifestyle modifications 
Evidence suggest that sodium restriction; maintaining adequate intake of dietary potassium, 
calcium and magnesium; stopping excessive alcohol consumption; restriction in caloric 
intake while eating abundant fruits, vegetables and low-fat dairy products; weight loss in 
obese people; regular dynamic exercise, and abstaining from smoking might reduce blood 
pressure and cardiovascular risks (Opie and Steyn, 1995; August, 2003;). Life style 
modifications are encouraged since they are safe and inexpensive though the major 
problem with them is their low long-term sustainability. 
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2.6.2 Intervention through drug treatment 
Drug treatment is used on the basis that the medication will decrease blood pressure and as 
a result prevent the cardiovascular and renal complications associated with raised blood 
pressure. The established drugs are classified into six broad classes depending on their 
mechanism of action. The classes are; diuretics, beta-blockers, angiotensin-converting 
enzyme (ACE) inhibitors, calcium- channel antagonists, alpha-blockers and angiotensin -
receptor antagonists. These drugs are administered either as monotherapy or as a 
combination therapy depending on the stage of hypertension. There is still a lot of 
controversy as to which drug is better than the other. 
Based on evidence from clinical trials even in Africa, it is suggested that low dose thiazides 
(a diuretic) might be the most cost-effective way to start pharmacological treatment in most 
patients (Man in't Veld and van den Meiracker, 1995; Opie and Steyn, 1995; Seedat, 1999; 
Seedat, 2000). It worthy noting that for each class of antihypertensive drug, indications or 
contraindications exists. For instance, stable heart failure is an indication for thiazides, 
aldosterone receptor blockers, ~-blockers, or angiotensin converting enzyme (ACE) 
inhibitors but not for angiotensin receptor blockers. A history of myocardial infarction 
favours the use of ~-blockers or ACE inhibitors while renal impairment, micro albuminuria, 
or proteinuria is an indication for ACE inhibitors or angiotensin receptor blockers (Wing et 
al. , 2003). Systolic hypertension warrants the use of thiazides or long - acting 
dihydropyridines (Staessen et al., 2003). Black people with hypertension respond better to 
thiazides or calcium - channel blockers than to inhibitors of the renin system, in terms of 
both blood pressure reduction and prevention of complications associated with it. It has 
been shown that black South Africans, just like other blacks, do not respond well to ~-
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blockers or angiotensin converting enzyme (ACE) inhibitors but rather to diuretics and/or 
Ca2+ antagonists (Seedat 1989; Middlemost et ai., 1992; Materson et ai., 1993; Middlemost 
et ai., 1994; Skoularigis et ai., 1994; Opie and Steyn, 1995; Seedat, 1999; Seedat, 2000) 
2.7- ARRYTHMIA 
Arrhythmias are disturbances in the heart rate and rhythm that may be due to abnormalities 
in the impulse formation or impulse conduction. Impulses may be initiated abnormally (1) 
by slow diastolic depolarisation of automatic cells in ectopic sites or (2) by 
afterdepolarisation that reach threshold (Berne and Levy, 2001). On one hand, ectopic foci 
comes into play when the automatic cells in atrium, atrioventricular (AV) node, or His-
Purkinje system initiate propagated cardiac impulses either because the sinoatrial node is 
suppressed, or because the rhythmicity of the ectopic foci is abnormally enhanced. On the 
other hand, under abnormal conditions, afterdepolarisation may appear either early or late 
into the phase 3 of a normally initiated beat, or the beginning of phase 4. If these 
afterdepolarisation reach threshold they may themselves trigger propagated impulses. 
Disturbances of impulse conduction consist of conduction block and re-entry. In 
conduction block there is failure of propagation in a cardiac fibre as a result of a disease 
process due to a number of reason for instance, ischaemia, inflammation, scar tissue or 
calcified portions of the heart, or a drug. On the other hand, in re-entry a cardiac impulse 
may traverse a loop of cardiac fibres and re-enter previously excited tissue when the 
impulse is conducted slowly around a loop and the impulse is blocked unidirectionally in 
some section of the loop. 
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Abnormalities in the sinus rhythms may be associated with a pathological (a) increase in 
heart rate (over 1 ~O/min) called tachycardias or tachyarrhythmias or (b) reduction in heart 
rate (less than 60/min) and called bradycardias or brady arrhythmias. Tachycardias 
manifest themselves in anyone of the following arrhythmias; premature beats, ventricular 
tachycardias, atrial or ventricular flutter, atrial or ventricular fibrillation (Guyton and Hall, 
2000). 
2.7.1- Techniques used for the production of experimental arrhythmias 
In experimentally induced arrhythmias, the techniques used for the production of the 
arrhythmias may be divided into three groups, namely; chemical, electrical and mechanical 
(Szekeres 1971 , Wilson, 1984). These three differ in the arrhythmogenic stimuli that are 
used to induce the arrhythmias. Since different arrhythmogenic stimuli exert their 
arrhythmogenic effect by different mechanisms, it is essential to determine antiarrhythmic 
activity of any test drug based on arrhythmias induced by different arrhythmogenic 
techniques. 
Antiarrhythmic action may be studied on isolated parts of the heart like the isolated atria 
and isolated papillary muscle or on the isolated heart using the Langendorff heart 
preparation and heart-lung preparation, and lastly in the intact animal that is either 
anaesthetised or unanaesthetised. The rat is particularly suitable for assays where a large 
number of experimental animals are to be used. The Lambeth Conventions (Walker et al. , 
1988) give guidelines as well as classification, quantification and analysis of arrhythmias 
during experimental studies. 
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2.7.1.1 Chemically induced arrhythmias 
Various substances with different chemical structure and biological actions have and are 
used to produce experimental arrhythmias. These chemical agents can be used either alone 
or in combination. Their arrhythmogenic effect is due to their influence on either the 
properties of the myocardium or their direct excitation of the central nervous system. Thus, 
the site of action of these substances is different from one kind of substance to another. 
The agents are either applied locally directly to the myocardium or injected into the 
bloodstream. 
In local application approach, the drugs act as permanent stimulus at the site of application 
giving rise to ectopic activity (Szekeres, 1971). The best-known agent is aconitine and it 
has been used to produce tachycardia, flutter and fibrillation, depending on concentration. 
Aconitine induces arrhythmia by modifying sodium channels of the cardiac fibres resulting 
to high -frequency automaticity based on delayed repolarisation (Vaille et at., 1992). 
Aconitine-induced arrhythmias respond to classes I-III antiarrhythmic drugs. Other drugs 
that can be used to induce such arrhythmias are acetylcholine, veratrum alkaloids and high 
doses of cardiac glycosides. 
Although arrhythmia can be induced by local application of the agent directly onto the 
myocardium, the widely used method of chemically inducing arrhythmia is by intravenous 
application of the arrhythmogenic agent. The agents that are commonly used in this 
approach include, Barium chloride (BaCh), calcium chloride (CaCh), epinephrine, and to 
some extent chloroform. 
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2.7.1.1a Induction of arrhythmia by BaCh 
In mammalian heart, injection of BaCh may induce arrhythmias by decreasing the efflux of 
potassium. According to Szekeres (1971), the decreased potassium efflux enhances 
rhythmicity of the myocardium and causes prolongation of the action potential. This model 
is sometimes not preferred because it has a low margin of safety as only slightly higher 
doses than the one required to induce ventricular extrasystole precipitates ventricular 
fibrillation (Papp et ai. , 1967). 
2.7.1.1b Induction of arrhythmia by epinephrine 
Injection of epinephrine in higher doses induces arrhythmias that can be readily 
antagonised by ~-receptor blocking agents and other antiarrhythmic agents. Its action lasts 
for a very short time and according to Szekeres (1971), the effective period is not longer 
than 30 seconds after its administration. 
2.7.1.1c Induction of arrhythmia by CaCl2 
Injection of CaCh to the intact animal induces ventricular arrhythmia that eventually leads 
to fibrillation attributed to direct action of it on the myocardium. CaCh is thought to 
enhance spontaneous ectopic activity and it initiates asynchronous propagation of impulses 
(Szekeres, 1971). It is advisable to inject the drug very slowly since rapid injection leads to 
lasting fibrillation resulting in death. CaCh perfusion causes ventricular fibrillation within 
the first minute following its administration. The arrhythmia is due to an increase in the 
free intracellular Ca2+ concentration that promotes abnormal generation of impulses and 
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alters normal automaticity thereby inducing abnormalities of impulse conduction 
responsible for re-entry, re-excitation resulting in ventricular fibrillation (Vaille et ai., 
1992). The authors showed that this model is selective since it is only prevented by agents 
that block slow inward Ca2+ current. These agents belong to class IV antiarrhythmic agents 
as per Vaughan Williams classification. 
2.7.1.Jd Induction of arrhythmia by chloroform 
This model has the features of simplicity and economic. The major disadvantages with it 
are that of being heavily influenced by elevated sympathetic tone and its lack of 
discrimination when it comes to the classes of antiarrhythmic drugs. Brooks et ai., (1989), 
assert that its lack of discrimination is its major defect since any bradycardia agent, central 
nervous system and respiratory depressants, and a-adrenolytic agents appear to be active 
against it. Thus, this model is sensitive to agents belonging to all classes of antiarrhythmic 
drugs as per Vaughan-Williams classification. On the other hand, it is my opinion that this 
model might be used as a quick way of checking whether a test compound has potential 
antiarrhythmic properties since the model is responsive to all classes of antiarrhythmic 
drugs. 
2.7.1.2 Mechanically induced arrhythmias 
The interventions that induce arrhythmia mechanically alter fundamental properties of the 
myocardium within a circumscribed area giving rise to local blocks and spontaneously firing 
ectopic foci. Two models that utilise this approach are the coronary artery ligation model 
and the coronary artery ligation-reperfusion model. Regional myocardial ischaemia and 
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reperfusion are both powerful arrhythmogenic stimuli. These arrhythmias are attributed to 
re-entry and are inhibited by sodium conductance inhibitors and potassium inhibitors (Curtis 
and Hearse, 1989). Theoretically, both classes of drugs may encourage ventricular 
fibrillation and ventricular tachycardia to terminate since they effectively increase the re-
entry wavelength. 
The rat heart is used frequently to investigate arrhythmias resulting from ischaemia and 
reperfusion because of its lack of collaterals (Maxwell et ai. , 1987), and because the rat atria 
exclusively receive its blood supply from extracoronary vessels (Halpern, 1957). This leads 
to reproducible zones of severe ischaemia upon ligation of the coronary artery. Furthermore, 
the use of the rats makes much economical sense since large numbers of animals are used in 
these experiments to generate quantitative information. It is worth noting that the differences 
observed in rats from other larger hearts compels an investigator to confirm the findings in 
other species. 
The mechanism of initiation of ischaemia-induced arrhythmias is different from the 
mechanism responsible for initiating the reperfusion-induced arrhythmias. This was shown 
by Curtis and Hearse (1989), who by using perfused rat heart showed that perfusion of the 
non-ischaemic tissue with high potassium concentration prevented the induction of 
ischaemia-induced ventricular fibrillation but not reperfusion-induced ventricular 
fibrillation. On the other hand, the authors showed that both types of arrhythmias are 
maintained by a common electrophysiological mechanism since a high intracellular 
potassium concentration increased spontaneous termination of ventricular fibrillation 
regardless of whether the fibrillation was induced by ischaemia or reperfusion. 
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2.7.1.2a Coronary artery ligation (CAL) Model 
There are a number of cardiac diseases that involve acute ischaemia and as a result a 
number of experimental models have been designed to mimic part of the complex events 
occurring in the human disease. Experimentally, ischaemia is often induced by the 
occlusion of the coronary artery. In exposed hearts coronary occlusion can be 
accomplished by typing a ligature around the coronary artery or by clamping. In 
anaesthetised animals with the chest closed, a coronary artery can be occluded either by 
inflating a balloon occluder positioned around the artery or by suddenly tightening a snare 
previously placed around the vessel (Wit and lanse, 1992). Large animals like dogs, pigs 
and cats are used to study ventricular arrhythmias whilst rats are mostly used to study 
changes in the metabolic pathways resulting from ischaemic and reperfusion (lanse et ai., 
1998). The arrhythmias produced by coronary artery ligation are etiologically similar to 
the arrhythmias occurring in man in association with local ischaemia brought about by 
heart infarction. 
It is thought that there is species difference when it comes to these arrhythmias. These 
differences are due to differences in the electrophysiological properties of the heart and 
differences in cardiac and coronary artery anatomy (Wit and lanse, 1992). The variability 
in the presence or absence of collaterals in different species is one contributing factor to the 
observed species difference. For instance, pigs and rats are devoid of coronary collaterals, 
which is not the case with dogs (Maxwell et ai., 1987). Thus following coronary occlusion, 
there is a higher chance of residual blood flow through collaterals in dogs and neither in 
rats nor pigs. In the larger animals on the one hand, the arrhythmias induced by ischaemia 
occur in two distinct phases that are commonly called phase 1A and phase 1B (lanse et ai., 
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1998). These phases correspond to the two phases that have been observed in humans. 
According to Wit and lanse (1992), available data from humans suggest that there is an 
early phase of acute arrhythmia and a delayed phase of subacute arrhythmia that are 
separated by a period of decreased arrhythmias. On the other hand, in smaller species like 
rats there seem to be no clear separation of type 1A from type lB. 
The factors that will determine whether or not this arrhythmia occurs are; the size of the 
ischaemic area, the degree of collateral flow, heart rate, the mode of coronary artery 
occlusion, presence of a previous infarction, activity of the autonomous nervous system 
and hypertrophy in the non-ischaemic myocardium (Wit and lanse, 1992; lanse et ai. , 
1998). These arrhythmias respond best to strong class I agents (Brooks et ai, 1989). The 
authors contend that other workers have also shown that class IV agents like Verapamil and 
nifedipine do suppress extrasystoles that occur in this model. 
2.7.1.2h Coronary Artery Ligation! Reper/usion (CALR) Model 
In experimental animals, restoration of blood flow to the myocardium after a brief period of 
ischaemia is associated with the occurrence of severe ventricular arrhythmias. This 
reperfusion-induced arrhythmia is related to the ventricular fibrillation and sudden cardiac 
death that are seen in humans upon release of coronary spasm or platelet disaggregation 
causing restoration of blood flow to a previously ischaemic region of the myocardium. 
Thus, reperfusion arrhythmias are distinct from ischaemia-induced arrhythmias and they are 
encountered in man (Manning and Hearse, 1984). Unlike the arrhythmias that occur upon 
coronary artery occlusion, the reperfusion-induced ones have a rapid onset (within 20 
seconds after release of ligature) and are of short duration, 1-2 minutes. Their severity is 
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dependent upon the duration of the preceding occlusion. Kane et al., (1984) showed that the 
most severe reperfusion-induced arrhythmias occur after an occlusion period of 5 or 15 
minutes when 56 and 50 % of the animals developed ventricular fibrillation respectively. 
The authors showed that when duration of occlusion was reduced to 2 minutes or extended 
to 20 minutes, the number of the arrhythmias was markedly reduced and no ventricular 
fibrillation occurred. Thus, the severity of these arrhythmias is highly dependent on the 
duration of the ischaemia. 
The actual mechanisms of initiation and maintenance of reperfusion-induced arrhythmias are 
less well established and it is unclear whether re-entry or automaticity predominates. The 
suggestion that abnormal automaticity might be the cause of the arrhythmias is supported by 
the fact that reperfusion elicits delayed after-depolarisation capable of triggering 
automaticity (Opie et al., 1986; Pogwizd and Corr, 1986). There is also evidence that 
suggest that generation of oxygen radicals may playa major role in causing the tissue injury 
that is associated with reperfusion (Jeroudi, et al., 1994: Roth, et al., 1997). 
These arrhythmias, in contrast to those that occur when the occlusion is present, do not 
appear to be influenced by alterations in autonomic nervous activity. This fact is backed by 
evidence that has shown that reperfusion-induced arrhythmias are not affected by bilateral 
vagotomy and ~l-adrenoceptor blockade with atenolol (Kane et al., 1984). Drugs that block 
the fast inward sodium channel (class I antiarrhythmic drugs according to the Vaughan 
Williams classification) are effective, particularly in reducing the incidence of reperfusion-
induced ventricular fibrillation in rats. Although class I drugs are generally effective in the 
rat, they are not clearly antiarrhythmic in dog and pig reperfusion arrhythmia models 
(Brooks et al., 1989). This might be due to species difference as has been discussed before. 
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It is also postulated that antioxidants and calcium antagonists may offer a protection against 
reperfusion injury that results from the increased generation of reactive oxygen radicals 
(Bernier and Hearse, 1988; Jeroudi, et ai. , 1994; Roth, et ai. , 1997). Roth et aI. , (1997) 
showed that, during reperfusion, diminished superoxide radical production of circulating 
neutrophils has beneficial effects on tissue injury that is caused by reactive free radicals. 
Thus, antioxidants offer a cardioprotection effect during heart ischaemia-reperfusion. 
2.7.1.3 Electrically induced arrhythmias 
This is the oldest and widely used technique for producing experimental arrhythmias. It has 
the advantages of not being harmful to the myocardium when the stimuli is not extremely 
strong, and it can be used to reproduce some of the main types of arrhythmias of clinical 
importance (Szekeres, 1971). Either a single electrical shock or serial shocks, or 
progressively increasing rate of stimulation or prolonged application of galvanic current may 
be performed to produce arrhythmia or fibrillation by electrical stimulation of the heart. 
According to Szekeres (1971 ), serial shock is the best method of stimulating the 
myocardium since with it, it is possible to produce some of the main types of arrhythmias of 
clinical importance. However, this technique is highly involving and needs expertise and 
thus would not be recommended for screening anti-arrhythmic drugs but rather it can be 
used to study those test drugs that have shown a high potential after being screened using the 
chemically induced arrhythmias. 
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2.7.2 Classification of antiarrhyhmic drugs 
Drugs used to restore disorders of cardiac rhythm and rate are known as anti-arrhythmic (or 
anti dysrhythmic ) drugs and their pharmacological properties are complex. Antiarrhythmic 
drugs exert their effects widely by modulating conduction velocity orland refractory period 
duration (Janse et al., 1998). Conduction velocity on the one hand, depends on the passive 
electrical properties of the myocardium, and on the characteristics of the sodium (Na +) and 
Ca + channels. On the other hand, potassium (K+) currents determine repolarisation that in 
turn determines the action potential duration and the refractory period duration. According 
to Janse et al., (1998), agents that prolong the action potential duration, and thereby the 
refractory period, are effective against re-entrant arrhythmias by prolonging the 
wavelength. The prolongation of the wavelength either prevents the initiation of a re-
entrant arrhythmia by a premature impulse or terminates an existing arrhythmia. 
There are various ways of classifying anti-arrhythmic drugs, but the most widely accepted 
classification is the one suggested by Vaughan Williams (1991). This classification is 
based on the action of the drug on the electrophysiological properties of the myocardium 
tissue and on the interaction with membrane receptors and ion channels. This classification 
is by no means rigid as some drugs have effects belonging to more than one class. An 
example of this is Quinidine that has both class I and class III properties. In addition, many 
of the anti-arrhythmic drugs have other clinical uses such as vasodilators, antihypertensive, 
anti -cholinesterase. 
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2.7.2.1 Class I anti-arrhythmic drugs 
These drugs directly change membrane conductance of ions, particularly those ofNa+ and 
K+. Thus, these drugs exert their antiarrhythmic effect by depressing the conduction 
velocity, prolonging the refractory period and increasing the threshold of excitability of the 
myocardium (Vogel and Vogel, 1997). Depending on the effect of the drugs on the action 
potential duration, class I drugs are further subdivided into classes lA, IB and IC. 
Class IA drugs lengthen the action potential duration that is reflected on the ECG reading 
as lengthening of the QT -interval. Examples of drugs belonging to this class are Quinidine, 
disopyramide and procainamide. Class IB drugs shorten the action potential duration and 
examples of the drugs in this class are lodoacaine, phenytoin and mexiletine. Lastly, class 
IC drugs produce effects of both class IA and class IB drugs (Vogel and Vogel, 1997). 
2.7.2.2 Class II anti-arrhythmic drugs 
These drugs reduce adrenergic influence on the heart. These ~-adrenergic antagonists exert 
their anti-arrhythmic effects by either reducing or blocking the electrophysiological effects 
of catecholamines that are mostly mediated by an increase in the slow Ca2+ inward current 
(Vogel and Vogel, 1997). Examples of drugs belonging to this class are atenolol, timolol 
and bretylium. 
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2.7.2.3 Class III anti-arrhythmic drugs 
Drugs belonging to this class prolong the action potential and thus lead to an increase in the 
effective refractory period. Blocking of the outward repolarising currents is the main 
mechanism of action of these drugs (Vogel and Vogel, 1997). 
2.7.2.4 Class IV anti-arrhythmic drugs 
Class IV agents block slow Ca2+ channels thereby suppressing the slow Ca2+ inward current 
and calcium dependent slow action potentials (Vaille, et al., 1992; Vogel and Vogel, 1997). 
2.8- PHARMACOLOGY OF INOTROPIC DRUGS 
Inotropic mechanisms effectively influence contractility of muscular tissue such as the 
heart. In the heart, positive inotropic (cardiotonic) interventions strengthen the force of 
contraction of the heart whilst negative inotropic interventions weaken muscular 
contraction (Scholz, 1984; Siegl, 1986). The cardiac contractile state in turn determines 
how well the heart functions as a pump by muscle shortening, developing pressure in the 
ventricular cavity, and ejecting blood. The increase in the contractility of the heart is 
ultimately dependant on either the increase in the intracellular free Ca2+ that interacts with 
the contractile proteins or to an increased sensitivity of the myofilaments for the Ca2+ or 
both. 
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Inotropic drugs are currently used to preserve or restore myocardial function in patients 
with heart disease. Because depression of the myocardial contractility plays a vital role in 
the development of heart failure, it is logical to attempt to enhance the inotropic state of the 
failing heart by using positive inotropic agents. Thus, efforts have been directed at 
developing positive inotropic agents that increase the contractile performance of the heart 
without elevating myocardial oxygen consumption (i.e. increasing heart rate and vascular 
resistance) or evoking arrhythmias. In hypertrophic cardiomyopathy, negative inotropic 
interventions are used to improve cardiovascular hemodynamics (Siegl, 1986; Sasayama, 
1996). 
2.S.1 Regulation of cardiac muscle contraction and relaxation 
Depolarisation of the sarcolemma, that is the sodium (Na+)- dependent upstroke of the 
action potential, is the initial event. This depolarisation of the cell membranes allow the 
extracellular Ca2+ to move down its electrochemical gradient into the cell through 
membrane bound Ca2+ channels. This Ca2+ (slow Ca2+ inward current) serves to fill 
intracellular stores and triggers the release of much larger amounts of activator Ca2+ from 
the sarcoplasmic reticulum into the cytosol where it reacts with the contractile apparatus. 
Interaction of the activator Ca2+ with troponin C initiates molecular re-arrangement of 
regulatory proteins, tropomyocin and troponin, thereby allowing interaction of actin and 
myosin. Because of crossbridge attachments between actin and myosin, cardiac muscle 
contracts, and tension is developed. Dissociation of Ca2+ from the contractile apparatus 
and Ca2+ sequestration by the sarcoplasmic reticulum leads to relaxation. Cyclic adenosine 
monophosphate (AMP) modulates the handling of calcium in the sarcoplasm through 
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activation of a variety of cyclic AMP- dependent protein kinases. This is done by 
catalysing the transfer of the terminal phosphate of adenosine triphosphate (ATP) to form 
phosphoesters with several functional proteins within the cell in process termed 
phosphorylation. (Scholz, 1984; Siegl, 1986; Sasayama, 1996). 
All inotropic drugs interact with one or more of the above steps involved in the contraction 
and relaxation of the cardiac muscle. The positive inotropic drugs bring about their effects 
either by increasing cyclic AMP in the cytosol or by increasing the free intracellular Ca2+ 
and the sensitivity for the available Ca2+. 
2.8.1.1 Cyclic AMP increasing agents 
Agents that increase the concentration of intracellular cyclic AMP are expected to enhance 
the inotropic state of the heart by increasing the cytosolic calcium. Intracellular cyclic 
AMP can be increased either by promoting its synthesis by the activation of adenylate 
cyclase or by inhibiting its degradation using phosphodiesterase inhibitors. The major 
disadvantage with drugs belonging to this class is that increased cyclic AMP is linked to 
potential arrhythmogenic effects and increased energy expenditure. 
2.8.1.1a Activation of adenylate cyclase 
Adenylate cyclase is an enzyme that is located on the intracellular surface of the 
sarcolemmal membrane and it catalyses the conversion of ATP to cyclic AMP. Adenylate 
cyclase can be activated either by stimulation of receptors coupled to it or by a direct action 
on the enzyme itself or by a subunit of the enzyme. 
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There is a lot of evidence that suggest that agonists of the following sarcolemmal 
membrane receptor systems activate adenylate cyclase; ~-adrenergic, H2- histaminergic 
and glucagons. Agonists of ~-adrenergic receptors are the most widely used activators of 
adenylate cyclase, and they have been shown to have positive inotropic effect. Examples 
of these ~-adrenergic agonists are norepinephrine, epinephrine, isoproterenol, dopamine 
and dobutamine. The major problem with drugs that use this mechanism is that there is a 
possibility of the development of tolerance at the receptor site resulting in the reduction of 
the inotropic effect. 
Apart from indirect activation through the receptors, adenylate cyclase can also be 
activated directly. The best example that has been shown to work in this way is forskolin, a 
derivative from a medicinal plant called Coleus forskohlii. Forskolin stimulates adenylate 
cyclase in membranes and intact cells (Seamon et al., 1981). It has been shown to have a 
positive inotropic and chronotropic effects, and a blood pressure lowering activity (Lindner 
et aI, 1978; Metzger et aI, 1981). It also stimulates the voltage-sensitive calcium current 
that is believed to playa role in the inotropic effect (Hartzell and Fischmeister, 1987). The 
positive inotropic effect of forskolin is very similar to that induced by ~-adrenergic agonists 
although the former does not require neither membrane surface receptors nor a functional 
guanine nucleotide-binding subunit (Seamon and Daly, 1981). Nevertheless, it is believed 
that forskolin requires specific binding site to induce its cardiac activities since derivatives 
of it with some modifications fail to have any effect on isolated heart preparations nor in 
activating adenyl ate cyclase (Seamon et al., 1983; Schmidt and Kukovetz, 1989). 
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2.8.1.1b Inhibition of phosphodiesterase 
Intracellular cyclic AMP concentration can also be increased by reducing its degradation to 
inactive metabolites by phosphodiesterase (PDE). Inhibition of PDE activity elevates the 
concentration of cyclic AMP and thereby enhancing developed tension. Examples of drugs 
that belong to this class of positive inotropic drugs are amrinone and I-methyl-3-
isobutylxanthine (IBMX) (Sasayama, 1996; Xiong et al. , 2001). Phosphodiesterase 
inhibitors have an advantage over ~-adrenergic agonists because their ability to increase 
cyclic AMP concentration is not diminished by membrane receptor tolerance. Thus, these 
drugs are suitable for patients with congestive heart failure who require chronic inotropic 
therapy. 
2.8.1.2 Drugs that increase either free-intracellular Ca2+ or Ca2+ sensitivity 
As mentioned before, the increase in force of myocardial contraction is ultimately due to an 
increase in intracellular free calcium that interacts with the contractile apparatus or to an 
increased sensitivity of the myofilaments for Ca2+. Inhibitors of Na+,K+-ATPase, like 
digitalis glycosides, belong to the class of drugs that increase intracellular free calcium. It 
is thought that inhibitors of Na+,K+-ATPase cause an increase in the intracellular sodium 
ion concentration. This elevated intracellular sodium activity enhances Ca2+ entry and/or 
reduces Ca2+ efflux via sodium-calcium exchanger system. Thus, there is an increase in the 
development of cardiac tension because of the increased concentration of intracellular free 
calcium. 
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Modulating the sensitivity of the contractile apparatus, especially the troponin C, for the 
free Ca2+, can also regulate contractility of the cardiac muscle. For instance, magnesium 
ions and acidic pH have been shown to decrease the sensitivity of contractile proteins for 
Ca2+ (Ogawa, 1985). On the other hand, several calmodulin inhibitors like bepridil, 
calmidazolium and sulmazole, increase the sensitivity of contractile proteins to calcium 
(Herzing et al., 1981; Silver et al., 1986; Herzing et al., 1996). These calcium sensitising 
agents would be vital in patients who are in a state of lack of activator calcium as it 
happens in hypocalcaemia. The only problem would come when these agents are applied 
in a state of increased activator calcium as present in ischaemic myocardium (Francis and 
Cohn, 1990). There are however, reports of some extracts that have a safe inotropic 
principle able to work under both low and high calcium load. Gilani, et al. , (1999) have 
reported of a n-butanolic fraction from Berberis aristata fruit which might be cardiotonic 
under conditions of low levels of activator calcium and cardioprotective under ischaemic 
calcium overload. 
2.9- MEDICINAL PLANTS 
For a very long time plant and animal products with therapeutic values have been used as 
the main source of drugs. Despite the increase in the use of synthetic drugs, plants remain 
one of the major sources of drugs. Rates (2001) asserts that of the 252 drugs considered as 
basic and essential by the World Health Organisation (WHO), 11 % of these are 
exclusively of plant origin and a significant number of the remainder are synthetic drugs 
obtained from natural precursors. Examples of drugs obtained from plants are; digoxin, 
quinine, quinidine, vincristine, vinblastine, atropine and penicillin. 
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Apart from direct use of plant materials, plants also provide lead compounds that have and 
still are leading to the discovery of new therapeutic properties (Hamburger and 
Hostettmann, 1991). The newly discovered therapeutic properties are then used in 
designing and synthesizing new drugs with similar or more potent therapeutic values. 
Lastly, plants provide compounds that are used as experimental tools in pharmacological, 
biochemical, haematological and physiological studies. Examples of such compounds are 
forskolin, cannabinoids, muscarine, yohimbine and colchicines (Williamson et ai., 1996). 
The interest in the use of natural products derived from plants for therapeutic purposes has 
seen a tremendous increase in demand recently. It is estimated that about 80% of the world 
population relies on medicinal plants for their primary health care needs (Vulto and Smet, 
1988; Groombridge, 1992; WHO/IUCN/WWF, 1993). This demand in natural products 
has seen a rise in the world market for it, and according to Soldati (1997) the world market 
for over the counter phytomedicinal products was worthy more than US $ 10 billion. The 
sales of these products are increasing at the rate of about 10 % each year in most developed 
countries (Houghton and Raman, 1998) and in South Africa the market is estimated to be 
worth R2.3 billion per year (Copeland, 2003). The interest in natural products has also led 
to the WHO to declare 31 st August as the day of African tradition medicine with 2000-2010 
being declared as the decade for African tradition medicine (WHO, 2003). Furthermore, to 
show the importance of natural products, WHO and most governments consider 
phytotherapy in their health programs and they have set up basic procedures to be followed 
when validating drugs that are sourced from plants (Vulto and Smet, 1998). In South 
Africa, the Medicines Control Council has established a unit dealing with complementary 
medicine, and has earmarked more than 10,000 substances for evaluation and regulation 
(Copeland, 2003). 
43 
Plants can be used as therapeutic resources in three main ways. They can be used fIrstly as 
herbal teas or home made remedies, secondly as crude extracts and thirdly as isolated 
active compounds after been subjected to successive extraction and purifIcation processes 
(Rates, 2001). When used as herbal teas or other home made remedies it is with the 
assumption that the plant is a medicinal one. By defInition, a medicinal plant is either any 
plant used in order to relieve, prevent or cure a disease or alters physiological and 
pathological process, or any plant employed as a source of drugs or their precursors (Rates, 
2001). Plants are used as crude extracts when they are considered as phytopharmacetical 
preparations or herbal medicines. In this case, the material is obtained exclusively from a 
plant in the crude state. When pure active compounds are to be used, plants are subjected 
to successive extraction and purifIcation procedures in order to isolate the compounds of 
interest. On the one hand, when these compounds are active themselves they can be used 
directly as drugs examples of which are quinine and digoxin. On the other hand, 
compounds like diosgenin can be used as precursors in hemisynthetic processes or as 
models for total synthesis with well-defIned pharmacological activity or as models for 
structure-activity relationship studies used to determine prototype drugs (WHO, 1992; 
Rates, 2001). 
2.9.1 Selecting a Plant 
A suitable plant is selected as a candidate source for herbal medicine or an isolated active 
compound in several ways. These include random collection of plant material, targeted 
collection based on consideration of chemotaxonomical relationships, observation of 
tradition use of plants in folk medicine, observation of plant toxic effect to animals and its 
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surrounding, and a combination of several criteria (Malone, 1983; Soejarto, 1996; 
Williamson et ai., 1996). 
The strategy widely used in selecting a plant is the careful observation of the use of the 
plant resources in folk medicine commonly referred to as ethnopharmacology or 
ethnobotany. The preparation procedures of plants used by ethnic groups provide vital 
information of how best to extract active compounds from the plant materials. According 
to Rates (2001), the formulation used in folk medicine provides information about 
pharmacological activity, the best route of drug administration, and the doses to be tested. 
It is worthy pointing out that extracts of plants selected using this approach should not just 
be tested for the pharmacological action claimed by the ethnic people but rather should be 
screened on a wide range of models as possible (Williamson et ai. , 1996). It is my view 
that this approach of screening the extracts on a wider range of models would help in 
identifying novel therapeutic properties that would otherwise not been known had the 
investigator stuck to only the tradition use of the plant. 
In terms of chemical content, once a therapeutic action of a particular plant has been 
attributed to a certain compound, it is possible to hypothesise that plants that contain 
similar compounds would have similar therapeutic values. According to Williamson et ai., 
(1996), this approach is greatly dependant on chemotaxonomic information relating 
different classes of compounds to different plant species. 
The other plant selection approach that has yielded many vital drugs is by working with 
plants that are known to indigenous people as being poisonous. Williamson et ai., (1996) 
assert that poisonous plants more than plants used regularly in folk medicine have a higher 
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potential to contain highly specific and potent compounds that can be used as drugs or as 
probes for the elucidation of biological phenomena. Examples of important drugs of plant 
origin that came from poisonous plants are; tubocurarine (arrow poison), atropine (poison), 
picrotoxin (fish poison), muscarine (poisonous mushroom), dicoumarol (poisonous clover), 
and physostigmine (ordeal poison). 
Once the plants are selected as possible sources for drug development, it is vital to take into 
account the preservation of natural diversity and environment. The preservation prevents 
the extinction of some plant species that may have interesting chemical compounds for 
potential drug development or may have genes vital for the biosynthesis of new compounds 
(Soejarto, 1996; Brito and Nunes, 1997; Rouhi, 1997). Thus, there is need for the 
encouragement of plant preservation and replanting, and sensible use of the plant resources 
in terms of the amount and parts of the plant. People should be encouraged to use parts that 
can easily regenerate without killing the plant, for instance leaves and barks should be used 
more than using roots. 
2.9.2 Preparation of the plant material and isolation of active compounds 
The process of getting a pure biologically active compound is complex and involves a 
multidisciplinary collaboration of botanists, plant taxonomists, pharmacognosists, chemists, 
pharmacologists and toxicologists (Hamburger and Hostettmann, 1991). Once a plant is 
selected for drug development, there is need for a botanist to taxonomically identify it and 
collect part of the plant for herbarium preservation. This "voucher specimen" is deposited 
in a herbarium and it serves as a reference material for future use. It is common practice to 
record the date, time, season, location and terrain from where the material was collected. 
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Once this is done, the collected material is subjected to a stabilisation process that is 
usually done by drying at ambient temperature under a shady area. In some studies, the 
materials are dried in an oven with controlled air flow (Conde Garcia et ai., 2003). In cases 
where the stability of the test compound is unknown, the stabilisation process involves 
freezing, lypophilisation and use of alcohol vapour (Williamson et ai., 1996; Houghton and 
Raman, 1998). 
The dried material is cut into very small pieces and if possible ground into powder before 
being subjected to a suitable extraction process to yield crude extracts. The extraction 
process involves mostly the use of solvents with varying polarity. Water is also used as a 
solvent since in traditional practices it is the solvent of choice. If the compound of interest 
is known, the selected method of extraction is the one that gives the highest yield and 
purity of the compound. Preliminary chromatographic analysis by thin layer 
chromatography (TLC) and/or high-performance liquid chromatography (HPLC) is then 
done to get an idea on the kind of compounds available in the crude plant extract 
(Hamburger and Hostettmann, 1991). 
The crude extracts are subjected to bioassay and toxicity evaluation to check if they have 
any biological activity. Then, detailed chromatographic methods like TLC and column 
chromatography are employed to obtain isolated active compounds. To get pure 
compounds, it is imperative that the active plant extracts are sequentially fractionated and 
then each fraction obtained is submitted to bioassays and toxicity evaluation (Houghton 
and Raman, 1998; Rates, 2001). The easiest toxicity evaluation can be performed using 
brine shrimp toxicity test (Meyer et ai., 1982). The brine shrimp test is easy, cheap and 
rapid, and thus convenient as a general bioassay tool. 
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The next step is to verify the purity of the isolated compounds before being submitted for 
the determination of their chemical structure. The elucidation of the structure can be done 
by spectroscopic methods like; ultraviolet/visible spectrum, infrared (IR) spectrum, mass 
spectrum and nuclear magnetic resonance (NMR) spectra (Houghton and Raman, 1998). 
The last steps involve partial or total synthesis of the compounds. It is also vital to prepare 
derivatives or analogues of the compounds for the investigation of structure-activity 
relationships. In most cases, the derivatives are bound to have a different action from the 
original compound. Lastly, if the compounds have a high commercial value, a large-scale 
isolation is commissioned for further pharmacological and toxicological tests. 
2.10 BOTANY OF PLANTS USED IN THIS STUDY 
The medicinal plants that were used in this study were selected based on their reported 
triterpenoids content according Anne Hutchings Inventory of Zulu Medicine (1996). This 
strategy involved targeted collection of plants based on consideration of chemotaxonomical 
information that was found in the above inventory. The following sections describe the 
botany of the medicinal plants that were used in this study. 
2.10.1 Buddleja salvii/olia (LOGANIACEAE) 
This plant is found in various tropical countries. This shrub can grow up to five meter in 
height and has a spread of 4 meters. It produces silver grey powdery leaves and white to 
cream or lilac to purple coloured flowers (Figure 1) 
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Figure 1. Buddleja salviifalia shrub (www.images.google.com) 
In tradition medicine, the roots have been reported to be used as decoctions used for 
stomach upsets, flatulence, and diarrhoea and as a gargle for coughs. Leaves are used as an 
eyewash and for colic whilst flower decoctions are used to watch sores (Watt and Breyer-
Brandwijk, 1962; Roberts, 1990). Verbascoside has been isolated from this plant 
2.10.2 Psidium guajava (MYRTACEAE) 
Psidium guajava, commonly called guava, occurs naturally in Central America but is found 
in many parts of the world where it has become naturalised. It is a shrub or a small tree 
that has a characteristically smooth trunk that result from the peeling off the barks. It 
produces small white flowers in summer, followed by rounded or pear-shaped, many-
seeded fruit (Figure 2). The inside of the fruit can be pink, white, or red. 
Guava leaves are commonly used for diarrhoea (Watt and Breyer-Brandwijk, 1962; 
Hutchings et aI., 1996; VanWyk et al., 1997). The leaves are also used for other ailments 
including toothache, diabetes, fever, coughs, ulcers, boils and wounds (Van Wyk et al., 
1997; Jaiar et al., 1999; Tona et al., 1999). Roots are used for venereal diseases, leprosy, 
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abdominal pains and scabies (Hutchings et ai., 1996). In Taiwan, fruits are used to treat 
diabetes mellitus (Hsu and Cheng, 1992). 
Figure 2. Leaves and fruits of Psidium guajava (www.images.google.com) 
The chemical constituents found in the plant include essential oils, triterpenoids like 
cratergolic, guaijavolic, oleanolic and ursolic acids), and numerous tannins (Osmna et ai., 
1974; Smith and Siwatibau, 1975; Morton, 1981; Lutterodt, 1989). Ellagic acid found in 
the leaves is thought to contribute to the beneficial effects observed in its use in treating 
diarrhoea since the acid is a known astringent and haemostatic (Bruneton, 1995). 
Antibiotic activity is attributed to guajaverin and psidolic acids (Bardy et ai., 1982). 
Quercetin is thought to contribute to the anti-oxidant, anti-carcinogenic, anti-HIV and 
antibiotic effects observed with the plant (Cheng and Yang, 1983; Loyoza et ai., 1994; Van 
Wyk et ai., 1997). Fruit extracts lower blood glucose levels in streptozocin-induced 
diabetic rats (Hsu and Cheng, 1992). Guava leaves have also been shown to have 
antinociceptive effects in chemical and thermal tests of analgesia (Lutterodt and Maleque, 
1988; Re et ai., 1999; Shaheen et al., 2000). 
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2.10.3 Syzygium cordatum (MYRTACEAE) 
S. cordatum is found in the tropical regions, and in South Africa it is widely distributed in 
the eastern and north-eastern parts. The tree is medium-sized and grows up to 15 meters in 
height. The plant has rough dark brown bark and the leaves are broad, with a bluish green 
colour (Van Wky, et al., 1997). It produces cream- to pinkish coloured flowers that give 
way to egg-shaped, red to dark purple berries (Figure 3). 
The plant is used to treat respiratory ailments, tuberculosis, stomach complaints and 
diarrhoea (Watt and Breyer-Brandwijk, 1962; lwu, 1993; Hutchings et al., 1996). The bark 
and roots are used for headaches and wounds whilst the root on its on is used to increase 
the flow of milk in nursing mothers (Hutchings et a!., 1996). 
Figure 3. Syzygium cordatum (www.images.google.com) 
Compounds isolated from wood and bark include pentacyclic triterpenoids such as 
friedelin, arjunolic acid, gallic acid, and steroidal triterpenoids such as ~-sitosterol and 
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ellagic acid (Candy et al. , 1968; Bruneton, 1995). The exact biological activity of this 
plant is not well known but the effects are most likely to be those associated with 
triterpenoids. Triterpenoids have been shown to have a wide variety of biological activities 
as has already been discussed in chapter one of this thesis. 
2.3.4 Centella asiatica (APIACEAE) 
C. asiatica is found in Africa, Asia, Australia, South America and the southern part of 
North America. (Van Wyk et al. , 1997). It is a perennial weed that is often found in moist 
places. This creeping plant forms thin stems with characteristically round or kidney-shaped 
leaves on long, slender stalks (Figure 4). 
Figure 4. Centella asiatica leaves (www.images.google.com) 
The plant is reported to be used for treating leprosy and various skin conditions, and it is no 
wonder that it said to be a vital constituent of dermatological products (Bruneton, 1995). It 
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is also widely used for wound treatment, fever, syphilis and as a diuretic and purgative 
(Iwu, 1993). Cheng and Koo (2000) presented results that suggested that Centella asiatica 
prevented ethanol induced gastric mucosal lesions by strengthening the mucosal barrier and 
reducing the damaging effects of free radicals. The wound healing activity is attributed to 
a triterpenoids saponin called asiaticoside (Van Wyk et al., 1997; Brinkhaus, et al., 2000). 
It is also reported that asiaticoside and other triterpenoids available in the plant have anti-
tumour properties (Babu et al., 1995). Total triterpene fraction of Centella asiatica 
(TTFCA) has been shown to improve microcirculation and capillary permeability in 
patients with venous hypertension (Belcaro et al., 1990a; Belcaro et al., 1990b; Cesarone, 
et al., 1994). The effect of the plant on microcirculation and capillary permeability might 
explain why the plant is used for the treatment of varicose veins and haemorrhoids 
(MacKay, 2001). In Chinese medicine the plant is used to alleviate symptoms of 
depression and anxiety due to its anxiolytic activity (Bradwejn et al., 2001). Other 
biological activities attributed to C. asiatica include antibacterial, antifungal, anti-
inflammatory, anti-allergic, hypotensive, antipyretic and peptic ulcer healing (Van Wyk et 
al.,1997). 
2.3.5 Prunus africana (ROSACEAE) 
Prunus africana is found mainly in afromontane forests along the mist belt regions of 
South Africa and further north into tropical Africa (Von Breitenbach, 1986). It is a tall tree 
that may reach more than 30 meters in height (Figure 5). The tree has buttress roots and a 
coarse, dark brown and black coloured bark. The dark green, glossy leaves smell of 
almonds when crushed. The tree produces small white flowers that are followed by 
reddish-brown berries (Coates Palgrave, 1977; Schippmann,2001). 
53 
The bark is used to treat intercostal pain (Pujol, 1990) and benign prostate hypertrophy 
Figure 5 a and b. Prunus africana tree (www.images.google.com) 
(Cunningham and Mbenkum, 1993; Bruneton, 1995). A water extract of the stem-bark is 
traditionally used in the treatment of bovine basesiosis whilst a powdered stem-bark mixed 
in water is used traditionally as a remedy for stomachache and as a purgative in humans 
and animals (Kokwaro, 1976). 
Some of the chemical constituents that have been isolated from the plant include 
phytosterols, pentacyclic triterpenoids esters, amygdalin that is a cyanogenic glycoside 
(Watt and Breyer-Brandwijk, 1962; Bruneton, 1995). Bark extracts yield friedelin, ursolic 
acid, maslinic acid, 2a-hydroxyursolic acid, epimaslinic acid (Catlano et a!., 1984). The 
reported activity of the tree against prostatic adenoma is possibly due to ~-sitosterol (Debat, 
1970). Oral administration of aqueous extract of Prunus africana stem-bark in rats has 
been shown to cause a slight dosage rate-associated increase in plasma alanine 
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aminotransferase (ALA T) and plasma creatine kinase (Gathumbi et ai. , 2000). The 
increase in ALAT suggests that the extract causes liver damage whilst a rise in plasma 
creatine kinase is indicative of the presence of cardiotoxic components in the plant. 
2.10.6 Terminalia sericea (COMBRETACEAE) 
T. sericea is found in the sandy savanna areas of Southern Africa (Coates Palgrave, 1977). 
The tree grows to about 5-8 meters in height and has a wide spreading crown. The coarsely 
fissured bark is grey to brown in colour whilst the leaves are characteristically silver-haired 
and crowded at the branch tip (Figure 6 a and b). The tree produces long fruits with two 
broad papery wings surrounding the thickened central part (Palmer and Pitman, 1972). 
Roots are used as remedies for stomach disorders, diarrhoea (Hutchings et aI. , 1996), 
treating schistosomiasis, pneumonia and eyewashes (Palgrave, 1981), infertility, venereal 
diseases, gynaecological disorders, general weakness and sore throats (Gelfand et ai. , 
1985). The bark is used to treat diabetes and wounds (Watt and Breyer-Brandwijk, 1962) 
whilst the leaves have been reported to be used to treat wounds and menorrhagia 
(Hutchings et ai., 1996). 
Figure 6 a and b. Terminalia sericea (www.images.google.com) 
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Several pentacyclic triterpenoids have been isolated from this tree, of which sericic acid 
and sericoside are the main compounds (Bombardelli et al. , 1974). These triterpenoids 
have been shown to have anti-ulcer, anti-inflammatory and cicatrising activity. The trees 
also produce tannins, which might explain the anti-diarrhoeal activity attributed to the plant 
(Hutchings et al. , 1996). 
2.10.7 Plantago major (pLANTAGINACEAE) 
The plant is thought to have originated in Europe but it is now commonly found naturalised 
throughout the world (Wells et al. , 1986). Plantago major ((Figure 7 a and b) together 
with Plantago lanceolata (Figure 8) are cosmopolitan annual or perennial hbs that are often 
stemless (Hutchings et al. , 1996). It can grow up to 15 meters with the size varying 
depending on the growth habitat. The leaves grow in rosettes, and they are ovate to 
elliptical with parallel venation. The flowers are small, brownish-green in colour and 
growing on long non-ramified spikes (Samuelsen, 2000). 
Figure 7 a and b. Plantago major (www.images.google.com) 
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Recent ethnophannacological studies show that this herb is used in many parts of the world 
to treat a variety of diseases. For instance, the plant decoctions are used for eye infections, 
toothache, rheumatism and uterine problems, and as vennifuges, tonics and diuretics 
(Gurib-Fakim et ai., 1993). According to Samuelsen (2000), the plant is also used to treat 
skin diseases, infectious diseases, problems concerning the digestive system, respiratory 
system, reproduction, the circulation, against tumours, for pain relief and for reducing 
fever. 
The seeds contain a lot carbohydrates and lipids (Samuelsen, 2000). Compounds isolated 
from the leaves include tannins, oleanolic acid, iridoids, catalpol and flavonoids (Pailer et 
ai. , 1969; Hutchings et ai., 1996). Extraction work on the leaf wax yielded oleanolic acid, 
ursolic acid, 18~-glycyrrhetinic acid and sitosterol (Ringbom et ai., 1998). Studies in 
China have shown that the plant extracts have anti-microbial activity and complex 
cardiovascular effects in animals (Chan and But, 1986). Other biological activities that 
have been attributed to P. major include anti-ulcerogenic activity (Yesilada et ai. , 1993), 
antioxidant and free radical scavenger activity 
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Figure 8 Plantago lanceolata (www.images.google.com) 
(Campos and Lissi, 1995). The reported diuretic effect of this plant is debatable since 
whilst some investigators have confirmed it (Caceres et al., 1987) others have failed to 
confirm it (Doan et al., 1992). This difference might be due to differences in the species of 
animals used in the studies since the former group tested the diuretic effect in rats whilst 
the latter group tested the effect in humans. 
2.10.8 Tetradenia riparia (LAMIACEAE) 
T riparia (Figure 9 a and b) is common in the tropical Africa and its distribution extends 
from eastern parts of South Africa into Namibia and Angola and northwards through east 
tropical Africa to Ethiopia (Codd, 1985; Hutchings et al., 1996). The plant is a perennial 
shrublet or soft shrub that has succulent leaves and stems with glandular hairs. The leaves 
are strongly aromatic. 
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Figures 9 a and b. Tetradenia riparia (www.images.google.com) 
Leaf decoctions and infusions are used for respiratory ailments, diarrhoea, influenza, 
malaria, gall sickness and dropsy of the lower limbs (Hutchings et ai. , 1996). 
Compounds from leaves include the diterpenoid diol and various similar diterpenoids such 
as 8(14), 15-sandaracopimaradiene-7a, 18 diol, umuravumbolide, ibozol, and 
deacetylboronolide (Hakizamungu et ai. , 1988). The diterpenoid diols from the leaves 
(particularly the 7, 18-diol) have antispasmodic activity guinea-pig ileum and on 
noradrenalin-induced contractions of rabbit aorta (Van Puyvelde et ai. , 1987). Extracts 
from leaves have also been shown to have in vitro antibiotic activity (Van Puyvelde et ai. , 
1986; Van Puyvelde et ai. , 1994). 
2.10.9 Combretum molle (COMBRETACEAE) 
The Combretum moUe (Figure 10) is common in the tropics especially in Africa. The tree 
produces fruits that have four or more wings on it. 
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Figure 10. Combretum moUe tree (www.images.google.com) 
Fresh or dry leaves are used for dressing wounds, snakebites, fever and anthelmintics, and 
as abortifacients (Watt and Breyer-Brandwijk, 1962). Roots are used for constipation, 
swelling of the abdomen, infertility, diarrhoea, bleeding after birth, convulsions, and as an 
aphrodisiac (Gelfand et al. , 1985). 
Chemical constituents that have been isolated from the plant include mollie acid, xyloside, 
arabinoside and large amounts of triterpenoids (Rogers and Thevan, 1986; Lawton and 
Rogers, 1993). The relative abundance of triterpenoids might explain the anti-
inflammatory, ant-microbial and molluscicidal activities associated with this plant. 
2.10.10 Eugeniajamholana (MYRTACEAE) 
The plant is found in the tropics and some parts of North America. The tree produces 
green unripe berries that become purple when ripe (Figure 11). 
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Figure 11 Eugeniajambolana (www.images.google.com) 
The pulp extract as well as the seed extract of E. jambolana fruits display hypoglycaemic 
activity although the action is said to be speedy (Achrekar, et al., 1991 ; Wang and Ng, 
1999; Grover, et al., 2000). Oral administration of the extract in normoglycemic and 
streptozotocin-induced diabetic rats causes the serum insulin levels to rise. It has also been 
shown that incubation of the extracts with isolated islets of Langerhans from normal and 
diabetic rats augments insulin secretion from the islets. These extracts inhibited insulinase 
activity from liver and kidney (Achrekar, et al. , 1991; Wang and Ng, 1999; Vikrant, et al. , 
2001). Although many studies have shown the hypoglycaemic activity of this plant, one 
study reported that the plant does not exhibit this activity. Pepato et aI., (2001) reported 
that Eugenia jambolana leaf decoction had no antidiabetic activity in Streptozotocin-
diabetic rats treated for 17 days. This discrepancy might only be explained as being due to 
differences in the extraction process between the groups. It is my view that extraction 
processes can result in losses of active compounds 
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The various plants belonging to Eugenia uniflora L. (Myrtaceae) are used in North-eastern 
Argentina as a treatment for hypertension. Intraperitoneal administration of the aqueous 
crude extract (ACE) decreased blood pressure of normotensive rats (Consolini, et at., 
1999). The results from this work suggest that the empirical use of Eugenia uniflora L. 
(Myrtaceae) is mostly due to a hypotensive effect mediated by a direct vasodilating 
activity, and to a weak diuretic effect that could be related to an increase in renal blood 
flow. Although, the authors do not specify the species of Eugenia used in their study, one 
can postulate that Eugenia jambutana might also have its hypotensive through the above-
mentioned mechanism. 
Various terpenoids including monoterpenoids, sesquiterpenoids, and triterpenoids have 
been isolated from the plant. The plant also produces saponin. Oleanolic acid isolated 
from its flowers has been reported to have strong anti-fertility effect in male albino rats 
(Rajasekaran et at., 1988). 
Ethanol extracts of the plant showed significant inhibitory activity against castor oil 
induced diarrhoea and PGE2 induced enteropooling in rats. The extracts also showed a 
significant reduction in gastrointestinal motility in charcoal meal tests in rats Thus, the 
results obtained establish the efficacy of the plant materials as anti-diarrhoeal agents 
(Mukherjee, et at., 1998) 
2.10.11 Clerodendrum trichotomum (VERBENACEAE) 
The plant is found in the warm tropical areas. It is a shrub that produces light to dark-pink 
flowers (Figure 12). 
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The plant has been reported to be used to reduce blood pressure. In addition to the blood 
lowering effect, plants belonging to this genus have been shown to have anthelminitic 
properties, sedative effects and muscle stimulating action (Gupta et a!., 1994) 
Figure 12. Clerodendrum trichotomum (www.images.google.com) 
The chemical constituents that have been isolated from the plant might include saponins. 
Intravenous administration of extracts from the dried leaves elicited renal vasodilatation 
and increased urine flow and urinary sodium excretion in dogs and rats (Lu et al., 1994). 
Oral administration reduced blood pressure of spontaneously hypertensive rats but not 
normotensive control rats. Chronic administration also prevented increases in blood 
pressure of spontaneously hypertensive rats. 
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2.10.12 Psychotria serpens (RUBIACEAE) 
The plant is found in the tropical areas. P. serpens is a shrub that has succulent leaves and 
stems. It has its inflorescence at the terminal and the flowers bud green and turn white 
(Figure 13). It produces green bellies that turn yellow to orange in colour. 
Whole herbs of Psychotria serpens are used a lot in folklore medicine. In Taiwanese 
folklore, the whole herb is used as an antirheumatic, analgesic, muscles relaxing, and 
circulation promoting drug (Chung, 1979). 
Ursolic acid was found to be one of the active principles of cytotoxic anti-leukaemic 
extracts from dried whole plants (Lee et al., 1988). The authors clearly indicated that 
ursolic acid showed significant cytotoxicity against the growth of lymphocytic leukaemia 
cell lines as well as a human lung carcinoma cell line. It also showed marginal cytotoxicity 
in the human colon and mammary tumour cells. 
Figure 13. Psycho tria serpens (www.images.google.com) 
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3.0 MATERIALS AND METHODS 
3.1- ETHICAL CONSIDERATION 
The Ethic Committee of the University of Durban-Westville approved the procedures 
followed in this study. Principles of laboratory animal care were followed. 
3.2 MATERIALS 
Silica gel, TLC plates and all the solvents were purchased from Merck, SA. Sea water 
collected from the Indian ocean in Durban. Brine shrimp eggs (Artemia salina Leach) were 
bought from a pet shop since they are readily available in these shops as food for tropical 
fish, and they remain viable for years in the dry state. Sodium thiopentone was purchased 
from Rhone-Pulenc, SA whilst Verapamil (isoptin) was purchased from Knoll AG, 
Germany. Isoproterenol (Isoprenaline) was purchased from Winthrop laboratory, New 
York whilst propranolol was bought from I.C.! Macclesfield, Great Britain. Quinidine 
chloride and Amiodarone hydrochloride were bought from Sigma, SA. Authentic oleanolic 
acid (95 % purity) and ursolic acid (97 % purity) were purchased from Africa International 
Food and Cosmetic Technologies (AfrIFaCT). 
3.3 PLANT IDENTIFICATION AND COLLECTION OF PLANT MATERIAL 
Fresh leaves of 16 different plant species were collected in different areas in K wazulu-
Natal province between March and July 2001 (see Table 2). The plants were identified 
and authentificated by a botanist, Prof. H. Baijnath, before been deposited as herbarium 
specimens and assigned collector's number no. MHC1-16 in the Ward Herbarium at the 
University of Durban-Westville. The 16 plants are; Psidium guineense, Psidium guajava 
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(white fruit) , Psidium durbanse (hybrid), Psidium guajava (Pink fruit) , Plantago major, 
Psychotria serpe us, Plantago lanceolata, Clerodendrum trichotomum. , Eugenia 
jambulana, Buddleja salviifolia., Combretum molle, Centella asiatica, Tetradenia riparia, 
Syzygium cordatum, Prunus africana and Terminalia sericea. 
T bi 2 D t a e . a es, oca lOn, mass an vouc er num er 0 p. an rna ena s co ec e f d h b fIt t'l lltd 
Name of Plant Date Location Weight of Herbarium 
Collected Crushed Specimen 
Leaves (g) Voucher 
Number 
Psidium guajava 14-03-01 Opposite nursery at 350.0 MHlOl 
(small fruit) dog section ofUDW 
Psidium guajava 14-03-01 Road to bio-kinetic 303.39 MHl02 
(white fruit) building, UDW 
Psidium guajava 14-03-01 Opposite T -junction 350.0 MHl04 
(Hybrid) to sports centre 
Psidium guajava 16-04-01 Near junction of 755.0 MHl03 
(Pink fruit) Essex terrace & road 
toUDW 
Plantago major 17-04-01 Mboweni 635.0 MHl08 
10-06-01 Paddock sugar 
10-06-01 Packlane 
Psychotreia 03-06-01 Isipingo 900.0 MHl16 
serpeus 
Plantago 16-04-01 Along freeway & 1431.0 MHl09 
lanceolata Chatsworth 
Clerodendreum 10-06-01 25km from Port 1383.0 MHl07 
trichotomum Shepstone 
Eugenia 17-04-01 Entrance to 1381.0 MHl06 
jambulana Silvergrane road 
Buddleja s. 20-04-01 200m from UDW 364.0 MHl13 
rector's house 
Combretum molle 20-04-01 300m from UDW 301.0 MHl12 
rector's house 
Centella asiatica 18-04-01 Nursery grounds at 384.0 MHl14 
UD W dog section 
Tetradenia riparia 17-04-01 Silvergrane nature 142.0 MHl15 
reserve 
Syzygum cordatum 21-04-01 Behind botany 1648.0 MHl05 
department, UDW 
Prunus africana 14-06-01 Silvergrane nature 964.0 MHlII 
reserve 
Terminalia sericea 10-06-01 Japanese gardens, 663.0 MHlI0 
Durban 
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3.4 BIOASSAY-DIRECTED ISOLATION OF ACTIVE PRINCIPLES OF PLANTS 
3.4.1 Extraction of plants 
The leaves from all the collected plants were air-dried, and milled into fme powder using a 
commercial blender. The powder of each plant was allowed to stand sequentially in 
hexane, dichloromethane (DCM) ethyl acetate and methanol. This exhaustive extraction 
was done under room temperature. The powder stood in the solvent for two days before 
filtering, using a 30cm filter paper (Whatman, England). The filtrate was then concentrated 
in vacuo using a rotary evaporator at a temperature of 55°C. The concentrated extract was 
recovered using minimal amounts of chloroform before being air-dried. The extraction was 
repeated 3 times and the extracts were combined to form four crude extracts per plant (refer 
Figure 14) 
3.4.2 Thin layer chromatography 
* 
The crude plant extracts were analysed by TLC to reveal the type of chemical constituents 
they contain. This technique was carried out by spotting a diluted solution of each crude 
extract on a TLC plate with authentic oleanolic acid, ursolic acid, uvaol, and methyl 
maslinate. The TLC plate was developed with ethyl acetatelhexane (8 :2) in a TLC tank. 
The developed TLC plate was visualised by initial exposure to ultraviolet light before 
spraying with anisaldehyde/sulphuric acid/alcohol solution* and heated at 110°C for 5 
minutes. Appearance of a blue or violet-blue colouration indicated the presence of 
triterpenoids (Hostettmann and Marston, 1995). 
• This spray reagent was prepared prior to use by mixing equal volumes of a 9: I solution of 
ethanoVanisaldehyde and 9: I ethanoVconcentrated Sulphuric Acid 
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This led to the isolation of different compounds like ursolic acid and oleannolic acid. Ethyl 
acetate crude extracts were initially selected over the other crude extracts because 
preliminary screening showed strong presence of triterpenoids in this fraction (personal 
communication from Prof. F.O Shode). 
I Plant material -1 
1. Hexane (3 times) 
2. Evaporation 
I I Hexane extracts I IMarc 1 I 
1. DCM (3x) 
2. Evaporation 
I DCM extracts I I Marc 2 I 
1. Ethyl acetate (3x) 
2. Evaporation 
I Ethyl acetate extracts I I Marc 3 l 
1. Methanol (3x) 
2. Evaporation 
, 
I Methanol extracts I Marc4 
Figure 14. Schematic presentation of the sequential crude extraction using 
different solvents. 
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3.4.3 Isolation and purification of compounds 
Since preliminary experiments had indicated that the ethyl acetate crude extracts contained 
most of the active compounds, that is the triterpenoids, only the ethyl acetate crude extracts 
was subjected to further purification process. The crude extracts were sequentially 
fractionated on silica gel 60 (particle size 0.0063- 0.200 mm) column chromatography with 
gradient elution (100 % hexane to 60 % hexane/ethyl acetate). All the collected fractions 
were subjected to a TLC analysis together with authentic triterpenoids. Fractions were 
pooled according to similar TLC profiles and the pooled fractions were concentrated in 
vacuo using a rotary evaporator at 50°C. The concentrates were reconstituted using 
minimal amounts of chloroform and allowed to air dry in preweighed vials. 
3.4.4 STRUCTURE ELUCIDATION 
The eluates that had similar TLC profiles to the authentic triterpenoids were combined and 
subjected to further chromatographic purifications. This process produced 80 % - 98 % 
pure isolates. These isolates were subjected to spectroscopic analysis using IH and 13C 
NMR techniques. 
The chemical structures of the isolates were revealed when their spectral data were 
compared with the spectral data of authentic triterpenoids namely; oleanolic acid, ursolic 
acid, uvaol, methyl maslinate, methyl corosolate and betulunic acid 
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3.5 TEST FOR TOXICITY 
All the crude ethyl acetate extracts and the pure triterpenoids from the plants collected were 
subjected to brine shrimp bioassay test according to the method of Meyer et al (1982). 
LCso's and 95 % confidence interval was determined from the 24 hour counts of the 
survived naupii by intersection. 
3.5.1 Hatching the Shrimp 
Two teaspoons of brine shrimp eggs were sprinkled into the one side of a beaker containing 
natural sea water that was continuously being aerated with compressed air. Covering, with 
aluminium foil, the sides and top, darkened one side of the beaker. The eggs were allowed 
48 hours to hatch. 
3.5.2 Sample preparation 
Samples were prepared by dissolving 20 mg of extracts and the pure triterpenoids in 2 ml 
of methanol. Appropriate amounts of solution (5 Ill, 50 Ill, and 500 III for 10, 100, and 
1000 Ilg/rnl, respectively) transferred to 1.25 cm discs of filter paper. Control discs were 
prepared using only methanol. Three replicates were prepared for each dose level. The 
discs were placed in vials and then dried in an oven for 1 hour. 
3.5.3 Bioassay 
After 48 hours, 10 shrimp were transferred to each sample vial (30 shrimp per dilution) 
using a disposable pipette, and seawater was added to make 5 ml. The vials were 
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maintained at 37°C. Survivors were counted after 24 hours, and the percent deaths at each 
dose and control were determined. 
3.6- ANIMALS USED 
Wistar male rats weighing between 300 and 320g were used. These rats were housed in the 
University of Durban-Westville' s Biomedical Resource Centre. They were exposed to the 
following physico-chemical factors; a 12 hour light: 12hour dark cycle, temperature of 21 0 
C ± 2, carbon dioxide content of <5 000 p.p.m., ammonia content of <50 p.p.m., noise 
levels of < 60 decibels, and under constant relative humidity of 50 % ± 5. Water and 
standard pellet food were provided ad libitum. The bedding comprised of chemically 
neutral, dust free sawdust and wood chips, gamma irradiated at 2,5 Megarads. Before the 
experiments, the animals were fasted overnight. 
Guinea pigs of all sexes that were above 600g were used. The guinea pigs were 
respemised and fasted overnight. The reserpine was administered to elucidate whether the 
positive inotropic was attributable to an indirect sympathomimetic action since reserpine 
deplete endogenous junctional noradrenaline stores (Salzmann et ai., 1985). They were 
provided with water and food ad libitum. 
3.7- URINARY PARAMETERS IN RATS 
The animals were placed in individual Nalgene metabolic cages in order to collect excreted 
urine for electrolyte analysis. The test compound was administered intraperitoneally at a 
dose of 60 mglkg in 5 ml distilled water per kg body weight, and the urea was applied in a 
dose of 1 glkg body weight. Urine excretion was recorded 5 and 24 hours after the 
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administration of the test compound. The electrolyte content of the urine was analysed 
using Beckman Synchron EL-ISE Electrolyte System (Germany). Six test animals were 
used per group. 
3.7.1 Diuretic activity in rats (LIPSCHITZ test) 
The test is based on water and sodium excretion in test animals and compared to rats 
treated with a high dose of urea. The "Lipschitz-value" of diuretic activity is the quotient 
between excretion by test animals (6 per group) and excretion by the urea control (Vogel 
and Vogel, 1997). 
In order to evaluate the diuretic effect, urine volume excreted per 100 g body weight was 
calculated for each group. Results were expressed as the "Lipschitz-value", i.e., the ratio 
TIU, in which T is the response of the test compound, and U is that of the urea treatment. 
Indices of 1.0 and more was regarded as a positive effect. With potent diuretics, values of 
2.0 and more can be obtained. For Saluretic drugs like hydrochlorothiazide, values around 
1.8 are reported whilst loop diuretics like furosemide, values of 4.0 or more are expected. 
In order to indicate the duration of the diuretic effect, the "Lipschitz-value" were calculated 
for both the 5 and 24 hour excretion period. 
3.7.2 Saluretic parameters 
Excretion of electrolytes is as important as the excretion of water for the treatment of 
hypertension. Saluretic drugs and potassium-sparing diuretics were developed to prevent 
potassium loss. The diuresis test in rats was modified in such a way that potassium and 
chloride as well as osmolality are determined in addition to water and sodium (Vogel and 
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Vogel, 1997). Ratios between electrolytes can be calculated indicating carbonic anhydrase 
inhibition or a potassium sparing effect. 
Just as in the Lipschitz test, the 5 and 24 hour urine was collected and analysed using 
Beckman Synchron EL-ISE Electrolyte System (Germany). Hydrochlorothiazide (25 
mglkg body weight) was used as a standard. From the electrolyte content in the urine, the 
sum ofNa+ and cr excretion was calculated as a parameter for saluretic activity. The ratio 
Na+j cr was calculated for natriuretic activity. Values greater than 2.0 indicated a 
favourable Natriuretic effect whilst ratios greater than 10.0 indicated a potassium-sparing 
effect. The ratio cr; Na+ + K+ (ion quotient) was calculated to estimate carbonic anhydrase 
effect. Carbonic anhydrase inhibition was excluded at ratios between 1.0 and 0.8 whilst 
with decreasing ratios slight to strong carbonic anhydrase inhibition was assumed. 
3.8 BLOOD PRESSURE MEASUREMENTS 
Systolic, diastolic and mean blood pressures in each conscious wistar rat were determined 
by indirect method using tail-cuff method and by the direct method. 
3.8.1 Indirect BP measurements 
Four wistar rats were used per test compound, in addition to six untreated control wistar 
rats. Before recording the actual experimental readings, the rats were trained for four 
consecutive days to minimise stress reactions and thus increasing the reliability of our 
results. The training regime comprised the whole procedure that would be followed during 
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the actual readings. A tail-cuff computerised blood pressure monitor (lITC Life Sciences 
31, USA) was used. 
The blood pressure monitor works with an lITC hardware system to determine both the 
blood pressure and the heart rate. Typically the system employs a an automatic scanner 
and pump in addition to a photoelectric sensor in the tail sensing cuff and amplifier to 
measure and count the heart beat pulses in the animals tail. The use of the photoelectric 
sensor permits measurement at the lowest ambient temperature possible thereby reducing 
heat stress on the animal and as such yielding results that closer to the values obtained by 
cannulation. The results were displayed as data plots and summary data of systolic, 
diastolic and mean blood pressures, and heart rate on the computer screen. We used the 
medium restraining devises and the 15 mm tail cuffs in accordance with the rats' size. 
Three closes readings were averaged for each rat per session, and the measurements were 
done at the same time of day to prevent circadian rhythmic changes in pressure. The room 
temperature was kept 30°C and the restraining devices were warmed before placing the 
animal. This method was validated in our laboratory by simultaneous direct (cannulation 
through the left common carotid artery) and indirect (tail-cuff method) measurements of 
blood pressure as is required according to Bufiag (1991). There was good correlation 
between direct and indirect blood pressure measurement. For systolic blood pressure r = 
0.96, for diastolic blood pressure r = 0.67, and for heart rate r = 0.87. 
Two types of measurements were performed: 
• After a single intraperitoneal application of the test compound , systolic and 
diastolic blood pressure and heart rate were monitored for 60 minutes in 10 
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minutes intervals so as to record the effects of the compound and also the 
duration of the effect. 
• The same parameters were monitored for 6 consecutive days just before the 
animals received a daily single intraperitoneal (Lp.) injection of the test 
compound .. 
3.8.2 Direct BP measurements 
Six anaesthetised wistar rats were used to detect the effect of the test compounds on blood 
pressure and heart rate. The rats were anaesthetised by intraperitoneal (i.p.) injection of 
sodium thiopentone, 40 mglkg body weight (Rhone-Pulenc, SA). For continuous 
monitoring of mean arterial blood pressure and heart rate, the left carotid artery was 
cannulated and a catheter was connected to a pressure transducer (Statham MLT 0380, Ad 
instruments), compatible with the PowerLab System ML410/W. The electrocardiogram 
(ECG) was monitored throughout the experiments (ECG-Cl, ESAOTE Biomedica, Italy, 
and PowerLab System ML410/W. Changes in ECG were recorded from standard lead II 
only at 25-mmlsec chart velocity. The evaluation of inotropic and dromotropic effects, and 
action potential duration was based on the computer analysis of the ECG registered by the 
PowerLab System. Blood pressure values were expressed as means of three consecutive 
measurements 
3.9 BIOCHEMICAL DETERMINATIONS 
Blood glucose in whole blood was estimated by Glucometer Elite, Bayer Diagnostics, 
France. The blood was collected from the cut tail tip 30 minutes after intraperitoneal 
administration of the test compound. 
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3.10 CARDIOTONIC EXPERIMENTS 
In all experiments, authentic OA (95 % purity) and UA (97 % purity) were used a reference 
substances for the tested triterpenoids 
3.10.1 Cardiotonic measurements in guinea pig atria 
Guinea pigs of either sex weighing 400-600 g were used to study the cardiotonic effects of 
the triterpenoids and the plant extracts according to the method described by Gilani et al. 
(1999). The guinea pigs were reserpinised (1 mg/kg) 24 h before being sacrificed by 
cervical dislocation. The reserpine was administered to elucidate whether the positive 
inotropic was attributable to an indirect sympathomimetic action since reserpine deplete 
endogenous junctional noradrenaline stores (Salzmann et al., 1985). The heart was quickly 
removed and placed in oxygenated physiological solution (Krebs-Hanseleit buffer). The 
left and right atria were separated carefully and cleaned of fatty tissue. The preparation 
was fixed to a bipolar platinum point electrode mounted in a 20 ml tissue chamber 
containing the physiological salt solution at 37°C, and was constantly being aerated by 
carbogen (02 containing 5% C02). Right atria were allowed to beat spontaneously under a 
resting tension of 1 g, and the left atria were electrically stimulated by 0.7 ms pulses of 10-
15 V, 2 Hz. All the preparations were equilibrated for a 30 minute period before the 
addition of any test compound. Isometric contractions and, in right atria, rates of 
spontaneous beating were recorded by means of a force-displacement transducer (U go 
Basile, Italy) on a recorder (Ugo Basile, Italy) 
For the evaluation of cardiotonic responses, the following protocol was used: After the 30 
minutes equilibration period, the atrium was thoroughly washed (at least 3 times) and its 
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viability was tested by administering isoprenaline (0.1, 0.25 Ill) as a reference substance. 
The tissue was then washed 3 times and equilibrated for 15 minutes and it was washed a 
further 3 times. After baseline values were obtained, cumulative doses of each test 
compound were added to the tissue bath, and its inotropic and chronotropic effects were 
recorded for a total of 10 minutes. The test compounds were added to the tissue bath in a 
cumulative fashion (0.05, 0.50, 1.00 mg/ml) at 3 minute interval to obtain a complete dose-
response curve. The tissue was then washed three times and equilibrated for a 15 minutes 
before being checked for its viability and comparison with effect of isoprenaline. Upon 
being washed thoroughly, the tissue was further equilibrated for a 15 minutes and washed 
again before testing another compound. Each tissue was used for a maximum of four test 
compounds. 
3.10.2 p-adrenergic effects of crude plant extracts and pure compounds 
To see if the inotropic effects of the extracts and the pure triterpenoids were mediated 
through a ~-adrenergic -like mechanism, the atria was pre-treated with propranolol (1 IlM), 
a ~-adrenoceptor blocking agent (Hoffman and Lefkowitz, 1990). The test compounds 
were applied 5 minutes after the application of propranolol to allow complete block of the 
~-receptors. 
We also checked whether the test compounds could either block or potentiate the effect of 
isoprenaline. This was done by firstly obtaining baseline values of the tissue then 
cumulative dose of isoprenaline (0.1 , 0.25 and 0.5 Ill) followed by the test compounds. 5 
minutes later, isoprenaline administration was repeated and compared to the control values. 
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3.10.3 Cholinergic experiments 
To study the involvement of cholinergic receptors in the mechanism of action of our test 
compounds on the guinea pig myocardium, 5 ~g1ml of atropine sulphate was used. 
Involvement of the cholinergic mechanism was performed by introducing the extracts 
before and after adding the atropine sulphate to the tissue bath. 
3.11- ANTIDYSRHYTHMIC EXPERIMENTS 
The effects were evaluated on chemical and ischaemia-reperfusion models of arrhythmia. 
For chemically induced arrhythmia, we used the CaCh-, BaCh-, and adrenaline induced 
models of arrhythmia. For the ischaemia-reperfusion induced arrhythmia, we used the 
coronary artery ligation/reperfusion model. The Lambeth convention' s guidelines were 
followed (Walker et ai., 1988). As positive controls, we used all four classes of 
antiarrhythmic reference drugs according to the Vaughan Williams classification (1991). 
The reference drugs used were: for class I (sodium fast channel blockers) quinidine 
chloride was used; for class II (~-adrenergic antagonists), propranolol hydrochloride was 
used; for class III (prolonged action potential by blocking potassium channels) amiodarone 
hydrochloride was used; for class IV (slow calcium channel blocker) verapamil was used. 
The optimal dosages for the animals are shown together with the results and were 
determined during the preliminary experiments. These drugs were administered through 
the cannulated right jugular vein. The drug administration was standardised to injections of 
0.2 ml per 100 g body weight over a period of 1 min to prevent inducing arrhythmias. 
In the intact animal, all the information necessary for the detection of arrhythmias is 
adequately provided by a single ECG lead with sufficient resolution (Walker et ai., 1988). 
78 
Thus in accordance with the Lambeth conventions, the ECG (ECG-C 1, ESAOT , 
Biomedica, Italy) itself was taken as a sole basis for definition, classification, and 
quantification of arrhythmia. Changes in ECG were registered with needle electrodes only 
from the standard lead II at 25-mmlsec chart velocity. The ECG records were kept in the 
department where they will be for at least the next seven years as is postulated by the 
Lambeth Conventions. 
3.11.1 Chemically induced models of arrhythmia 
To test the anti-arrhythmic effect of our test compounds on the chemically induced 
arrhythmia, six anaesthetised rats were used per compound. The rats were anaesthetised by 
intraperitoneal injection of sodium thiopentone (40 mg/kg body weight). All the chemicals 
used to induce the arrhythmias were administered through the cannulated right jugular vein. 
The arrhythmias were induced 20 minutes after intraperitoneal administration of a test 
compound. This was done like this to check whether the test compounds had any 
prophylactic potential on the occurrence of the chemically induced-arrhythmias. Before 
the application of the test compound, control ECG of each arrhythmogenic chemical was 
registered. 
3.11.1.1 BaCh -induced arrhythmia 
BaCh-induced arrhythmias were used to investigate the antiarrhythmic action of our test 
compound on the rhythmicity of the myocardium and prolongation of the action potential 
by decreasing the efflux of potassium. Unlike the dosage of 2 mg/kg as was used by 
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Petkov and Manolov (1972), a dosage of 1 mg/kg was used in this study because it was 
found in preliminary experiments that the former dose killed the rats. BaCh (1 mg/kg) was 
administered intravenously 20 minutes after intraperitoneal administration of the test 
compounds. Control ECG of BaCh alone was recorded so as to compare it with the ECG 
obtained from the BaCh applied on the background of the test compound. 
3.11.1.2 eaCh - induced arrhythmia 
CaCh-induced arrhythmia was used to evaluate possible antiarrhythmic calcium 
antagonistic effects of the test compounds. The arrhythmia was initiated by administering 
a 2.5 % CaCh solution (140 mg/kg) (Papp et al. , 1966) on the background of the test 
compound that was administered 20 minutes before. Changes in ECG were recorded after 
the application of CaCh before and on the background of the test compounds 
3.11.1.3 Adrenaline-induced arrhythmia 
Adrenaline-arrhythmia in rats were induced through intravenous injection of adrenaline in a 
dose of 10 Ilg/kg for the evaluation of ~-blocking activity (Barrett and Cullum, 1968). Just 
like above, changes in ECG were recorded after the application of CaCh before and on the 
background of the test compounds. 
3.11.2- Ischemia-reperfusion arrhythmia 
To evaluate the effect of the test compounds on the ischaemia-reperfusion model of 
arrhythmia, six anaesthetised rats were used per each compound. The rats were 
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anaesthetised by intraperitoneal injection of sodium thiopentone (40 mg/kg body weight). 
The trachea was cannulated and artificial respiration was achieved by a positive-pressure 
rodent respirator (Phipps and Bird Inc., USA). This artificial respiration used atmospheric 
air at a tidal volume of approximately 5 ml at a rate of 25 breaths per minute. Throughout 
the whole experiment, changes in ECG (ECG-Cl , ESAOT Biomedica, Italy) were 
monitored from standard limb lead II with needle electrodes. Haemodynamic parameters 
(mean arterial pressure and heart rate) were monitored from a cannulated carotid artery 
with a catheter connected to a Statham MLT 0380 pressure transducer (Ad instruments), 
compatible with the PowerLab System ML410/W, Australia. 
Regional myocardial ischaemia model of arrhythmia and the reperfusion model of 
arrhythmia were used since as has been stated in chapter two, these two arrhythmias are 
initiated by different mechanisms (Curtis and Hearse, 1989). Ischaemia-reperfusion 
arrhythmias were induced according to the method described by Kane et al., (1984) with 
slight modifications. In anaesthetised and artificially ventilated rats, the chest was opened 
using a left thoracotomy, followed by sectioning of ribs 4 and 5, approximately 2 mm to 
the left of the sternum. Positive pressure artificial respiration was started immediately to 
maintain normal peol, POl and pH parameters. After incising the pericardium, the heart 
was exposed out of the chest using gentle pressure on the rib cage. A 6/0 silk non-
traumatic suture was passed through the epicardial layer under the left main coronary 
artery, about 2 mm from the origin. A small plastic button was threaded through the 
ligature and placed in contact with the heart. The end of the ligature was passed through a 
small vinyl tube and exteriorised. The heart was massaged before being replaced in the 
chest, and then thorax was closed after removing the residual air to avoid pneumothorax. 
The animal was left to recover for 15 minutes. Any animal in which this procedure 
81 
produced arrhythmias or a sustained fall in blood pressure to less than 70 rrunHg was 
discarded. Applying tension to the ligature could then occlude the artery and reperfusion 
was achieved by releasing the tension 
Two types of studies were undertaken for the antiarrhythmic actions of our test compounds. 
In the first type of experiments, the artery was occluded for 30 minutes to induce 
experimental ischaemia, and then the tension was released for 20 minutes to produce 
reperfusion. In this study, any heart that was not in sinus rhythm during 2 seconds just 
before and at the moment of reperfusion was excluded from the reperfusion study and was 
immediately replaced (Walker et ai., 1988; Curtis and Hearse, 1989). The ischaemia were 
done either 20 minutes after intraperitoneal administration of the test compound or 10 
minutes after intravenous injection of the antiarrhythmic drugs. In the second set of 
experiments, the drug pre-treatment was replaced by ischaemic preconditioning produced 
by three 3-minutes occlusion periods interspaced with 3-mnutes reperfusion period. After 
the last 3-mute reperfusion, the artery was occluded for 30 minutes (to produce ischaemia) 
followed by 20 minutes reperfusion. 
To determine whether reperfusion was in fact occurring, 0.1 ml 100-1 (body weight) of a 10 
% solution of fluorescein (Sigma) was administered through the jugular vein immediately 
before sacrificing the animals. The heart was rapidly removed from the chest and placed in 
ice cold KCI solution (10 % weight/volume) for 1 min to cause cardioplegia. A gross 
examination of the heart was made under ultraviolet light to determine whether areas of 
non-perfused myocardium were present. These appeared dark blue under ultraviolet light 
whereas perfused were stained green. The hearts were then photographed under ultraviolet 
light to give a permanent record. As a comparison, this procedure was also carried out in 
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hearts with a permanent ligation, after 30 minutes of ischaemia, and in control non-
ischaernic hearts. 
3.12- STATISTICAL ANALYSIS 
All results were evaluated originally as means ± SEM. After statistical analysis, the results 
were presented, when indicated, as % of the baseline value. For all analyses, INSTAT 
V2.04 program was used, including one-way and two-way ANOVA, (-test and Chi-square 
test. A p-value less than 0.05 was considered to be statistically significant. 
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4.0 RESULTS 
4.1 PLANT MATERIALS AND EXTRACTS 
The extraction process yielded four different crude extracts per plant. The four types of 
extracts were; the hexane crude extracts, chloroform crude extracts, ethyl acetate crude 
extracts and the methanol crude extracts. Thus, 64 different crude extracts from 16 
different medicinal plants were obtained. The weight of these crude extracts are shown in 
appendix 2. As was indicated in the methodology section in chapter 2, the preliminary 
studies had shown that the crude ethyl acetate extracts contained many of the triterpenoids 
than the other extracts. Thus, we only used the ethyl acetate crude extract to investigate the 
cardiovascular effects of them. We also used the ethyl acetate crude extracts to isolate and 
purify the triterpenoids. 
Both TLC and NMR (appendix 5) revealed that indeed the crude ethyl acetate extracts 
contained a number of triterpenoids. Table 3 shows the approximate percentage of the 
triterpenoids extracted from the crude ethyl acetate extract. All the plants contained 
triterpenoids though in different concentration. The highest yield was obtained from 
Buddleja salviifolia followed by Syzygum cordatum then Psidium guajava (white fruit) and 
Eugeniajambulana. The least amount oftriterpenoids was obtained from Centella asiatica 
followed by Tetradenia riparia then Terminalia sericea and Clerodendrum. The isolation 
and purification processes yielded the following triterpenoids; oleanolic acid, ursolic acid, 
uvaol and methyl maslinate (Figure 15). Oleanolic acid was the most predominant of all 
the triterpenoids. Oleanolic acid (OA) recrystallised from methanol as colourless crystals 
with a melting point of about 307-308 °C. Its spectral data (Fig. 42) were identical with 
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literature values (Maillard et al., 1992). Ursolic acid (VA) recrystallised from methanol as 
colourless crystals with melting point of 286°C. Its spectral data (Fig. 43) were identical 
with literature values (Seo et al. , 1975a). Uvaol (UV) recrystallised from 
methanolldichloromethane as colourless crystals with a melting point of about 221-223 °C. 
Its spectral data (Fig. 44) were identical with literature values (Siddiqui et al. , 1986). 
Methyl maslinate (MM) was only eluted when the crude ethyl acetate extract was subjected 
to a silica gel column chromatography with gradient elution using a 60 %/ 40 % 
hexane/ethyl acetate solvent system. The eluates containing MM were obtained only from 
the last fractions. MM was used without recrystallisation, and its spectral properties (Fig. 







HO lo • 
uv 
MM 
Figure 15. Structures of oleanolic acid (OA), ursolic acid (UA), uvaol (UV) and methyl 
maslinate (MM) 
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Table 3: Approximate percent yield of triterpenoids from crude ethyl acetate extracts 
from different plants 
NAME OF PLANT ESTIMATED % YIELD OF 
TRITERPENOIDS 
Psidium fluaiava (small fruit) 0.29 
Psidium ~uajava (white fruit) 0.37 
Psidium guajava (Pink fruit) 0.13 
Psidium ~ajava (hybrid) 0.15 
Syzygum cordatum 0.62 
Eu~enia jambulana 0.33 
Clerodendrum L 0.04 
Plantaflo maior 0.25 
Plantago lanceolata 0.11 
Terminalia sericea 0.04 
Prunus africana 0.29 
Combretum moUe 0.05 
Buddleja salvlfolia 0.69 
CenteUa asiatica 0.01 
Tetradenia rilJaria 0.02 
Psychotreia serpeus 0.09 
4.2. TOXICITY RESULTS 
Acute toxicity of the ethyl acetate crude extracts from all the 16 plants and three 
triterpenoids: oleanolic acid, ursolic acid and uvaol was done using brine shrimp (Artemia 
salina) bioassay. We were unable to do toxicity test of methyl maslinate (MM) because it 
was not dissolving in methanol, and it could only dissolve in DMSO. However, DMSO 
proved to be toxic on its own and hence could not be used as a solvent for testing the 
toxicity in brine shrimp. On the other hand, all the crude ethyl acetate extracts from the 16 
plants, and OA, UA and UV showed very low toxicity. The LCso of them are shown in 
table 4 below. On the basis of the low toxicity of all the tested substances, we assumed that 
MM had also low toxicity, and hence it was applied in the experiments at the same doses as 
the other compounds. 
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Table 4: LCso of phytochemical extractives and authentic oleanolic acid, ursolic acid, 
uvaol and methyl maslinate evaluated on brine shrimp test 
Group LCso (mglml) 
Oleanolic acid 0.100 ± 0.035 
Ursolic acid 0.950 ± 0.040 
Uvao} 1.100 ± 0.040 
Methyl maslinate -
Psidium guajava (small fruit) 0.850 ± 0.035 
Psidium guajava (white fruit) 1.500 ± 0.045 
Psidium guajava (Pink fruit) 1.000 ± 0.050 
Psidium guajava (hybrid) 0.600 ± 0.045 
Syzygum cordatum 1.200 ± 0.050 
Eugenia jambulana 0.100 ± 0.045 
Clerodendrum capense 0.100 ± 0.045 
Plantago major 0.100 ± 0.046 
Plantago lanceolata 0.700 ± 0.035 
Terminalia sericea 6.000 ± 0.080 
Prunus africana 3.300 ± 0.085 
Combretum moUe 5.200 ± 0.080 
Buddleja salvifolia 1.800 ± 0.040 
CenteUa asiatica 1.800 ± 0.040 
Tetradenia riparia 4.000 ± 0.065 
Psychotria serpens 0.010 ±0.004 
LCso-Mean ± SEM 
4.3. EFFECTS ON URINARY PARAMETERS 
The urinary analysis for the diuretic, saluretic and natriuretic effects of oleanolic acid , 
ursolic acid and the phytochemicals are presented in table 5a and 5b. Table 5a are the 
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results from the urine that was collected 5 hours after intraperitoneal administration of the 
test compounds whilst table 5b contains analysis of the urine that was collected 24 hours 
after intraperitoneal injection of the test compounds. No carbonic anhydrase inhibition was 
detected. 
4.3.1 Diuretic effects of the test compounds 
The results of the Lipschitz test analysed usmg the unne collected 5 hours after 
intraperitoneal injection indicate that all the test compounds except Psidium guajava (small 
fruit) and Psidium guajava (white fruit) had a diuretic effect that was comparable to that of 
hydrochlorothiazide (Figure 5a). On the other hand, the results from the urine collected 24 
hours after intraperitoneal administration show that only, oleanolic acid, ursolic acid, 
Syzygum cordatum, Eugenia jambolona, Plantago lanceolata, Tetradenia riparia and 
Psychotreia serpens exhibited a diuretic effect that was comparable to that of 
hydrochlorothiazide (Figure 5b). 
4.3.2 Saluretic effects of the test compounds 
Table 5a show the saluretic effects of the test compounds after 5 hours intraperitoneal 
application of them. It can be seen from these results that only ursolic acid displayed a 
slight saluretic effect on the animals. Analysis of the urine collected after 24 hours indicate 
that only Eugenia jambolona and Psidium guajava (small fruit) had a saluretic effect that 
was comparable to that of hydrochlorothiazide (Table 5b). 
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TABLE 5a: Diuretic, Saluretic and Natriuretic activity of oleanolic, ursolic and 
phytochemical extractives (5 hours after intraperitoneal administration) 
Lipschitz CI 
GrouplParameter Diuresis Value Na+CI NalK Na+K 
(mlllOOg (T/u) (mmolll) (mmolll) (mmolll) 
b.w) 
Urea (lg/kg h.w.) 1.4 ± 0.2 - 440 ± 12.6 1.67 ± 0.17 0.654 ± 0.02 
Hydrochlorothiazide 3.5 ± 0.6 2.50 520 ± 8.4 3.44 ± 0.10 0.834 ± 0.02 
(25mg/kg b.w) 
Oleanolic acid (60 1.4 ± 0.2+ 1.00 376 ± 15.7*+ 1.07 ± 0.12+ 0.618 ± 0.05+ 
mg/kg) 
Ursolic acid (60 1.6 ± 0.3+ 1.10 442 ± 12.8 + 1.47 ± 0.17+ 0.466 ± 0.03*+ 
mg/kg) 
Psidium guajava 0.80 ± 0.10*+ 0.58 297 ± 12.0*+ 0.90 ± 0.11 *+ 0.525 ± 0.06*+ 
(small) 
Psidium guajava 1.10±0.2+ 0.79 353 ± 19.0*+ 0.86 ± 0.05*+ 0.610 ± 0.01 *+ 
(white) 
Psidium guajava 2.60 ± 0.2 1.86 241 ± 7.4*+ 1.24 ± 0.08+ 0.544 ± 0.01 *+ 
(Pink) 
Psidium guajava 1.42 ± 0.10+ 1.01 188 ± 12.5*+ 0.92 ± 0.10*+ 0.572 ± 0.01 *+ 
(hybrid) 
Syzygum cordatum 1.67 ± 0.2+ 1.19 246± 406*+ 1.32 ± 0.13+ 0.530 ± 0.02*+ 
Eugenia jambulana 1.86 ± 0.2+ 1.33 242 ± 13.1 *+ 1.26 ±0.30+ 0.480 ± 0.01 *+ 
Clerodendrum L 2.61 ± 0.2 1.86 232 ± 7.5*+ 1.49 ± 0.06+ 0.526 ± 0.01 *+ 
Plantago major 2.11 ± 0.3 1.51 225 ± 1.0*+ 1.26 ± 0.14+ 0.522 ± 0.01 *+ 
Plantago lanceolata 2.28 ± 0.3 1.63 227 ± 12.0*+ 1.55 ± 0.50+ 0.548 ± 0.05*+ 
Terminalia sericea 2.67 ± 0.2 1.91 233 ± 12.6*+ 1.29 ± 0.25+ 0.502 ± 0.01 *+ 
Prunus africana 3.19 ± 0.3 2.28 2.71 ± 8.2*+ 1.44 ± 0.08+ 0.508 ± 0.01 *+ 
Combretum moUe 2.74 ± 0.2 1.96 239 ± 7.6*+ 1.38 ± 0.01 + 0.510 ± 0.02*+ 
Buddleja salvifolia 2.15 ± 1.54 282 ± 2.6*+ 1.10±0.11+ 0.569 ± 0.01 *+ 
0.2 
CenteUa asiatica 2.52 ± 1.80 249 ± 10.0*+ 1.50 ± 0.04+ 0.515 ± 0.01 *+ 
0.3 
Tetradenia riparia 2.26± 1.61 256 ± 1.0*+ 1.59 ± 0.09+ 0.506 ± 0.01 *+ 
0.3 
Psychotreia serpeus 1.62 ± 1.16 330 ± 10.0*+ 1.12 ± 0.8+ 0.552 ± 0.01 *+ 
0.1+ 
Mean ± SEM. All phytochemicals were applied in a dose 100mg/kg b.w. except 
Psychotreia serpeus (60 mglkg b.w.) 
* The difference is significant compared to effect of urea 
+ The difference is significant compared to effect of hydrochlorothiazide 
T /u "Lipschitz-value" ratio in which T is the response of the tested compound and U is the 
urea response 
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TABLE 5b: Diuretic, Saluretic and Natriuretic activity of oleanolic, ursolic and 
phytochemical extractives (24 hours after intraperitoneal administration) 
Lipschitz CI 
GrouplParameter Diuresis Value Na+CI NalK Na+K 
(mlllOOg (T/u) (mmolll) (mmolll) (mmolll) 
b.w) 
Urea (lglkg b.w.) 7.0± 0.6 - 281 ± 10.0 1.32 ± 0.12 0.648 ± 0.01 
Hydrochlorothiazide 14.6 ± 0.5 2.08 382 ± 7.6 2.43 ± 0.12 0.672 ± 0.01 
(25mglkg b.w) 
01eanolic acid (60 7.0 ± 0.4+ 1.00 269 ± 8.4+ 0.92 ± 0.13+ 0.539 ± 0.01 + 
mg/kg) 
Ursolic acid (60 6.8 ± 0.4+ 0.97 227 ± 12.2+ 0.83 ± 0.10+ 0.566 ± 0.02+ 
mglkg) 
Psidium guajava 2.30 ± 0.2*+ 0.33 350 ± 11.0+ 1.04 ± 0.10+ 0.528 ± 0.02+ 
(small) 
Psidium guajava 2.62 ± 0.38 229 ± 9.0+ 1.11 ± 0.15+ 0.435 ± 0.02*+ 
(white) 0.15*+ 
Psidium guajava 4.86 ± 0.3*+ 0.69 240 ± 1.0+ 1.71 ± 0.16+ 0.420 ± 0.01 *+ 
(Pink) 
Psidium guajava 3.03 ± 0.2*+ 0.43 223 ± 10*+ 1.41 ± 0.50+ 0.429 ± 0.01 *+ 
(hybrid) 
Syzygum cordatum 6.62 ± 0.3+ 0.96 278 ± 10.0+ 2.08 ± 0.34 0.428 ± 0.03*+ 
Eugenia jambulana 6.25 ± 0.2+ 0.90 309 ± 11.0+ 3.05 ± 0.16 0.410 ± 0.01 *+ 
Clerodendrum L 3.99 ± 0.3*+ 0.57 275 ± 5.9+ 1.84 ± 0.10+ 0.406 ± 0.01 *+ 
Plantago major 4.04± 0.2*+ 0.58 226 ± 1.7*+ 1.96 ± 0.14+ 0.422 ± 0.02*+ 
Plantago lanceolata 6.28 ± 0.3+ 0.90 241 ± 8.9+ 2.23 ± 0.12 0.410 ± 0.01 *+ 
Terminalia sericea 4.25 ± 0.2*+ 0.61 233 ± 10.0+ 1.56 ± 0.14+ 0.477 ± 0.05*+ 
Prunus africana 4.65 ± 0.1 *+ 0.66 211 ± 12.0*+ 1.31 ± 0.12+ 0.499 ± 0.04*+ 
Combretum moUe 4.96 ± 0.2*+ 0.71 174 ± 2.9*+ 1.28 ± 0.06+ 0.501 ± 0.01 *+ 
Buddleja salvifolia 4.90 ± 0.3*+ 0.70 239 ± 12.6+ 1.87 ± 0.05+ 0.443 ± 0.01 *+ 
CenteUa asiatica 4.34 ± 0.2*+ 0.62 236 ± 1.0+ 1.66 ± 0.03+ 0.461 ± 0.02*+ 
Tetradenia riparia 6.58 ± 0.2+ 0.93 235 ± 1.4+ 2.00± 0.04+ 0.416 ± 0.04*+ 
Psychotreia serpeus 6.22 ± 0.2+ 0.90 261 ± 10.0+ 2.10 ± 0.10 0.411 ± 0.01 *+ 
Mean ± SEM. All phytochemicals were applied in a dose 100mg/kg b.w. except 
Psychotreia serpeus (60 mg/kg b.w.) 
* The difference is significant compared to effect of urea 
+ The difference is significant compared to effect of hydrochlorothiazide 
T/u "Lipschitz-value" ratio in which T is the response of the tested compound and U 
is the urea response 
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4.3.3 Natriuretic effects of the test compounds 
The results of natriuretic effects of ursolic acid, oleanolic acid and the 16 phytochemicals 
are presented in tables 5a and 5b. All the test compounds did have some natriuretic effect 
on the rats at 5 hours after their administration. Analysis of the urine collected after 24 
hours from the time the compounds were administered, showed that oleanolic acid, ursolic 
acid, Psidium guajava (small fruit), P. guajava (white fruit), Psidium guajava (hybrid), 
Terminalia sericea, Prunus aji-icana and Combretum moUe had no natriuretic effect even 
after 24 hours. Psidium guajava (Pink fruit), Plantago major, Clerodendrum L, Buddleja 
salvii/olia, Tetradenia riparia and CenteUa asiatica had a slight natriuretic effect. Syzygum 
cordatum, Eugenia jambolana, Plantago lanceolata and Psychotreia serpens had similar 
natriuretic effects to those of hydrochlorothiazide as their effects were not significantly 
different. Actually, Eugenia jambolana had better natriuretic effect than the 
hydrochlorothiazide. 
4.4- EFFECTS ON BLOOD PRESSURE 
The haemodynamic results of the pure triterpenoids isolated in this study, that is OA, UA, 
UV and MM, are presented in Table 6 and Figures 16 - 21. All the four triterpenoids 
showed a significant vasodepressor effect and sinus bradycardia that lasted for more than 
60 min. These effects were dose-dependent with the peak effect seen at 20 min after 
application. The most potent effects were shown by OA and MM. Table 7 and Figures 22 
and 23 shows the effect of isoprenaline after 15 minutes pre-treatment with the four 
triterpenoids and a propranolol, a beta-adrenergic blocker that acted as a reference drug. 
The pre-treatment with the triterpenoids decreased the vasopressor and tachycardic effects 
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of isoprenaline. Oleanolic acid had the most potent effect than the other three triterpenoids 
as its reduction of the vasopressor effect of isoprenaline was similar to that of the reference 
drug, propranolol. 
The results of blood pressure and heart rate effects of the phytochemicals after a single 
intraperitoneal application (100 mg! kg b.w) are presented in Table 8 and Figures 24a -
26b. All the phytochemicals showed a trend of decreased blood pressure on the 10 minutes 
after a single intraperitoneal application except those from Clerodendrum capense, Prunus 
a/ricana, Psidium guajava (hybrid), Terminalia sericea and Plantago lanceolata. Of the 
plants that showed a decreased trend of blood pressure, only Syzygum cordatum, Eugenia 
jambolana, Plantago major, Buddleja salviifolia, Tetradenia riparia, Psidium guajava 
(Pink fruit) and Psychotreia serpens had their effects persisting for more than 60 minutes. 
On the other hand, Psidium guajava (small fruit), Psidium guajava (white fruit), 
Combretum moUe and CenteUa asiatica had their hypotensive effects lasting for less than 
30 minutes. Only Eugenia jambolana, all the Psidium guajava subspecies, Terminalia 
sericea and Tetradenia riparia produced significant bradycardia activity in the animals 
after a single intraperitoneal injection of the phytochemicals. 
Table 9 and Figures 27a - 29b shows the haemodynamic effects of the phytochemicals 
after six days daily intraperitoneal treatment (100 mg/kg b.w). The daily dose was applied 
after the routine every morning blood pressure measurements. All the phytochemicals save 
those from Psidium guajava (Pink fruit), Psidium guajava (hybrid) and Terminalia sericea 
reduced blood pressure at one time or another. Clerodendrum capense reduced blood 
pressure every other day whilst Syzygum cordatum reduced blood pressure on the second 
day only. Plantago major reduced blood pressure on the 1 st, 5th and 6th days whilst Prunus 
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a/ricana, Combretum moUe and Buddleja salviifolia reduced blood pressure on the 5
th 
and 
6th days. Plantago lanceolata and CenteUa asiatica consistently reduced blood pressure 
from the third day onwards whilst Eugenia jambolana, Tetradenia riparia and Psychotreia 
serpens consistently reduced blood pressure right from the first day. Only Syzygum 
cordatum, Psidium guajava (Pink fruit), Clerodendrum capense, Plantago major, Plantago 
lanceolata, Combretum moUe and Psychotreia serpens did not have any bradycardia effect 
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Figure 17. Changes in heart rate after Lp (40 mg/kg) application of different doses of OA, UA, UV 
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Figure 21 . Changes in mean arterial pressure (MAP) after i.p (60 mg/kg) application of OA, UA, UV 
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Figure 22. Effects of isoprenaline (1 ug/kg) on heart rate after 15 minute pretreatment with 
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Figure 23. Effects of isoprenaline (1 ug/kg) on mean arterial pressure (MAP) after 15 minutes 
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Figure 24a. Follow-up changes in systolic blood pressure (mm Hg) after a single Lp. of 
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P. lanceolata T. sericea P. africana C. molle B. salviifolia C. asiatica T. riparia P. serpens 
Name of Phytochemical 
Figure 24b. Follow-up changes in systolic blood pressure (mm Hg) in rats after a single i.p. 
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Name of Phytochemical 
P. major 
Figure 2Sa. Follow-up changes in diastolic blood pressure (mm Hg) in rats after a single i.p. 
injection of phytochemical extractives (100 mg/kg b.w) 
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Figure 25b. Follow-up changes in diastolic blood pressure (mm Hg) of rats after a single i.p. injection 
of the phytochemicals (100 mg/kg b.w) 
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Figure 26a. Follow-up changes in heart rate (beats/min) of wistar rats after a single i.p injection of 
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Figure 26b. Follow-up changes in heart rate (beats/min) of Wistar rats after a single i.p. injection of 
the phytochemical extractives (100 mg/kg b.w) 
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Figure 27a. Changes in systolic blood pressure (mm Hg) of Wistar rats treated with the 
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Figure 27b. Changes in systolic blood pressure (mm Hg) of Wistar rats treated with the 
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Figure 28a. Changes in diastolic blood pressure (mm Hg) of Wistar rats treated with 
phytochemicals (100 mg/kg b.w) for 6 consecutive days 
• control 
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Figure 28b. Changes in diastolic blood pressure (mm Hg) of Wistar rats treated with 
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Figure 29a. Changes in heart rate (beats/min) of Wistar rats treated with the phytochemical 
extractives for 6 consecutive days 
• control 







. Oay 1 
COay 2 
COay 3 
























T. sericea P. africana C. molle B. 
salviifolia 
Name of Phytochemical 
C. asiatica T. riparia P. serpens 
Figure 29b. Changes in heart rate (beats/min) of Wistar rats treated with the phytochemical 









Table 6: Changes in heart rate (HR) and mean arterial pressure (MAP) after intraperitoneal 
application of different doses of triterpenoids. The parameters were measured using the direct method 
Baseline 10 minutes 20 minutes 30 minutes 40 minutes 60 minutes 
~roup Dose HR MAP HR MAP HR MAP HR MAP HR MAP HR MAP 
(m2lk2) 
OA 20 495 ± 96±6 L6% LIO% L6% L18% L6% L20% L6% L12% L8% L8% 
8 
40 480 92±4 L6% L22% 0 L40% L6% L40% L6% L20% LIO% L20% 
±10 
60 4S0± 104 ± 6 L6% L38% L8% L60% LIO% LSO% L8% LSO% LlO% L50% 
8 
VA 20 480± 84±4 L6% 0 L6% L2% L6% L14% L6% L14% L6% L20% 
6 
40 46S ± 96±4 L6% 0 LS% LS% LS% L20% L6% L30% L6% PO% 
6 
60 480± 94±6 L8% L4% LIO% tlO% L6% L22% L8% P6% L6% L40% 
8 
MM 20 420± 110 ± 8 L4% L40% P% L40% P% LS4% P% LS4% LS% LS4% 
8 
40 400± 100 ± L6% LSO% L10% L60% 0 0 0 0 0 0 
8 10 
60 400± lIS ± 8 L10% L60% 0 0 0 0 0 0 0 0 
6 
UV 20 43S± 98±4 P% LI0% L4% L20% L6% L2S% 0 L30% L6% L20% 
7 
40 430 100± 6 P% LlS% L9% L2S% L9% L30% LlO% L40% LI0% L30% 
±10 
60 420± 96± 6 0 0 LI0% L30% L10% PO% L12% LSO% L12% L50% 
8 
Mean ± SEM; All changes are significant compared to control values L - Decrease 
OA - Oleanolic acid VA - Vrsolic acid MM- Methyl maslinate UV - Vvaol 
HR - Heart rate (beats/min) MAP - Mean arterial pressure (mm Hg) 
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Table 7: Beta-adrenolitic effects of triterpenoids isolated from plants in wistar rats: Effects of isoprenaline 





i.p. (10 mg/kg) 




i.p. (10 mg/kg) 






Baseline 1 minute 3 minute 5 minute 10 minute 15 minute 
MAP HR MAP HR MAP HR MAP HR MAP HR MAP HR 
150 450± 125% 126% 135% 129% 127% 124% 127% 127% 130% 123% 
± 4.2 8.0 
145 462± 120% 10% 122% 18% 130% 16% 128% 18% 121% 18% 
± 6.0 8.8 
135 440± 110% 0 115% 19% 112% 15% 112% 110% 110% 19% 
±4.0 9.0 
142 41O± 11% 10% 15% 0 110% 0 110% 0 110% 0 
±6.6 8.8 
148 416 15% 14% 15% 18% 112% 14% 120% 12% 115% 14% 
± 8.0 ±12.0 
Mean ±SEM 
Percentage decrease compared to the original effect of isoprenaline before treatment 
Mean arterial pressure (mm Hg) 
Heart rate (beats/minute) 
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Table 8: Follow-up changes in blood pressure (mm Hg) and heart rate (beats/min) of Wi star rats after a single intraperitoneal injection 
" ...... - ., •• J .. ...,_ •.• _ • .••• __ • _ ........ __ ..... _ ... , .............. ........... -.~. _ ........ ""' - ... -- ---- ---- -.... - ----""'-
Baseline 10 minutes 20 minutes 30 minutes 60 minutes 
Group/Parameter SBP DBP HR SBP DBP HR SBP DBP HR SBP DBP HR SBP DBP HR 
Vehicle 124 80 ± 438 121 78 440 123 79 445 121 82 400 123 82 445 
(DMSO) ±2 2 ±11 ±2 ±2 ±1O ±3 ±3 ±10 ±2 ±2 ±1O ±3 ±3 ±1O 
Psidium 116 84 ± 411 102 82 386 110 86 387 118 88 400 108 86 391 
guajava (small) ±2 3 ±4 ± 5* ±5 ±8* ±2* ±2 ±4* ±2 ±2 ±7 ±6 ±8 ±8 
Psidium 126 89 ± 388 114 90 360 113 87 381 . 110 89 365 120 94 388 
guajava (white) ±4 2 ±4 ±4* ±3 ±8* ±2* ±2 ± 6 ± 3* ±2 ±1O ±3 ±8 ±12 
Psidium 116 93 ± 380 107 85 366 113 92 355 109 90 359 105 88 344 
guajava (pink) ±2 3 ±1O ± 3* ±2* ±IO ±2 ±3 ±11 ±2* ±4 ±12 ±4* ±5 ±13* 
Psidium 115 92 ± 405 109 88 368 112 99 378 117 96 366 116 92 372 
guajava (hybrid) ±2 4 ±II ±4 ±2 ±12* ±5 ±5 ±12 ±3 ±4 ±3* ±2 ±3 ±14 
Syzygum 122 89 ± 357 110 86 371 106 80 359 110 87 346 110 88 344 
cordatum ± I 4 ±6 ± 2* ±3 ±1O ±2* ± 1 * ±IO ± 1* ±4 ±1O ±2* ±2 ±8 
Eugenia 125 91 ± 386 112 82 365 112 86 362 109 90 340 107 83 350 
jambulana ±4 3 ±5 ±4* ±4 ±12 ±2* ±5 ±8* ±4* ±4 ±10* ±2* ±2* ±Il* 
Clerodendrum 125 89 ± 380 123 81 372 119 80 353 114 88 372 124 88 372 
capense ± 2 2 ±11 ±3 ±3 ±II ±3 ±3 ±12 ±3 ± I ±II ±3 ±4 ±12 
Plantago 125 91 ± 379 112 90 356 110 92 366 106 82 355 108 85 372 
major ±3 3 ±12 ± 3* ±3 ±6 ±1 * ±2 ±5 ± 3* ± 3* ±1O ±2* ±2 ±Il 
Plantago 132 93 ± 366 134 98 364 134 98 350 131 93 342 122 94 358 
lanceolata ±3 3 ±9 ±2 ±3 ±10 ±3 ±3 ±8 ±3 ±3 ±1O ±3* ±3 ±9 
Terminalia 126 96 ± 376 128 93 339 130 99 326 127 95 354 131 99 390 
sericea ±3 2 ±9 ±3 ±2 ±1O ±3 ±3 ±IO* ±3 ±3 ±1O ±3 ±3 ±1O 
Prunus 126 93 ± 363 128 96 380 126 95 383 127 94 381 129 96 365 
africana ±3 3 ±9 ±2 ± I ±1O ±3 ±3 ± 10 ±3 ± I ±IO ±3 ± 3 ±6 
Combretum 130 94 ± 368 123 90 366 124 94 354 128 97 343 129 96 365 
moUe ±2 3 ±IO ±2* ± 3 ±9 ±2* ±3 ±9 ±3 ±3 ±9 ±3 ±2 ±9 
Buddleja 132 96 ± 369 121 94 356 119 91 376 II7 90 369 118 89 372 
salvifolia ± 1 2 ±1O ± 2* ±2 ±9 ±2* ±2 ±1O ±2* ±2 ±9 ±3* ±2* ±1O 
CenteUa 125 90 ± 355 118 88 354 122 93 341 121 93 373 125 91 354 
asiatica ± 2 1 ±8 ±2* ±2 ±1O ±2 ± 1 ±1O ±2 ±2 ±2 ± 2 ±2 ±1O 
Tetradenia 127 92 ± 367 120 90 348 116 92 340 122 88 330 128 88 339 
riparia ± 2 2 ±1O ±2* ± I ±9 ±I* ±2 ± 9* ±2 ±2 ±9* ±3 ±3 ±9* 
Psychotreia 131 96 ± 363 116 87 362 120 92 367 120 90 372 125 87 380 
serpeus ± 2 2 ±10 ± 2* ± 2* ±8 ±2* ±2 ± 9 ±2* ±2* ±1O ± 3 ±2* ±9 
Mean ± SEM; SBP - Systolic Blood Pressure; DPB - Diastolic Blood Pressure; HR - Heart Rate * Significant compared to baseline value 
DMSO - Dimethyl sulfoxide The phytochemicals were applied intraperitoneally in a dose 100 mg/kg b.w. except for Psychotreia serpeus and DMSO (60 mglkg b.w.) 
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Control 1 da) 2 days 3 da)s 4 days 5 days 6 da~s 
Group/ SBP DBP HR SBP DBP HR SBP DBP HR SBP DBP HR SBP DBP HR SBP DBP HR SBP DBP HR 
Parameter 
Vehicle 126 80 438 122 82 430 123 86 418 125 84 420 124 85 430 123 80 ± 442 121 81 ± 448 
(DMSO) ±2 ±2 ±11 ± 1 ±I ±8 ±2 ±2 ±IO ±2 ±2 ±8 ±2 ±I ±8 ± 1 2 ±7 ±2 I ±9 
P. guajava 116 84 411 113 88 365 102 84 377 1I4 90 380 118 88 368 115 83 ± 363 119 87 ± 380 
(small) ±2 ±3 ±4 ±3 ±5 ±7* ±4* ±5 ±IO* ±I ±3 ±Il ±3 ±3 ±10 ±3 2 ±IO* ±3 2 ±9* 
P. guajava 126 89 388 114 90 383 122 100 379 121 84 352 115 86 352 120 88 ± 363 122 91± 345 
(white) ±4 ±2 ±4 ±4* ±2 ±7 ±3 ±4 ±8 ±2 ±1 * ±6* ±2* ±2 ±9* ±3 3 ± 6* ±I 2 ±IO* 
P. guajava 116 93 380 114 97 368 116 83 386 118 85 400 125 89 367 118 83 ± 376 115 88 ± 380 
(pink) ±2 ±3 ±IO ±3 ±3 ±IO ±3 ±1* ±12 ±2 ±2 ±8 ±2 ±2 ±7 ±3 4 ± 11 ± 1 3 ±IO 
P. guajava 115 92 405 113 89 363 115 86 366 122 88 373 119 88 376 118 82 ± 372 124 93 ± 393 
(hybrid) ±2 ±4 ±1I ±3 ±2 ±9 ±3 ± 1 ±12* ±2 ±2 ±6* ±3 ±2 ±9 ±2 4 ±11 * ±1 1 ±8 
Syzygum 122 88 357 118 88 335 100 78 350 123 85 345 119 89 328 124 93 ± 344 122 89± 359 
cordatum ± 1 ±4 ±6 ±3 ±3 ±7 ±3* ±2* ±10 ±2 ±2 ±8 ± 1 ± I ±7 ± 1 I ±IO ±2 1 ±8 
Eugenia 123 91 386 118 79 342 105 82 360 112 88 369 108 80 358 116 90 ± 377 117 87 ± 372 
jambulana ±2 ±3 ±5 ±2 ±2 ±11 * ±2* ±2* ± 8* ± 2* ±3 ±6 ±2* ±2* ±8* ± 1* 2 ±10 ±2* 2 ±IO 
Clerodendru 125 89 380 114 90 362 120 92 365 109 80 367 120 92 363 116 82 ± 380 117 84 ± 373 
trichotomum ±2 ±2 ±11 ±2* ±2 ±8 ± I ± I ±9 ±3* ±2 ±8 ±2 ± I ±9 ± 2* 2* ±8 ±2 2 ±7 
Plantago 125 91 379 110 82 372 120 93 358 119 86 347 119 92 358 112 82 ± 373 112 90± 363 
major ±3 ±3 ±IO ±3* ±4* ±IO ±2 ± I ±IO ±2 ±2 ±10 ±3 ±2 ±6 ±2* 2* ±9 ±2* I ±9 
Plantago 132 93 366 127 94 373 131 94 380 124 88 370 110 86 341 106 83 ± 368 116 87 ± 350 
lanceolata ±2 ±3 ±9 ±3 ±3 ±9 ±3 ±2 ±9 ±2* ±2 ±8 ± 3* ±2 ±9 ±2* 1* ±8 ±2* 2 ±6 
Terminalia 126 96 376 125 94 357 128 92 352 129 93 363 121 91 350 127 94 ± 367 123 89 ± 341 
sericea ±3 ±2 ±9 ±3 ±3 ±9 ±3 ±3 ± 9* ± I ±2 ±9 ±3 ±2 ±6* ±3 2 ±2 ±3 2 ± 9* 
Prunus 125 93 363 126 90 369 126 87 352 121 83 348 120 91 363 116 85 ± 338 115 86 ± 362 
africana ±3 ±3 ±9 ±3 ±3 ±9 ± 1 ±2 ±9 ±2 ±2* ±4 ± 1 ±2 ±9 ±2* 1* ± 6* ± 1* 1* ±8 
Combretum 130 94 368 131 95 352 126 88 357 128 97 365 125 96 372 120 86 ± 356 118 88 ± 363 
molle ±3 ±3 ±IO ±3 ±2 ± 8 ±3 ±2 ±IO ±2 ± 1 ±IO ±2 ±2 ±5 ±2* 2* ±5 ± 3* 2 ±9 
Buddleja 132 96 369 129 88 366 130 94 340 126 90 353 119 88 345 113 85 ± 343 109 88 ± 342 
salvi/olia ± I ±2 ±IO ±2 ±2* ±9 ±3 ±2 ±5 ±2 ±2 ±6 ± 1* ±I* ±4* ±2* 1* ±4* ±2* 1* ± 6* 
Centella 125 90 364 118 90 341 122 94 353 116 85 347 112 85 340 116 90 ± 340 1I5 86 ± 350 
asiatica ±2 ± I ±8 ±2* ±2 ±9 ± 1 ±2 ±9 ± 3* ±2 ±9 ±2* ±2 ±8* ± 1* 2 ± 8* ±2* 2 ±6 
Tetradenia 127 92 367 122 94 354 115 86 348 110 83 334 115 87 340 117 87 ± 344 1] 5 86 ± 340 
riparia ±2 ±2 ±9 ±2 ±2 ±9 ± 3* ±2 ±9 ± 2* ±] * ±IO* ± 1 * ± 1 ±7* ±2* 2 ± 8* ± 2* 2 ± 8* 
Psychotreia 131 96 363 116 89 355 114 83 350 110 80 346 109 85 352 ] 12 82 ± 347 1 ]4 82 ± 354 
serpeus ±2 ±2 ±8 ±I * ± 1 ±9 ±2* ±1* ± 8* ± 3* ±2* ±9 ±2* ±2* ±2 ± 1* 1* ±7 ±2* 2* ±6 
Mean ± SEM; SBP - Systolic Blood Pressure; DPB - Diastolic Blood Pressure; HR - Heart Rate * Significant compared to baseline value 
The phytochemicals were applied intraperitoneally in a dose 100 mg/kg b.w. except for Psychotreia serpeus and DMSO (60 mglkg b.w.) 
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4.5 EFFECTS OF PHYTOCHEMICALS ON BODY WEIGHT 
A few of the phytochemicals caused a significant decrease in the body weights of the animals 
when the test compounds were administered for six days (Table 10). The most pronounced 
decrease was seen in the rats that were injected with Syzygum cordatum. In these animals, the 
body weights were reduced from the second day up to fifth day, and from the sixth day the 
weight started to pick up again. Psidium guajava (hybrid) decreased the body weight from day 
4 onwards whilst Plantago lanceolata caused a significant decrease in weight from day 5. No 
side or toxic effects were noticed during the 6 consecutive days of phytochemical 
administration. 
4.6 ACUTE EFFECTS OF PHYTOCHEMICALS ON BLOOD GLUCOSE LEVELS 
Blood glucose was estimated by Glucometer Elite, Bayer Diagnostics, in the whole blood 
collected from the rat's tail tip. The blood glucose levels were estimated before and 20 
minutes after acute treatment with the phytochemicals. The results of the blood glucose levels 
are presented in table 11. Of all the test compounds, phytochemicals from Psidium guajava 
(small fruit) Psidium guajava (white fruit), Clerodendrum capense, Terminalia sericea and 
Tetradenia riparia displayed a potent hypoglycaemic activity. The most potent activity of 
these plants was that ofPsidium guajava (white fruit). 
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Table 10: Changes in body weight mass (g) of Wistar rats treated with 
phytochemicals for six consecutive days 
Group/ Control Day 1 Day 2 Day 3 Day 4 DayS Day 6 
Parameter 
Psidium guajava 210±4 211 ± 5 210 ± 5 211 ± 5 210±4 211 ± 3 214± 3 
(small) 
Psidium guajava 206 ±2 201 ± 3 199±4 197 ± 4* 203 ±4 203 ±4 208±4 
(white) 
Psidium guajava 260± 5 259± 5 260±6 253 ± 6 246± 7 239± 6 248 ± 8 
(pink) 
Psidium 236± 5 228 ± 5 228 ± 6 222±6 216 ± 7* 213 ± 8* 212 ± 8* 
guajava (hybrid) 
Syzygum 230± 5 220± 7 208 ± 6* 210 ± 6* 210 ± 6* 211 ± 8* 216 ± 8 
cordatum 
Eugenia 245 ± 5 237± 5 237 ± 5 230± 5 230± 6 229 ± 5* 236± 7 
jambulana 
Clerodendrum 208 ± 5 202±6 198 ±4 203 ± 5 203 ± 5 203 ± 6 206±6 
trichotomum 
Plantago 216± 6 214 ± 5 213 ± 5 211 ± 6 214± 5 215 ± 4 214± 3 
major 
Plantago 233 ± 4 239± 3 242±4 242± 5 242±4 250 ± 6* 254 ± 8* 
lanceolata 
Terminalia 226± 6 229±6 232± 7 233 ± 7 233 ± 6 237± 6 243 ± 6* 
sericea 
Prunus 274±9 271 ± 8 270± 9 265 ± 9 265±9 267± 9 267± 9 
africana 
Combretum 232 ± 8 230± 9 233 ± 9 234± 9 234± 8 240± 8 232± 7 
moUe 
Buddleja 258 ± 9 259± 9 257± 9 263 ± 9 263 ± 8 266± 7 269±6 
salvifolia 
CenteUa 255 ± 8 252± 6 257 ± 7 261 ± 8 261 ± 7 260±7 262±6 
asiatica 
Tetradenia 238 ± 8 236± 8 239± 8 242± 9 242± 9 239± 6 243 ± 6 
riparia 
Psychotreia 238 ±4 232 ± 3 236± 3 236±3 236± 4 237± 5 243 ±7 
serpeus 
Mean±SEM 
* The difference is significant compared to the control value 
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Table 11. Blood glucose levels in wistar rats before and 20 minutes after i.p. 
application of phytochemicals 
Parameter Glucose level Glucose level 20 mins after 
before treatment treatment(mmoVlitre) 
(mmoVlitre) 
Psidium guajava 4.7 3.3 
(small) 
Psidium guajava 4.7 2.8 
(white) 
Psidium guajava 4.7 4.6 
(Pink) 
Psidium guajava 4.7 4.5 
(hybrid) 
SyZYf{um cordatum 4.7 4.6 
EUf{enia jambulana - -
Clerodendrum L 5.0 4.0 
Plantago major 5.0 5.1 
Plantago lanceolata 3.2 3.5 
Terminalia sericea 4.6 3.6 
Prunus africana 4.6 4.9 
Combretum molle - -
Buddleja salvifolia 4.6 5.2 
Centella asiatica - -
Tetradenia riparia 4.1 3.4 
Psychotreia serpeus - -
All phytochemical extracts were injected intraperitoneally in a dose 40 mglkg b.w. 
data not available 
4.7 CARDIOTONIC ACTIVITY OF TEST COMPOUNDS 
4.7.1 Cardiotonic effects of the phytochemicals and pure triterpenoids in guinea pig 
atria 
Table 12 and figures 30a-30d show the results of the cardiotonic effects of the 
phytochemicalsand the isolated triterpenoids on reserpinised guinea pig atria. Of all the 
test compounds, Plantago lanceolata, Prunus africana, Oleanolic acid, Ursolic acid and 
uvaol displayed a positive inotropic effect on the electrically stimulated left atria. The 
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negative inotropic effects were displayed by methyl maslinate, Syzygum cordatum, 
Combretum molle, Terminalia sericea, all Psidium guajava subspecies, and Eugenia 
jambolana. On the other hand, Clerodendrum capense, Plantago major, Psychotreia 
serpens, Buddleja salvii/olia, Centella asiatica and Tetradenia riparia displayed a dose-
dependent biphasic effect. No phytochemicals had any effect on the chronotropic activity 



















Name of Test compound 
Figure 30a. Dose-response relationship for the effect of crude ethyl acetate extracts on force of 











Name of Phytochemical extractives 
Figure 30b. Dose-response relationship for the effect of phytochemical extractives on the force 
of contraction as measured in electrically driven left guinea pig atria (means SEM; n = 3) 
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Name of Phytochemical extractives 
Figure 30c. Dose-response relationship for the effect of phytochemicals on force of contraction 
as measured in electrically driven guineapig atria (means SEM; n = 3) 
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Name of Phytochemical extractives 
Figure 30d. Dose-response relationship for the effect of the phytochemicals on force of 
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The pre-treatment of the atria with the oleanolic acid, ursolic acid and uvaol seem to 
potentiate the positive inotropic effect of isoprenaline, whilst methyl maslinate blocked the 
positive inotropic effect of isoprenaline (Figure 31). The effects of oleanolic acid, ursolic 
acid and uvaol was reversible as washing of the tissue reverted inotropic effect to their 
baseline values. On the other hand, the effects of methyl maslinate were not reversible 
Pretreating the atria with propranolol completely blocked the inotropic effects of all the 
phytochemicals and the triterpenoids (Figure 32). Atropine sulphate had no effect on the 
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Figure 31. Effect of different doses of isoprenaline (ug/ml) on the background of 
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Figure 32. Effect of different doses of triterpenoids (mg/ml) on the background of 
propranolol (O.3mg/ml) 
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Table 12: Evaluation of inotropic effects of test compounds on guinea pig atria 
Parameter Inotropic response (mg) of atria at different 
concentrations of test compounds (mglml) 
Baseline 0.05 0.50 1.00 
Isoprenaline 2.83± IO.67± t 9.33± t IO.67± t 
277% 229 % 277% 
DMSO 24± 0 24±0.00 24.0±0.000 24.0±0.000 
Psidium guajava (small fruit) 3± 0 I.OO±1.000 O.SO±0.500 O.OO±O.OOO 
-I.. -67 % -I.. -83 % -I.. 
Psidium guajava (white fruit) 2.25±1.750 O.OO±O.OO -I.. O.OO±O.OOO O.OO±O.OOO 
Psidium guajava (Pink fruit) 1.33±0.833 l.OO±1.00 -I.. O.OO±O.OOO O.OO±O.OOO 
-99 % 
Psidium guajava (hybrid) 5±0 4.00±0.00 -I.. O.OO±o.OOO O.OO±O.OOO 
-20 % 
Syzygum cordatum 4.83±4.086 3.S0±2.784 3.33±2.404 2.33±1.364 
-I.. -27 % -I.. - 31 % -1..-52 % 
Eugenia jambulana 6.5±5.268 S.67±5.167 3.67±3.667 3.00±3.000 
-I.. -13 % -1..-44 % -I.. -54 % 
Clerodendrum L 0.83±0.167 O.67±0.167 I.SO±0.500 1.67±1.202 
-I.. -19 % t80% t 101 % 
Plantago major 2.33±1.856 2.33±1 .856 1.83±1.590 O.SO±0.289 
-I.. - 21 % -1..-79 % 
Plantago lanceolata 1.17±0.441 2.I7±1.424 3.33±2.833 6.S0±3.329 
t85% t 185 % t 556 % 
Terminalia sericea 4.83±3.609 2.67±1.691 I.SO±0.764 O.83±0.167 
-I.. -45 % -I.. -69 % -1..-83 % 
Prunus africana 1.17±0.441 O.SO±0.289 1.17±0.601 2.33±0.667 
-I.. - 57 % t99 % 
Combretum moUe 3.0±2.500 4.S0±3.500 1.33±0.667 2.I7±1 .922 
t 50 % -I.. -56 % -1..-28 % 
Buddleja salvifolia 5.0±4.500 7.67±7.167 6.S0±6.252 4.83±4.586 
t 53 % t 30 % -1..-3 % 
CenteUa asiatica 5.33±3.383 6.00±5.000 S.OO±4.509 3.33±1 .667 
t 13 % -1..-6 % -1..-37 % 
Tetradenia riparia 4.83±3.601 4.67±4.177 4.I7±3.919 6.00±3.000 
-1..-3% -I.. -14 % t24% 
Psychotreia serpeus 3.5±1 .607 O.83±o.601 O.67±0.667 1.33±o.882 
-I.. -76 % -I.. - 81 % -1..-62 % 
Mean ± SEM t Positive inotropic effect -I.. Negative inotropic effect 
* The difference is significant compared to the control value 
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4.7.2 Cardiotonic effects of the pure triterpenoids in anaesthetised wistar rats 
The inotropic and dromotropic effects of the triterpenoids in anaesthetised rats are 
presented in table 13. All the triterpenoids had a positive inotropic effect on the rats as 
shown by the increase in the amplitude of the QRS complex. The highest increases in the 
inotropic activity were shown by oleanolic acid and uvaol. It is interesting to note that 
even methyl maslinate (MM) had a positive inotropic effect in the rat model unlike in the 
guinea pig model where it had a negative inotropic effect. In terms of the dromotropic 
effects, only oleanolic acid increased the PQ interval. 
4.8 ANTIARRHYTHMIC ACTION OF TEST COMPOUNDS 
4.8.1 On CaCI2- induced arrhythmia 
Psidium guajava (white fruit), Syzygum cordatum, Buddleja salvii/olia, oleanolic acid and 
ursolic acid displayed antiarrhythmic effects on CaCh-induced arrhythmia. These 
antiarrhythmic effects were comparable to those of amiodarone. Centella asiatica, 
Tetradenia riparia and Psychotreia serpens displayed an antiarrhythmic activity that was 
comparable to that ofverapamil (table 14). 
4.8.2 On adrenaline-induced arrhythmia 
Psidium guajava (hybrid), Eugenia jambolana, Prunus africana, Terminalia riparia, 
oleanolic acid and ursolic conferred an antiarrhythmic effect on the adrenaline-induced 
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arrhythmia (Table 15). This protective effect was comparable to that of conferred by 
propranolol. 
4.8.3 On BaCh-induced arrhythmia 
Table 16 shows the result of the antiarrhythmic effects of the phytochemicals and the 
triterpenoids on BaCh-induced arrhythmia. Tetradenia riparia displayed an antiarrhythmic 
effect on this model that was comparable to that of propranolol. Ursolic acid and oleanolic 
acid displayed antiarrhythmic effects that were similar to those of amiodarone. 
4.8.4 On Ischemia-reperfusion arrhythmia 
Ursolic acid and methyl maslinate displayed antiarrhythmic activity on ischaemic-
reperfusion induced arrhythmia that were comparable to that of verapamil (Table 17). On 
the other hand uvaol and oleanolic acid displayed antiarrhythmic effects that were similar 
to that of propranolol. 
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• AUAt;; ... .:7 • .&.:.ITA.U. ...... U ... v ... ~.".aa" •• "...,.IiI._ \ ... X ------- ._- ---- ------ --' .... --, '-~- - - - --------. ... --
Baseline 3 minute 5 minute 10 minute 20 minute 30 minute 40 minute 60 minute 
Treatmen PQ QRS PQ QRS PQ QRS PQ QRS PQ QRS PQ QRS PQ QRS PQ QRS 
t (sec) (mV (sec) (mY) (sec) (mY) (sec) (mY) (sec) (mY) (sec) (mY) (sec) (mV) (sec) (mY) 
) 
Oleanolic 0.02 0.14 0.02 0.162 0.040 0.166 0.040 0.181 0.040 0.188 0.040 0.207 0.040 0.192 0.040 0.201 
acid i.p. o± 1± 5± ± ± ± ± ± ± ± ± ± ± ± ± ± 
(40 0.00 0.00 0.00 0.006 0.001 0.006 0.001 0.002 0.001 0.005 0.001 0.003 0.001 0.001 0.002 0.001 
mglkg) 2 6 2 * j *jx * j *jx * j *jx * j *jx * j *jx * j *jx * j 
15% 2 18% 2 28% 2 33% 2 46% 2 36% 2 43% 
Ursolic 0.02 0.26 0.02 0.283 0.020 0.287 0.023 0.294 0.022 0.296 0.025 0.293 0.023 0.298 0.022 0.296 
acid i.p 8± 8± 7± ± ± ± ± ± ± ± ± ± ± ± ± ± 
(40 0.00 0.00 0.00 0.006 0.001 0.003 0.002 0.004 0.002 0.003 0.002 0.003 0.003 0.006 0.002 0.003 
mglkg) 2 2 2 j5% * j * j * j * j * j * j 
7% 10% 10% 9% 11% 10% 
Methyl 0.01 0.12 0.02 0.143 0.015 0.153 0.020 0.180 0.025 0.170 0.025 0.184 0.020 0.180 0.020 0.170 
maslinate 8± O± O± ± ± ± ± ± ± ± ± ± ± ± ± ± 
acid i.p. 0.00 0.00 0.00 0.006 0.002 0.006 0.001 0.007 0.003 0.007 0.003 0.006 0.001 0.005 0.002 0.006 
(40 2 7 2 * j * j * j j 38% * j j 38% * j * j * j 
mg/kg) 19% 28% 50% 42% 53% 50% 42% 
Uvaol i.p. 0.01 0.12 0.01 0.150 0.015 0.246 0.015 0.229 0.015 0.245 0.015 0.182 0.018 0.180 0.015 0.186 
(40 5± O± O± ± ± ± ± ± ± ± ± ± ± ± ± ± 
mglkg) 0.00 0.00 0.00 0.006 0.002 0.006 0.001 0.007 0.002 0.006 0.002 0.006 0.002 0.006 0.003 0.007 
3 7 2 * j *jx *jx *jx * j * j * j 
25% 2 2 2 52% 50% 55% 
Mean ±SEM 
* The difference is significant compared to control values 
i.p. Intraperitoneally 
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TABLE 14: Effects of antidysrhythmic drugs and phytochemical extracts on CaCh-
induced arrhythmia 
Control CaCh (140 mglkg) intravenously 
Heart rate Heart rate 
decrease (%) decrease 
(%) 
Treatment 1 10 20 1 3 VPB VF Restoration Mortality 
min min min min min (%) (%) of sinus (%) 
rhythm 
(sec) 
Saline 0 0 0 20 26 100 80 40± 5 
Quinidine p.o. 5 12 9 8 6 100 80 60± 8 
(5 mg/kg) 
Propranolol i.v 25 30 30 20 20 100 60 60± 6 
(2 mg/kg) 
Amiodarone p.o 4 4 2 14 6 80 12 10± 3 
(10 mg/kg) 
Verapamil i.v. 18 30 32 10 8 20 0 20±2 
(2 mglkg) 
Oleanolic acid i.p. 0 4 12 1 1 60 8 10 ± 3 
(10 mg/kg) 
Ursolic acid i.p 1 10 18 1 1 60 8 10± 4 
(10 mglkg) 
P. guajava (small) 0 4 6 7 7 80 10 60± 3 
P. guajava (white) 0 6 0 6 6 60 8 30±4 
P. guajava (Pink) 0 9 6 3 3 80 12 60±4 
P. guajava (hybrid) 0 12 6 7 0 80 20 60±4 
Syzygum cordatum 0 0 13 7 0 60 20 60± 3 
Eugenia jambulana 0 20 22 20 20 80 80 0 
Clerodendrum L 0 10 14 13 7 80 80 60±4 
Plantago major 0 6 6 12 12 80 80 60±2 
Plantago 0 0 0 10 0 100 80 0 
Ian ceo lata 
Terminalia sericea 0 0 0 7 0 80 80 40±4 
Prunus africana 0 6 6 7 7 80 80 60±4 
Combretum moUe 0 13 13 13 10 80 80 60±4 
Buddleja salvifolia 0 18 20 0 0 60 60 60±2 
CenteUa asiatica 0 7 7 0 0 40 40 30 ± 6 
Tetradenia riparia 0 7 8 0 0 40 40 40± 6 
Psychotreia serpeus 0 7 7 0 0 40 20 30 ±4 . . . . All phytochemIcal extracts were Injected Intraperitoneally in a dose 100 mglkg h.w . 
Sinus rhythm restoration of the survived rats: Mean ± SEM 
VPB - Ventricular premature beats VF - Ventricular fibrillation 

























Table 15: Effects of antidysrhythmic drugs and phytochemical extracts on adrenaline-
induced arrhythmia 
Control Adrenaline (30 flglkg) intravenously 
Heart rate 
decrease %) 
Treatment 1 10 20 VPB VT VF Restoration Mortality 
min min min (%) (%) (%) of sinus (%) 
rhythm (sec) 
Saline 0 0 0 100 100 100 0 66 
Quinidine p.o. 4 4 8 80 60 60 60 ± 11 60 
(5 m~g) 
Propranolol i.v 20 15 15 20 0 0 20± 8 0 
(2m~g) 
Amiodarone p.o 2 9 2 100 80 80 0 60 
(10 mg/kg) 
Veraparnil i. v. 30 25 20 80 80 60 0 40 
(2 mg/kg) 
Oleanolic acid i.p. 6 21 21 20 2 8 1O± 6 8 
(10 mg/kg) 
Ursolic acid i.p 3 5 5 40 10 8 14± 7 10 
(10 mg/kg) 
P. guajava (small) 0 20 20 80 20 50 120 ± 10 30 
P. guajava (white) 0 20 20 80 10 50 120± 8 30 
P. guajava (Pink) 0 20 20 100 0 60 80± 8 30 
P. guajava (hybrid) 0 - 7 20 0 20 30± 6 20 
Syzygum cordatum 0 14 14 100 20 50 60± 10 40 
Eugenia jambulana 0 9 6 50 0 20 30± 8 20 
Clerodendrum L 0 6 6 80 2 20 30± 6 40 
Plantago major 0 5 5 80 40 20 30± 8 40 
Plantago lanceolata 0 8 10 50 20 10 30±4 40 
Terminalia sericea 0 20 20 80 0 60 30± 6 30 
Prunus africana 0 15 18 50 0 0 45 ±4 40 
Combretum moUe 0 6 3 50 50 20 30±4 40 
Buddleja salvifolia 0 20 20 60 0 60 60± 8 40 
CenteUa asiatica 0 3 0 50 50 20 30± 6 40 
Tetradenia riparia 0 18 13 50 0 0 45± 6 20 
Psychotreia serpeus 0 6 12 50 0 20 30± 4 20 . . . 
All phytochemical extracts were IDJected IDtraperitoneally in a dose 100 mg/kg b.w. 
Sinus rhythm restoration of the survived rats: Mean ± SEM 
VPB - Ventricular premature beats VT - Ventricular tachycardia 
VF - Ventricular fibrillation p.o. - Orally 
i.v. - Intravenously i.p. - Intraperitoneally 
129 
Table 17: Effects of antidysrhythmic drugs and triterpenoids on Ischemia-reperfusion 
induced arrhythmia in anaesthetised rats 
30 minute 20 minute reperfusion 
myocardial 
ischaemia 
Treatment VPB VT VF VPB VT VF(%) Total mortality 
(%) (%) (%) (%) (%) %) 
Saline-treated 77 77 22 22 33 0 22 
preconditioned 
Saline-treated noo- 89 77 67 44 44 44 67 
preconditioned 
Quinidine p.o. 83 66 17 33 33 0 17 
(5 mglkg) 
Propranolol i.v 66 33 17 33 33 33 33 
(2 mglkg) 
Amiodarone p.o 66 66 17 33 33 0 17 
(10 mglkg) 
Verapamil i. v. 83 66 50 66 50 50 50 
(2 mglkg) 
Oleanolic acid i.p. 66 33 33 33 33 33 33 
(40 mglkg) 
Ursolic acid i.p 83 50 50 66 50 50 50 
(40 mglkg) 
Methyl maslinate acid 83 66 66 83 50 66 66 
i.p. (40 mglkg) 
Uvaol i.p. 66 33 33 33 33 33 33 
(40 mglkg) . . 
Each group consisted of SIX rats except the two control (saline) groups that consisted of nine 
rats each 
VPB - Ventricular premature beats 
VT - Ventricular tachycardia 
VF - Ventricular fibrillation 
p.o. - Orally 
i.v. - Intravenously 
i.p. - Intraperitoneally 
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4.9- CONFIRMATION OF OCCURRENCE OF ISCHAEMIA 
Gross examination of the hearts under ultraviolet light confirmed that ligation of the 
coronary artery did cause ischaemia to occur. Figure 33 shows an example of a heart that 
displays blue areas indicating presence of non-perfused areas of a myocardium. On the 
other hand, figure 34 shows greenish areas that is an indication of the presence of perfused 
areas. 
Figure 33 Representative heart in which ischaemia had occurred 




The working hypothesis of this study was that triterpenoids of plant origin might provide 
cheap and accessible traditional medicine source for treatment of complicated hypertension 
if they have cardiotonic and antiarrhythmic effects in addition to their hypotensive effect. 
In order to test this hypothesis, pharmacological analysis of 16 different phytochemicals 
and 4 triterpenoids isolated from these phytochemicals was done. The analysis revealed 
that the triterpenoids and all the phytochemicals had determined physiological activity. As 
basic features, the isolated triterpenoids and some of the crude extracts had hypotensive, 
cardiotonic and antiarrhythmic effects on different models of hypertension as is shown in 
the summary of results below. Thus, the study demonstrated that triterpenoids of plant 
origin might provide cheap and accessible traditional medicine source for treatment of 
complicated hypertension. 
5.1 Summary of Results 
• The study reconfirmed the presence of triterpenoids in the selected medicinal plants 
• All the crude extracts and the isolated triterpenoids had a low toxicity 
• All the test compounds had acute and long-lasting vasodepressor activity in rats 
• The test compounds displayed natriuretic and diuretic effects that were comparable 
and sometimes better than those displayed by hydrochlorothiazide 
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• OA, VA, VV, Plantago lanceolata and Prunus africana displayed a positive 
inotropic effect on guinea pig atria. This inotropic effect was blocked by 
propranolol 
• Plantago major, Psychotria serpens, Buddleja salvii/olia, Centella asiatica, 
Tetradenia riparia and Clerodendrum trichotomum displayed a dose-dependant 
biphasic inotropic effect. 
• Syzygium cordatum, Eugenia jambolana, Combretum molle, Terminalia sericea, 
and all the four Psidium guajava subspecies displayed a negative inotropic effect. 
• All the isolated triterpenoids conferred antiarrhythmic effects on both chemically 
induced and ischaemia-reperfusion induced arrhythmia. 
• Psidium guajava (hybrid), Eugenia jambolana, Prunus africana and Terminalia 
riparia displayed an antiarrhythmic effect against adrenaline-induced arrhythmia 
whilst Psidium guajava (white fruit), Syzygium cordatum and Buddleja salvii/olia 
displayed antiarrhythmic effects against CaCh induced arrhythmia. 
• Crude extracts from Psidium guajava (small fruit) Psidium guajava (white fruit), 
Clerodendrum capense, Terminalia sericea and Tetradenia riparia displayed a 
potent hypoglycaemic activity. 
The specific biological profiles of the triterpenoids and the phytochemicals that have been 
investigated in this study will be discussed below. 
5.2 Isolation of crude and pure compounds 
The study has reconfirmed that many medicinal plants contain triterpenoids as part of their 
chemical constituents. In particular, the study has shown that all the medicinal plants that 
133 
were screened in the study have a certain percentage of triterpenoids in agreement to what 
was reported in the Anne Hutchings' inventory of Zulu Medicinal Plants (1996). The 
plants that were screened were Psidium guajava (small fruit) , Psidium guajava (white 
fruit) , Psidium guajava subsp. durbanse (hybrid), Psidium guajava (Pink fruit) , Plantago 
major, Psychotria serpeus, Plantago lanceolata, Clerodendrum trichotomum, Eugenia 
jambulana, Buddleja salviifolia., Combretum molle, Centella asiatica, Tetradenia riparia, 
Syzygium cordatum, Prunus africana and Terminalia sericea. The study was able to 
isolate four different triterpenoids namely, oleanolic acid (OA), ursolic acid (UA), uvaol 
(UV) and methyl maslinate (MM). These triterpenoids were isolated from the crude ethyl 
acetate extracts. 
The most abundant triterpenoids was OA followed by UA then UV and lastly MM. OA 
recrystallised from methanol as colourless crystals with a melting point of about 307-308 
°C. Its spectral data were identical with literature values (Maillard et al., 1992). UA 
recrystallised from methanol as colourless crystals with melting point of 286°C. Its 
spectral data were identical with literature values (Seo et al. , 1975a). UV recrystallised 
from methanolldichloromethane as colourless crystals with a melting point of about 221-
223°C. Its spectral data were identical with literature values (Siddiqui et al., 1986). MM 
was only eluted when the crude ethyl acetate extract was subjected to a silica gel column 
chromatography with gradient elution using a 60 %/ 40 % hexane/ethyl acetate solvent 
system. The eluates containing MM were obtained only from the last fractions. MM was 
used without recrystallisation, and its spectral properties were identical with literature 
values (Seo et al. , 1975b) 
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It should be noted that the calculated percentage yield is by no means the total value found 
in the plants. It is very likely that some of the triterpenoids were left in the methanol, 
hexane and dichloromethane crude extracts. This fact is backed by the results from other 
studies that have shown that the triterpenoids were extracted using the above solvents. For 
instance, there are reports that showed that ursolic acid was found in the methanol crude 
extract of Psychotria serpens (Lee, et al., 1988) and in the hexane crude extract of 
Plantago major (Ringbom, et al., 1998). Thus, it is safe to assume that the estimated 
percentage yield of triterpenoids presented in this study is lower than the actual value as it 
was calculated only from the crude ethyl acetate extracts. Nevertheless, of the crude ethyl 
acetate extracts the highest yield was obtained from Buddleja salvi/olia and Syzygium 
cordatum whilst the least yield was from Tetradenia riparia and Centella asiatica. 
All the crude ethyl acetate extracts and the isolated triterpenoids showed low toxicity when 
tested for toxicity using the brine shrimp test. The Hippocratic test on the animals to 
qualitatively determine toxicity was not done in this study due to cost constraints. 
However, previous studies have shown that in a 5 day follow up study, Hippocratic test of 
OA and UA on rats had low toxicity (Somova, et al., 2003a and 2003b). Thus the 
therapeutic values of the triterpenoids would not be contraindicated by the toxic effect as is 
the case with other plant derivatives like glycosides. 
5.3 Hypotensive effects of the phytochemicals and the triterpenoids 
The study has shown that the isolated triterpenoids and most of the phytochemicals had a 
hypotensive effect in Wistar rats. All the four triterpenoids showed a significant 
vasodepressor effect and sinus bradycardia that lasted for more than 60 min. These effects 
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were dose-dependent with the peak effect seen at 20 min after application. The most potent 
effects were shown by OA and MM. This finding is in disagreement with the results 
presented by Kolah et ai (2001) who showed that ursolic acid, oleanolic acid and a-amyrin 
had no vasodepressor effect in anaesthetised male Wistar rats. However, our results are in 
agreement with other studies that have also showed that triterpenoids might have 
hypotensive effects (Somova, et ai., 2003a and 2003b). 
As has been stated in the previous sections, mean systemic arterial pressure (MAP) is the 
product of cardiac output (CO) and the total peripheral resistance (TPR) that is the sum of 
all resistances to flow offered by all the systemic blood vessels. Thus, MAP = CO x TPR. 
Cardiac output is affected by stroke volume and heart rate whilst total peripheral resistance 
is mainly affected by the tone of the arterioles, which are the resistance vessels. There is a 
strong causal, reciprocal relationship between arterial blood pressure and blood volume, 
and as a result, blood volume is the major long-term determinant of blood pressure 
(Vander, 2001). On the other hand, baroreceptor reflexes that cause a decrease in the 
sympathetic firing and in the total peripheral resistance induce the immediate changes in 
blood pressure. 
In this study, the test compounds caused blood pressure decrease within 10 min and the 
hypotensive effect was sustained for a long time. This observation was suggestive of the 
involvement of short-term blood pressure regulating mechanism and a long-term blood 
pressure regulating mechanism. The short-term blood pressure regulating mechanism can 
be postulated to involve receptors that cause a decrease in total peripheral resistance. This 
point is strengthened by the observation that some test compounds displayed a positive 
inotropic effect. The presence of positive inotropic activity and a hypotensive activity is a 
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contradiction since one would expect the positive inotropic activity to cause an increase in 
the cardiac output that will in turn lead to an increase in blood pressure. Involvement of 
the reduction in total peripheral resistance is the probable way in which the effect of the 
increased cardiac output was offset. We postulate that that the test compounds might have 
caused a reduction in the total peripheral resistance that resulted in a decrease in the mean 
arterial pressure. The test compounds might have reduced the total peripheral resistance by 
either having an antagonistic effect on the vascular a-adrenergic receptors which when 
stimulated cause vasoconstriction. The other possibility might have involved the 
stimulation of the endothelial cells and/or the noncholinergic, nonadrenergic neurons to 
release vasodilators like nitric oxide. The vasodilators in turn act on adjacent vascular 
smooth muscles to cause vasodilatation. Thus, the postulated vasodilatation and the 
blocking of a-adrenergic receptors might have a caused a reduction in the total peripheral 
resistance. Since, MAP = CO x TPR, the postulated reduction in TPR should have caused 
the observed immediate hypotensive effect of the test compounds. 
The long-lasting hypotensive effect can be partly attributed to the diuretic and natriuretic 
effects that were displayed by these test compounds. These effects were shown to be long 
lasting since they lasted for at least 24 hours. The high Na+/K+ ratio of the treated animals 
was indicative of a reduced sodium retention in the loop of Henle. Thus, in terms of the 
pressure natriuresis curve, it is most probably shifted to the left whereby at any given 
pressure the kidneys are excreting more Na+. There might also be the possibility of an 
increased glomerular filtration rate that might contribute to the increased natriuresis. The 
increased natriuresis and diuresis caused by the isolated triterpenoids and the crude extracts 
might have caused a decrease in plasma volume that sequentially decreased blood volume, 
venous pressure and finally venous return. In accordance with the Frank-Starling 
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mechanism, the decreased venous return caused a decrease in cardiac output by decreasing 
end-diastolic volume and hence stroke volume. In some cases, in addition to the reduction 
in stroke volume, there was a reduction in heart rate. The reduction in stroke volume and 
heart rate led to a decrease in cardiac output (CO). Since MAP = CO x TPR, the decrease 
in cardiac output led to the observed long-lasting reduction in blood pressure. 
The hypotensive effect might also come about through the vasodilating effect caused by the 
binding of the triterpenoids on the ~-adrenergic receptors of arteriolar smooth muscles of 
the skeletal muscles. Because arterioles in skeletal muscles have large numbers of ~­
adrenergic receptors, agonists of these receptors cause dilation in this vascular bed. 
The above hypotensive effects suggest that the triterpenoids would be ideal for the 
treatment of hypertension in black hypertensive subjects. Black hypertensives have been 
reported to have a higher plasma sodium concentration than normotensives (Weissberg, et 
al. , 1987). Furthermore, it is generally accepted that thiazides diuretics are effective 
antihypertensive agents in black hypertensive patients and that they cause a greater 
decrease in blood pressure in blacks (V ACSAA, 1982; Moser and Lunn, 1982; Chobanian 
et al. , 2003). This better hypotensive response in black patients is postulated to be because 
more blacks than white have an expanded intracellular volume and low plasma renin 
activity (Seedat, 2000). The thiazides diuretic are ideal for most developed countries due 
to their low cost. In the same vain, since our phytochemicals have shown to have diuretic 
and natriuretic effects comparable and in some cases similar to hydrochlorothiazide, it can 
be suggested that the phytochemicals would be ideal to be used as a treatment of 
hypertension in Africa. The accessibility and abundant availability of these 
phytochemicals in Africa would make them ideal as a treatment for hypertension 
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considering that the health care resources in this region are particularly scarce. Thus, the 
use of these triterpenoids for the treatment of hypertension would be proposed and 
encouraged since they share some similarities with thiazide diuretics. 
Diuretics have also been reported to enhance the antihypertensive efficacy of multidrug 
regimens in addition to their being more affordable and achieving blood pressure control 
than other antihypertensive agents (Chobanian et al., 2003). This fact solidifies the 
assertion that the triterpenoids and some phytochemicals that have been shown to have 
diuretic effects should be used as adjuvant drugs to the western medicine as part of a 
multidrug therapy. 
5.4 Cardiotonic effects of the phytochemicals and the triterpenoids 
The study has shown that the triterpenoids had a positive inotropic effect on both isolated 
guinea pig atria and in vivo in anaesthetised rats except methyl maslinate that did not cause 
a positive inotropic effect in the in vitro experiments. The most potent positive inotropic 
effects were displayed by oleanolic acid and uvaol. The onset of the inotropic action was 
quick and the action was long lasting in both models. In the in vivo experiments, the action 
lasted for more 60 minutes. 
From the cardiotonic analysis, it was observed that though the inotropic response values 
varied a lot between tissues, the extracts caused a persistent trend in the inotropic actions. 
It was impossible to calculate the statistic differences between the baseline values and the 
dose response values due to the limited number of tissues tested per test compound. 
Nevertheless, the values obtained maintained a consistent trend that was enough to infer 
conclusions from. 
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Atropine sulphate, a cholinergic receptor inhibitor, did not block the inotropic effects of the 
triterpenoids. Thus, it can be postulated that the observed positive inotropic effects of our 
triterpenoids were not mediated by muscarinic receptors. We can also speculate that the 
positive inotropic effects were not mediated indirectly via liberation of catecholamines. 
This speculation is backed by the demonstration of the inotropic action in the reserpine-
treated guinea pig atria. However, the positive inotropic effects of the triterpenoids were 
blocked by a ~-adrenergic blocker, propranolol. This inhibition demonstrates that the 
positive inotropic effects of the triterpenoids were mediated through ~-adrenergic receptors. 
The experiments of the cardiotonic effect of isoprenaline after pre-treatment with the 
triterpenoids showed that OA, UV and UA had a potentiating effect on isoprenaline. The 
action was not additive since the effect of isoprenaline on the background of the 
triterpenoids was more than the maximum effect observed with isoprenaline alone. The 
study did not ascertain as through which mechanism the potentiating effect was done. We 
can only speculate on a number of possibilities that the potentiation might have come 
about. Firstly, the binding of triterpenoids to the ~-receptors might have caused a 
conformational change (allosteric modifications) to the adenylate cyclase complex that 
enhances the activity of isoprenaline. This mechanism has been shown to happen in brain 
tissues whereby pre-treatment of the tissues with forskolin potentiated the effect of 
hormones (Seamon, et al. , 1984). The second possibility is that the triterpenoids in 
addition to their acting through the receptors might also be working downstream to the 
receptors. In this case, the triterpenoids might have cause an increase in the free Ca2+ 
concentration. The increase would be either through the inhibition of phosphodiesterase or 
through an increase in the release of Ca2+ from Ca2+ stores like the sarcoplasmic reticulum. 
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The last possibility is that the triterpenoids might have increased the sensitivity of the 
contractile apparatus for Ca2+. This mechanism has been shown to be displayed by the n-
butanolic fraction from Berberis aristata fruit (Gilani et al. , 1999). 
Of all the plants screened, only Plantago lanceolata and Prunus africana displayed a 
positive inotropic action. A Medline search demonstrated that this is the first time that a 
positive inotropic effect of these plants has been reported. This inotropic effect was also 
blocked by a ~-adrenoceptor blocker, propranolol, indicating that the effect was mediated 
through the ~-adrenergic receptors. What was more intriguing was that these plants did not 
yield the highest percentage of triterpenoids in comparison to the other screened plants. 
This seem to suggest that the positive inotropic action of the two plants might be due to a 
synergistic effect of the triterpenoids and some other yet to be identified compound. It also 
showed that, for therapeutic purposes, a crude extract of the whole plant leaves might have 
better effects. 
A number of the plants screened displayed a dose-dependant biphasic inotropic effect. The 
plants that had this effect are Plantago major, Psychotria serpens, Buddleja salvii/olia, 
Centella asiatica, Tetradenia riparia and Clerodendrum trichotomum. These plants had a 
positive inotropic effect at one concentration and a negative inotropic effect at another 
concentration. This is not the first time that this kind of action has been reported since 
other studies of plant extracts have also shown it. For instance, Pennacchio, et al. , (1995) 
showed that Eremophila alternifolia extracts displayed a biphasic inotropic effect. This 
biphasic was not mediated by neither a-adrenergic nor ~-adrenergic receptors. 
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The study also showed that some of the screened plants have a negative inotropic effect on 
a guinea pig atria. The plants that had this action are Syzygium cordatum, Eugenia 
jamboiana, Combretum moile, Terminalia sericea, and all the four Psidium guajava 
subspecies. The mechanism of action was not demonstrated in this study. However, in 
case of the guavas, the negative inotropic effect was probably mediated through the 
cholinergic receptors. Conde Garcia et ai., (2003) have recently shown that the negative 
inotropic effect of guavas is not blocked by propranolol nor naloxone but by atropine 
sulphate. Thus, the negative inotropic effect did not involve ~-adrenergic receptors nor 
opiod membrane receptors but rather through cholinergic receptors. The authors assert 
that the guavas mostly probably inhibited Ca2+ inward currents thereby causing a negative 
inotropic effect. These negative inotropic agents might have the potential of being used in 
the treatment of hypertrophic cardiomyopathy whereby they can improve cardiovascular 
hemodynamics. They also point to their potential use as antiarrhythmic agents. 
5.5 Antidysrhyhmic effects of compounds 
The study has shown that the triterpenoids have antiarrhythmic effects on both chemically 
induced arrhythmias and ischaemia-reperfusion-induced arrhythmias. The study 
demonstrated that the triterpenoids had an antiarrhythmic effect against adrenaline-induced 
arrhythmia. The protective effect was comparable to that of propranolol, class II 
antiarrhythmic agent. Class II antiarrhythmic drugs exert their anti-arrhythmic effects by 
either reducing or blocking the electrophysiological effects of catecholamines that are 
mostly mediated by an increase in the slow Ca2+ inward current (Vogel and Vogel, 1997). 
Thus, in the fashion of class II antiarrhythmic drugs, the triterpenoids conferred their 
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Class IV agents block slow Ca2+ channels thereby suppressing the slow Ca2+ inward current 
and calcium dependent slow action potentials (Vaille, et ai. , 1992; Vogel and Vogel, 1997). 
This seems to suggest that UA and MM conferred the antiarrhythmic effect by blocking 
slow calcium inward currents that would have caused re-entry wavelets between the 
ischaemic areas and the non-ischaemic areas. The blocking of the calcium currents would 
in turn protect against reperfusion damage that is caused by calcium overload. On the other 
hand, UV and OA conferred a protective effect in the ischaemia-reperfusion induced 
arrhythmia that were comparable to that of propranolol, a typical class II antiarrhythmic 
agent. This indicates that UV and OA conferred their protective effect by a ~-adrenergic 
blocking activity. 
The triterpenoids might have also conferred their protective effect on the ischaemia-
reperfusion induced arrhythmia through their antioxidant activity. Recent reports have 
shown that triterpenoids have antioxidant activity (Balanehru and Nagarajan, 1991; Kitani 
et ai. , 1999; Zhang et aI. , 2001 ; Somova, et ai. , 2003a and 2003b). It has been reported that 
antioxidants and calcium antagonists can mitigate injuries caused by reperfusion (Jeroudi et 
ai. , 1994). There also reports that have that diminished superoxide radical production of 
circulating neutrophils during reperfusion has beneficial effects on tissue injury caused 
especially by free radicals (Roth, et ai. , 1997). Furthermore, Pataki, et ai., (2002) observed 
that grape seed proanthocyanidins have a protective effect against reperfusion-induced 
injury via their ability to reduce or remove or even inhibit the formation of free radicals in 
myocardium. In light of the role free radicals have on reperfusion arrhythmias, it can be 
postulated that our triterpenoids conferred an antiarrhythmic effect against ischaemia-
reperfusion induced arrhythmia through their antioxidant activity. 
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In terms of the crude ethyl acetate extracts, the study has demonstrated that Psidium 
guajava (hybrid), Eugeniajamboiana, Prunus africana and Terminalia riparia displayed a 
protective action against adrenaline-induced arrhythmia. The protective effect was 
comparable to that of propranolol, class II antiarrhythmic agent. On the other hand, 
Psidium guajava (white fruit), Syzygium cordatum and Buddieja saiviifolia displayed an 
antiarrhythmic effect against a CaCh-induced arrhythmia. The protective effect was 
comparable to that of amiodarone, class III antiarrhythmic agents. What is interesting 
about the antiarrhythmic effects of these phytochemicals is that they belong to class II and 
class III agents just as it was observed with the triterpenoids. Also of note is the fact that 
with the exception of Terminalia riparia, these plants were the ones that yielded the highest 
percentage of triterpenoids. Thus, it can be postulated that the antiarrhythmic effects of 
these phytochemicals was partly due to the presence of these triterpenoids. A quick 
Medline search showed that this is the first time antiarrhythmic effects of the above plants 
has been reported. 
5.6 Hypoglycaemic activity of the phytochemicals 
Ethyl acetate crude extracts from Psidium guajava (small fruit) Psidium guajava (white 
fruit), Clerodendrum capense, Terminalia sericea and Tetradenia riparia displayed a 
potent hypoglycaemic activity. The most potent activity of these plants was that of 
Psidium guajava (white fruit). Hypoglycaemic activity of the isolated triterpenoids was not 
done in this study but results from chronic studies have shown that triterpenoids have 
potent hypoglycaemic activity (Liu et ai., 1994; Matsuda et ai., 1998; Yoshikawa and 
Matsuda, 2000; Taniguchi et ai., 2002; Somova et 1., 2003a and 2003b). It can be 
postulated that triterpenoids might have the potential to contribute to the overall reduction 
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of the blood pressure in insulin-resistant animals. Further studies need to be done in such 
animals since our rats were not insulin-resistant. This work would be interesting to carry 
out in relation to diabetes since diabetic patients tend to be hypertensive as well. 
5.7 Interdependent link between structure of compounds and the observed 
cardiovascular effects 
Our results suggest that the triterpenoids have specific binding sites since slight changes in 
the structure of it affected the potency of the compound. For instance, OA was shown to be 
more potent than the other four triterpenoids despite the fact that VA is its isomer. Also VV 
was more potent at decreasing blood pressure than VA despite the fact that UV has the 
same structure like VA except a change of the carbonylic acid to its primary alcohol. On 
the other hand, MM did not have any effect save the antiarrhythmic ones though it is an 
isomer of OA that has the carbonylic acid substituted by an ether. This might point to the 
fact that specific binding sites mediate the cardiac effects of our triterpenoids just as was 
shown in the diterpene, forskolin (Seamon et al. , 1983; Schmidt and Kukovetz, 1989). 
These authors showed that modifications made on forskolin structure affected its potency 
on its cardiac function since derivatives of it with some modifications fail to have any 
effect neither on isolated heart preparations nor in activating adenyl ate cyclase. They 
attributed these varying potencies to the decrease in the binding capacity of the analogous 
to the specific binding site of Forskolin. On the other hand, particular side-chain 
modification of forskolin enhances the selectivity for the cardiac isofonn stimulation 
(Toya, Schwencke and Ishikawa, 1998). The present study has shown that modifications 
made to the triterpenoids derivatives affected their activity. Thus, there is interdependent 
link between the chemical structures of the triterpenoids isolated from the African 
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medicinal plants and specific cardiovascular biological activity like hypotensive, diuretic, 
cardiotonic and antiarrhythmic 
5.8 FUTURE WORK AND RECOMMENDATIONS 
I. Since it is common practice that people combine traditional medicine with western 
medicine, studies should be carried out to investigate the combine effects of our test 
compounds with those of the known drugs used to treat hypertension and its 
associated complications. 
II. There is need to check whether the triterpenoids have any direct effect on the 
vascular smooth muscles. In addition, studies can be carried out to check whether 
the triterpenoids have any effect on the blood flow 
III. There are reports that have showed that prolonged administration of some drugs 
causes tolerance that results in abolishment of their therapeutic properties. For 
instance, Papp et aZ., (1966), demonstrated that propranolol was ineffective against 
CaCh-induced fibrillation when it was administered for five days. Thus, studies 
should investigate whether a prolonged administration of the triterpenoids would 
decrease their potency. 
IV. The mechanisms of the positive inotropic effect of the test compounds need to be 
studied further by using selective agonists and antagonists of camp, adenyl ate 
cyclase and phosphodiesterase. 
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V. To elucidate the mechanism of the inotropic effect, experiments on the skinned 
myocardial fibres would be very important. Skinned fibres are deprived of 
functional intracellular and pericellular membrane systems making them easily 
permeable to ions and cellular metabolites (Herzig et ai., 1981). Furthermore, 
skinned fibres do not have the capability to store and release Ca2+ ions nor for 
producing and accumulating metabolites. As such, skinned fibres can be used to 
study the influence of our triterpenoids on the contractile apparatus under the 
conditions of constant intracellular calcium concentration without any disturbances 
from other cellular metabolites like ATP and cAMP. 
VI. Lastly, the experiments involving the guinea pig atria should be repeated since in 
bioassays a large number of experiments are required to obtain conclusive results. 
If such experiments are done, there is a need to increase the number of specific 
blocking tools used to investigate possible mechanisms involved in the inotropic 
actions so that the involvement of other receptors is investigated. For instance, the 
involvement of opiod receptors should be investigated using naloxone and other 
opiod receptor antagonists 
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6.0 CONCLUSION 
The study has reconfirmed that many of the medicinal plants used in Southern Africa 
contain triterpenoids as part of their chemical constituents. Of the 16 selected and screened 
plants, Syzygium cordatum and Buddieja saiviifolia crude ethyl acetate extracts yielded the 
highest percentage of the triterpenoids. The triterpenoids that were isolated and purified 
from the plants were oleanolic acid, ursolic acid, uvaol and methyl maslinate with oleanolic 
acid being the most abundant of them. All the isolated triterpenoids and the crude extracts 
were shown to have a low toxicity. 
The study has demonstrated that the four triterpenoids have blood pressure reducing 
activity in rats. All the phytochemicals reduced blood pressure in the acute experiments 
whilst in the chronic experiments all the phytochemicals except those from Psidium 
guajava (Pink fruit), Psidium guajava (hybrid) and Terminalia sericea reduced blood 
pressure. This vasodepressor activity was attributed to the natriuretic and diuretic effect 
that was exhibited by the triterpenoids. The natriuretic and diuretic effects were 
comparable, and in a few cases better than those of hydrochlorothiazide. In addition to this 
hypotensive effects, there are reports that have shown that triterpenoids have 
antiatherosclerotic (Somova et ai. , 2003a and 2003b); anti-diabetogenic (Liu et ai., 1994; 
Matsuda et ai., 1998; Yoshikawa and Matsuda, 2000; Taniguchi et ai. , 2002); anti-oxidant 
(Balanehru and Nagarajan, 1991; Kitani et ai. , 1999; Zhang et ai., 2001 ; Somova et ai., 
2003a and 2003b); anti-hyperlipidemic (Ma, 1986; Liu et ai., 1987; Somova et ai. , 2003a 
and 2003b). Thus, triterpenoids have a high potential of being used for the treatment of 
hypertension due to its action on the variety of factors that cause or are associated with the 
development of it. 
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The study has also shown that our triterpenoids have a positive inotropic effect on isolated 
guinea pig atria and in anaesthetised rats. The inotropic effect was shown to be mediated 
through ~-adrenergic activity. The triterpenoids, except MM, were also able to potentiate 
the positive inotropic effect of isoprenaline. However, the study did not demonstrate the 
mechanism through which this potentiating effect was achieved, and this needs further 
study. 
The other major point that has come out of this study is that triterpenoids have an 
antiarrhythmic effect against adrenaline-induced arrhythmia, BaCh-induced arrhythmia, 
and ischaemia-reperfusion induced arrhythmia but not against CaCh-induced arrhythmia. 
In terms of the adrenaline-induced arrhythmia, the protective effect of the triterpenoids was 
similar to that of a class II antiarrhythmic agent whilst for the BaCh-induced arrhythmia 
the protective effect was comparable to that of a class III antiarrhythmic agent. The 
triterpenoids offered a protective effect on ischaemialreperfusion-induced arrhythmia in a 
manner that was comparable to class II and IV antiarrhythmic agents. Furthermore, the 
study postulated that the triterpenoids conferred a protective effect on reperfusion-induced 
arrhythmia most probably through their antioxidant activity. 
The study has demonstrated that there is an interdependent link between the chemical 
structures of the triterpenoids isolated from the African medicinal plants and specific 
cardiovascular biological activity like hypotensive, diuretic, cardiotonic and 
antiarrhythmic. The triterpenoids that were isolated and used in this study displayed 
different potencies when subjected to the pharmacological analysis despite the fact that 
they are isomers of each other. Thus, the study has shown that there is a link between the 
chemical structure of the triterpenoids and its cardiovascular activity. 
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Therefore, evidence provided in this study indicated that triterpenoids have hypotensive, 
cardiotonic and antiarrhythmic activities. Since the triterpenoids have been demonstrated to 
be present in many of the medicinal plants of Southern Africa, the triterpenoids would 
provide a cheap and accessible traditional medicine source for the treatment of complicated 
hypertension in Southern Africa. 
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Krebs-Hanseleit Buffer (pH 7.4) 
Components InmM FW mmollL mMl5L 
NaCI 118.00 58.44 0.05844 x 118= 6.896g 34.480g 
KCI 4.70 74.55 0.07455 x 4.7= 0.350g 1.752g 
KH2P04 1.18 136.09 0.13609 x 1.18 = 0.160g 0.803g 
MgS04.7H20 1.17 246.48 0.24648 x 1.17 = 0.288g 1.442g 
CaCh.2H20 1.60 147.02 0.14702 x 1.6 = 0.235g 1.176g 
NaHC03 25.00 84.01 0.08401 x 25 = 2.100g 10.501g 
Glucose 11.10 180.16 0.18016 x 11.1= 1.999g 10.000g 




Weights of crude extracts from different plants 
Table 18 Weight (g) of crude hexane extracts 
Name of plant Code Weight of extract 
Jgl 
Psidium guajava (small fruit) MHl01/A 2.5 
Psidium guajava (white fruit) MHl02/A 2.564 
Psidium guajava (Hybrid) MHl03/A 3.74 
Centella asiatica MHl04/A 1.239 
Syzygum cordatum MHl05/A 1.239 
Psychotreia serpeus MHl06/A 1.501 
Syzygum cordatum MHl07/A 10.143 
Eugenia jambulana MHl08/A 13.323 
Clerodendreum l. MHl09/A 18.254 
Plantago major MHl10lA 10.71 
Psidium guajava (Pink fruit) MHl111A 4.425 
Plantago lanceolata MHl12/A 6.856 
Terminalia sericea MHl13/A 10.145 
Prunus africana MHl14/A 10.456 
Combretum molle MHl15/A 8.774 
Buddleja s. MHl16/A 2.768 
Centella asiatica MHl17/A 4.685 
Tetradenia MHl18/A 11.002 
Table 19. Weight (g) of Dichloromethane crude extracts 
Name of plant Code Weight of extract 
Jgl 
Psidium guajava (small fruit) MHl011B 5.971 
Psidium guajava (white fruit) MHl021B 4.33 
Psidium guajava (Hybrid) MHl031B 4.201 
Centella asiatica MHl041B 1.17 
Syzygum cordatum MHl051B 4.075 
Psychotreia serpeus MHl061B 8.222 
Syzygum cordatum MHl071B 29.279 
Eugenia jambulana MHl081B 22.008 
Clerodendreum l. MHl091B 32.784 
Plantago major MHl101B 7.678 
Psidium guajava (Pink fruit) MHl111B 20.247 
Plantago lanceolata MHl121B 18.589 
Terminalia sericea MHl131B 13.243 
Prunus africana MHl141B 21.481 
Combretum molle MHl151B 7.276 
Buddleja s. MHl161B 7.370 
Centella asiatica MHl171B 3.231 
Tetradenia MHl181B 5.328 
187 
T bl 20 W' h () f d th Itt t t a e elgl t 19 0 cru e e y ace a e ex rac 
Name of plant Code Weight of extract 
(2) 
Psidium guaiava (small fruit) MHiOllC 6.892 
Psidium guajava (white fruit) MHl02/C 5.378 
Psidium guajava (Hybrid) MHl03/C 3.116 
Centella asiatica MHl04/C 0.32 
Syzygum cordatum MHl05/C 2.11 
Psychotreia serpeus MHl06/C 8.089 
Syzygum cordatum MHl07/C 25.286 
Eugenia jambulana MH/08/C 14.860 
Clerodendreum 1. MHl09/C 10.152 
Plantago major MH/lO/C 3.886 
Psidium gua,java (pink fruit) MHlll1C 8.854 
Plantago lanceolata MHlI2/C 6.894 
Terminalia sericea MHlI3/C 5.247 
Prunus africana MHlI4/C 34.874 
Combretum molle MH/15/C 3.687 
Buddleja s. MHlI6/C 5.955 
Centella asiatica MHlI7/C 2.026 
Tetradenia MHlI8/C 1.016 
Table 21. Weight (g) of crude methanol extracts 
N arne of plant Code Weight of extract 
(2) 
Psidium guajava (small fruit) MHlOIID 4.244 
Psidium guajava (white fruit) MHl021D 5.441 
Psidium guajava (Hybrid) MHl031D 5.752 
Centella asiatica MHl041D 3.285 
Syzygum cordatum MHl051D 8.425 
Psychotreia serpeus MHl061D 162.016 
Syzygum cordatum MHl071D l37.323 
Eugenia jambulana MHl081D 18.312 
Clerodendreum 1. MHl09/D 66.338 
Plantago major MHlI01D 110.519 
Psidium guajava (pink fruit) MHlll1D 14.841 
Plantago lanceolata MHl121D 114.771 
T erminalia sericea MHll31D 63.265 
Prunus africana MHl141D 187.910 
Combretum molle MHl151D 36.612 
Buddleja s. MHl161D 16.156 
Centella asiatica MHl171D 61.049 
Tetradenia MHl181D 8.245 
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APPENDIX 3- PICTURES OF EXPERIMENTAL SET UP 
Figure 35. Scanned picture of the experimental set up for induction of ischaemia 
and reperfusion 
Figure 36. Scanned picture of the experimental set up for induction of ischaemia 
and reperfusion. The Powerlab system, ECG and rodent ventilator are shown. 
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Figure 37. Scanned pictures of the experimental system for cardiotonic studies 
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APPENDIX 4 
Representative ECGs from the analysis of chemically induced arrhythmia 
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Figure 39 .. ECG ofCaCh on the background of Buddleja salvii/alia 
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Figure 40. ECG of CaCh on the background of Eugenia jambalana 
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Figure 41. ECG of BaCh on the background of Tetradenia riparia 
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APPENDIX 5 
Spectral data of the isolated compounds 
Table 22: Chemical composition of the isolates and their plant source 
Spectral Isolate code Plant source Chemical composition 
number 
SH366 MHlO71B Syzygium cordatum Oleanolic acid (major) and 
betulinic acid (minor) 
SH367 MHlO9/C Clerodendreum trichotomum Betulinic acid 
SH372 MHlO7/C Syzygium cordatum Oleanolic and ursolic acids 
SH377 MHlO71D Syzygium cordatum Ursolic acid (major) 
SH398 MHlO8/C9 Eugenia jambolana Ursolic acid 
SH408 PMl151F Prunus africana Ursolic acid 
SH413 PMlO9/G Plantago major Oleanolic and ursolic acids 
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